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1 Introduction  
 
In 2000 an encephalopathic neonate who had been exposed to an episode 
(or episodes) of hypoxia/ischaemia (HIE) would probably have been imaged 
with a cranial ultrasound and may have received an MRI in selected teaching 
hospitals. MRI would probably not have been used in neonatal  units without 
teaching hospital paediatric MR units.  
 
The cranial ultrasound would have allowed assessment for hydrocephalus, 
germinal matrix and intraventricular haemorrhages, parenchymal cysts, mass 
lesions and gross congenital brain malformations.  
 
MRI for neonates was in its infancy with early case reports and cas e series of 
patterns of injury and things to look for on imaging both in HIE and in 
clinical mimics such as hypoglycaemia. Imaging protocols were starting to be 
tailored to neonates and new technology and imaging sequences (such as MR 
spectroscopy and dif fusion weighted imaging) were being applied to imaging 
of the neonatal brain.  
 
The clinical impact of HIE on subsequent developmental impairment and the 
anatomical substrate of cerebral palsy due to HIE was starting to be 
acknowledged and correlated.  
 
Neonatal care of the neonate with HIE was evolving and improving, 
particularly in terms of ventilation and prevention of hypocarbia due to 




In 2020 any neonate who requires unexpected neonatal care, let alone an 
encephalopathic neonate, will  be  investigated with cranial ultrasound and 
MRI of the head. The cranial ultrasound will  often be repeated regularly 
through the duration of their care on the neonatal unit. The MRI will  often 
be performed at the local hospital and will  involve the use of se quences 
such as DWI, susceptibil ity weighted imaging, diffusion tensor imaging and 
MR spectroscopy. The MR scanner may be on or near the neonatal unit and 
specif ic incubators may be used to transport the neonate to and from the 
scanner.  
 
MRI after myelination is complete (beyond two years of age) will  provide 
exquisite anatomical  information if  the child goes on to develop cerebral 
palsy. The report of the MR scan will  often include reference to clinical and 
radiological mimics of HIE, reference to specif i c anatomical substrates for 
subsequent neuro-disabil ity and information regarding prognosis. Some of 
the information included in the report will  reference new knowledge 
avai lable to the reporting radiologists regarding in utero injury to the fetus.  
 
Providing an accurate estimation of the t iming of the insult (or insults) is of 
increasing importance to the reporting radiologist and their hospital and 
earlier imaging (within the f irst days of l i fe) with DWI to aid the reporter 
with the issue of t iming and t o exclude post-natal causes of brain injury and 
encephalopathy such as metabolic disorders, infection and/or cardio -
respiratory dysfunction is required. It  is now known that some pathologies 
thought only to affect term neonates may affect the preterm brain  and also 
that pathology previously considered to only affect the preterm brain may 
affect the term neonate. The use of early MRI should now include 
statements from the radiologist regarding l ikely prognosis for the term 




There has been a huge expansion in the interventions available to the 
treating neonatal team and the impact on outcome from interventions such 
as therapeutic hypothermia has seen a dramatic improvement in 
neurological outcome for the term infant with HIE. The intervention s have 
also raised doubts about the applicabil ity of previously held dogma 
regarding the duration and nature of HIE at term.  
 
In the near future clearer guidelines should allow the reporting radiologist 
to better define the nature and timing of  the insult causing HIE, to exclude 
mimics and to provide better prognostic information to the clinical teams, to 
focus interventions and reduce subsequent neuro -cognitive disabil ity.  
 
This commentary wil l  review the l iterature in brain MR imaging of the term 
neonate with HIE over the last 20 years with specif ic reference to my 
published papers which have contributed to advances in the f ield and which 
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3 Commentary on thesis 
 
3.1 The term and preterm brain 
Babies are most commonly born  around 40 gestational weeks (gw) after 
conception and those delivered between 37 and 41 gw, are considered to be 
‘term’ babies. Babies may be born after term (beyond 41 gw). Normally 
delivery is achieved by 42 gw and these babies born between 41 and 42 gw  
are thus considered to be ‘post mature’. If  pregnancy proceeds towards 42 
gw then delivery is normally expedited or induced (with prostaglandin 
suppositories and / or oxytocin infusion) as beyond this gestation maternal 
and fetal outcome deteriorates as t he placenta starts to involute.  
 
Babies born before 37 gw are considered premature. Advances in neonatal 
care has improved survival massively, so that for example 50% of babies 
born at 24gw survive, although there is a high risk of poor long-term 
neurological outcome for this group.  
 
A term neonate with a brain injury, from whatever cause, may develop 
encephalopathy, which can manifest in a variety of ways including focal 
seizures, l ip smacking, general irr itabil ity and j itteriness or 
unresponsiveness. The more preterm a neonate is the more diff icult the 
clinical assessment for encephalopathy becomes. Ski l led clinical assessment 
to detect and characterise the seizures can be augmented by monitoring of 
brain electrical activity with either cerebral function monitoring (CFAM) or 




3.2 Hypoxic ischaemic encephalopathy 
Definitions 
In cases of neonatal hypoxic ischaemic encephalopathy the fetus and /or 
neonate is starved of energy supply to the brain due to a combination of 
reduced oxygen in the blood and impaired cardiac function. The fetus / 
neonate demonstrates symptoms and signs of encephalopathy, which may or 
may not be associated with subsequent early developmental  impairment 
manifest as motor impairment (cerebral  palsy) and /or  cognitive 
dysfunction.  
 
Asphyxia means that there is a reduced level of oxygen being supplied to the 
fetal brain.  
 
Encephalopathy  is a coverall  term for a state of brain dysfunction which in 
adults and older children can have a wide range of presentat ions, ranging 
from coma to seizures or cognitive dysfunction.  
 
Neonates  are children up to the age of 28 days fol lowing delivery.  
 
Term neonates  are children born near to full  gestation of 40 weeks after 
conception. Paediatr icians have traditionally considered a term neonate to 
have been born after 37 gw, reflecting physiological maturity (for instance 
lung function due to surfactant pr oduction). Confusingly radiologists have 
traditionally considered a term neonate to be one born after 36 gw. This is 
because the blood supply to the brain changes between 34 and 36 gw and 
this alteration in brain arterial blood supply affects the at -risk regions of the 




Preterm neonates  are therefore defined as being born before 37 gw by 
paediatricians. Alternatively, they a re defined as having been born before 34 
gw by radiologists. Radiologists consider neonates born be tween 34 and 36 
gw to have variable blood supply to the brain. Preterm and term neonates 
can be exposed to similar hypoxic / hypoperfusion insults and experience 
different patterns of damage with different clinical presentations.  
 
Early developmental  impairment  (EDI),  previously cal led global 
developmental delay, is characterised by a child’s development fall ing below 
2 standard deviat ions from the population mean in two or more domains 
(Hughes et al) .  EDI can be isolated, i .e .,  not associated with other f in dings 
l ike macrocephaly, dysmorphia, or associated with additional cl inical 
features. EDI affects 1 -3% of children and has many aetiologies, including 
genetic, metabolic, endocrine and structural brain abnormalit ies.  
 
The  Gross Motor Function Classificatio n System (GMFCS)  refers to a f ive-
point range ( levels I  -  V) of severity of motor impairment in CP with levels IV 
and V being the most severely affected persons (Pal isano et al) .  
GMFCS 
Hand function -  normal, l itt le useful function, no function  
Speech and swallowing –  mild dysarthria,  l imited speech, no swallow  
Cognitive function –  normal/mild, definite learning diff iculties, severe  
Mobility, Standing and sitt ing / stabil ity –  mild impairment, can sit,  unable 




Societal importance with relevance to the NHS; medicolegal overview and importance of 
timing for the ENS 
 
The neuro-radiologist may use imaging in the form of ultrasound, computed 
tomography or magnetic resonance imaging to assess the fetal / neonatal 
brain. My work since commencing as a paediatric neuro-radiologist in 
Sheffield in 2002 has focussed on trying to improve the qual ity of 
information which the radiologist is able to produce in a radiology report in 
such cases to assist the decision making for the clinical teams invo lved in 
care of the fetus / neonate and to assist the families to understand what has 
happened to their child.   
 
Many of the most expensive settlements for clinical negligence cases against 
the NHS over recent years have involved birth injury, with settlem ents 
regularly in the range of £5-10 mill ion, with some cases now settling for 
over £30 mill ion. This represents a huge f inancial burden to the NHS with 
clinical negligence settlement fees now accounting for 10% of the overall  
NHS budget and therefore has a massive societal importance for the United 
Kingdom. Neonatal brain imaging is a cornerstone of the early assessment of 
these cases as a predictor of outcome.  Neonatal brain imaging is used to 
assess both the nature of the insult/s, the extent of the insult/s and the 
timing of the insults.  In 2000 for most cerebral palsy cases the imaging 
would be performed late, by which I mean several days or weeks after the 
child was born or even many years later when trying to establish the l ikely 
cause/s of the cerebral palsy. In 2020 we now try to image earlier to provide 
more cl inical information to the clinical teams and family and to provide 
more information on the timing and nature of the insults .  
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Research questions addressed in the thesis 
How can the radiological  reporting of perinatal  brain injury on MR imaging 
be improved? 
a.     To make improvements that address some of the barriers to 
radiological  interpretation of MR brain imaging 
                      I .         Image acquisit ion  
                                          i .     Using a dedicated neonatal  3T MR scanner 
designed to be located on or close to the neonatal  unit  so that t imely 
high quality MR imaging became more accessible.  
                                         i i .     Improve accessibil ity of MR scanning for 
potentially unwell  neonates by using a dedicated MR compatible 
incubator designed to settle the neonate leading to reduced 
movement and easier completion of imaging.  
                     I I .         Identifying the new features of hypoxic ischaemic 
brain injury on MR imaging to demonstrate the anatomical  markers of 
the phenotypic expression of the brain injury more ful ly to the 
neonate exposed tp hypoxia.  
                    I I I .         Identifying and differentiating mimics of hypoxic 
ischaemic brain injury on MR imaging to understand more ful ly what is 
attributable to HIE and what has been caused by other condit ions 
which may complicate or mimic the condition clinically.  
b.    To improve understanding of the phenotypic expression of brain 
imaging changes identif ied in term HIE and to improve the 
prognostication required to guide clinical  care decisions and 
medicolegal  issues.  
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c.   To reduce the requirement for, and extent of,  investigation of 
children with early developmental  impairment.  
 
3.3 Acute profound hypoxia 
 
The commonest causs of neonatal encephalopathy in the term infant are 
perinatal hypoxia. Perintal hypoxia in a term infant is commonly divided into 
either acute profound hypoxia (APH) or chronic partial asphyxia (CPH). In 
reality there can be a mixture of the two mechanisms in play before during 
and after delivery.  
 
After discussing APH and CPH I wil l  describe how imaging has been 
optimised to improve the quality of information available to the reporting 
radiologist and then the clinical team. I wil l  then describe both the clinical 
and the radiological mimics of HIE in the term infant, affecting the preterm 
brain, in utero, at delivery and after del ive ry before describing the mimics of 
HIE occurring at and after delivery in the term brain. The impact of HIE on 
subsequent early development wil then be described. I  wi l l  h ighlight the 
areas where research which I have led in Sheffield has had an impact on 




In most cases of neonatal HIE the fetal and/or neonatal heart  rate slows 
below the normal range of 110-160 bpm, to a rate often less than 60 bpm 
because of  a catastrophic event such as acute cord compression , shoulder 
dystocia or uterine rupture. The fetal bradycardia may be demonstrated with 
auscultat ion, on a cardiotocograph (CTG a measure of the fetal heart  rate, 
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which because it  is non-invasive and as it  is now universally available for 
hospital deliveries is  often the biomarke r of the severity of fetal hypoxia 
prior to delivery), fetal scalp electrode or with trans -abdominal ultrasound.  
 
During labour it  has long been establ ished that fetal blood sampling is the 
best way to establ ish if  there is fetal acidosis (Beard et al).  Ho wever, this is 
invasive and not without risk. Transabdominal measurement of the fetal 
heart rate in relat ion to uterine contract ions (cardiotocography) can provide 
an indirect measure of fetal acidosis (Spencer). Fetal acidosis is rare if  there 
is good beat to beat variabil ity (5 -10 bpm) and no slowing with contractions. 
Fetal heart rate decelerations accompanied by fetal tachycardia and/or loss 
of beat-to-beat variabil ity are early markers of fetal  acidosis and late deep 
and/or delayed decelerations are frequently a marker of severe fetal 
acidosis.  
 
Observations in primates have demonstrated that the fetus is able to 
withstand up to ten minutes of acute / profound hypoxic (APH) ischaemia 
without sustaining neurological injury and that if  the insult extends beyond 
this duration, injury affecting the areas of the brain with the highest 
metabolic rates (energy demands) the deep grey nuclei ensue (Myers) . The 
totally asphyxiated baby monkeys (rather tha n near totally asphyxiated 
babies) suggest that irreversible brain damage may start to occur from about 
10 minutes after the start of bradycardia in a human fetus. The more severe 
the bradycardia (and thus the hypoxic ischaemic insult) then the more l ikely  





Clinical discussion with reference to impact on outcome 
 
Once brain damage commences from an acute profound asphyxia then the 
primate experiments suggest that over the following 15 -20 minutes the 
degree of brain damage progresses  in a now predictable way partly based on 
radiological assessment that the work in these thesis and other places has 
addressed. Beyond that t ime point then the baby monkey wil l  be very 
unlikely to survive (Myers). These timings have been e xtrapolated to human 
fetuses / babies and are most useful when the onset of a severe (less than 
60 bpm) bradycardia is clear from other data. In human fetuses and 
neonates the posterior putamen, anterolateral thalamus and peri -rolandic 
cortex are most vuln erable due to their high energy requirements compared 
to the rest of the brain at this stage of development in a beyond 36 gw 
fetus.  
 
One must acknowledge that the severity of bradycardias is more variable , as 
evidenced by periods of variably deterioratin g and improving fetal heart rate 
on CTG, in human cl inical practice and that the fetus may tolerate hypoxia 
better that the baby monkey. Fetal health prior to the HIE resulting in 
alterations in resi l ience and possible preceding chro nic partial hypoxia (CPH) 
is then important when estimating l ikely outcome. It  is therefore more 
accurate to suggest that the variabi l ity of  the onset of HIE and preceding 
fetal status alters the time prior to the onset of brain damaging acute 
profound asphyxia, but that once th is brain damage commences then the 
fetus/neonate will  only survive for a further 15 -20 minutes of  acute 
profound hypoxia. The duration of the bradycardia ends when the 




Westgate et al demonstrated that both ar terial and venous samples from the 
cord should be obtained and assessed to estimate the nature of an acidosis.  
This is now routine clinical practice in the UK for encephalopathic neonates 
born in hospital .  The venous gas is commonly the more easily obtaine d of 
the two samples. In APH the arterial sample is often more depressed that 
the venous sample (say pH 6.9 arterial versus pH 7.1 venous) whilst in CPH 
the two samples often demonstrate more closely aligned pH values. 
Interpretation of the results require s the examination of pCO 2  and the base 
deficit  of the extracellular f lu id from each vessel as well  as the pH to 
determine the contribution of metabolic and respiratory components to the 
acidosis (Westgate et al 1994).  
 
Ross and Gala attempted to rationali se an approach to interpreting cord 
arterial blood gas results in then predicting the length of the brain damaging 
period of CPH (Ross and Gala). They suggested that when the metabolic 
acidosis became worse than 12mmol/l ,  then there was l ikely to be eviden ce 
of brain damage in human and animal studies. They also reported a 
reduction of buffer base during the f irst stage and second stage of labour 
and during both normal delivery and in periods of fetal distress. Their report 
concluded that during a period of  subacute fetal compromise the base 
excess, a measure of  blood buffering capacity, may reduce by 1mmol/l per 6 -
15 minutes. For instance, if  a child is born with a cord arterial base excess of 
minus 24 mmol/m then the period of brain damaging metabolic acid osis 
probably started between 2 and 4 hours prior to the taking of the blood gas 
(presumed to be the time of delivery) being obtained. We have commenced 
a retrospective review attempting to use brain MR spectroscopy 
measurement of lactate as a surrogate ma rker of base excess in neonates 




The lactate elevation following HIE is l ikely to persist in brain tissue for 
longer than the 4 hours that Shah et al discovered when reviewing base 
deficit  recovery in 244 neonates (Shah et al) .  They discovered that in all  
cases except nine the base deficit  normalised within 4 hours of delivery 
regardless of whether the child had suffered from APH or CPH. The base 
deficit  recovered at 0.11 mmol l - 1  min - 1  over the f irst 4 hours after delivery 
whether the infant had suffered an APH or CPH episode. The rate of recovery 
was similar in infants with relatively good and with poor outcome.  
 
Frasch et al altered the rate of umbilical cord occlusions in near -term ovine 
fetuses from 1 minute every 5, to 1 every 3 to 1 every 2 over a one -hour 
period or until  fetal arterial pH decreased to less than 7.00 (Frasch et al).  
They found that each minute of cord occlusion led to base deficit  and serum 
lactate increases of 0.56 and 0.35 mmol/l per minute respectively. During a 
two-hour recovery, base deficit  and lactate normalised at rates of 0.09 and 
0.04 mmol/l per minute. The base deficit  and lactate correlated closely.  
 
A child’s impairments after HIE may result from a com bination of insults and 
not just an acute profound HIE, for instance if  there was also neonatal 
hypoglycaemia, kernicterus or CPH. 
 
Kayani et al (Kayani)  reported on 33 babies exposed to placental abruption –  
a common cause of an APH insult to the brain –  with varying periods of 
terminal bradycardia (90 bpm or less). Outcome was divided into good or 
poor. No neonatal data was presented. Outcome was assessed as good 
(22/33) at one year or older when there was no evidence of a developmental 
problem. The good outcome cases had a bradycardia lasting from 6 -65 
minutes. 25% good outcome cases had a bradycardia lasting longer than 33 
minutes. Therefore, one needs at least 10 minutes, and possibly much longer 
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before a child will  suffer from cerebral palsy.  Poor outcome (11/33) was 
death or survival with cerebral palsy.  Cognitive outcome was not assessed.  
The outcome measures were very l imited when compared to the GMFCS 
outcome measures.  
 
Naeye and Shaffer  retrospectively reviewed the clinical,  laboratory, brain 
imaging and placental f indings in 608 pregnancies that had produced term 
neonates with cerebral palsy of possible antenatal hypoxic ischemic 
aetiology (Naeye and Shaffer). This was a poorly designed study with no 
prospective data collection. Exclusion cr iteria  (e.g.,  congenital  brain 
malformation or genetic disorder) resulted in just 92 cases being included. 
The study had numerous f laws but suggested that cerebral palsy rarely 





Early radiology covers the imaging appearances over the f irst three months 
after delivery and can be further subdivided for individual pathologies and 
imaging modalit ies. Early CrUS wil l  demonstrate cerebral swelling for up to  a 
week after the insult  with increased echogenicity in the basal gangl ia and 
thalami. CT is rarely performed due to radiation dose to the newborn brain, 
but it  can produce very useful information if  it  must be used. CT is often 
used if  there is no MRI avai labil ity, if  th ere is birth trauma or if  the neonate 
is admitted via the emergency department. CT would demonstrate lower 
than normal attenuation in the putamen and thalamus for up to a week. MRI 
will  show acute low T1, high T2 signal and restricted diffusion in the 
lentiform nuclei and ventral posterolateral thalami with obscuration and 
loss of the posterior l imb of internal capsule (PLIC) with l ies between the 
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damaged structures.  There may also be high T2 signal in the globus pall idus, 
hippocampi and head of caudate nuc leus. The perirolandic cortex may 
demonstrate subcort ical high T2 signal,  and loss of cortical grey -white 
differentiation acutely and then cortical highlighting extending caudal ly to 
the posterior insular cortex from about day 7 -10. After about seven days 
there will  start to appear in the mildly damaged posterior putamen and 
ventral postero-lateral thalamus high T1 and slightly later (by a few days) 
low T2 signal which may last for 2 -3 months. If  damage is more severe a 
larger part of the antero-lateral thalamus will  be damaged and more of the 
putamen extending anteriorly.  
 
Late / follow up radiology 
 
CT may demonstrate focal low attenuation and volume loss in  the posterior 
putamen, perirolandic cortex and antero -lateral thalamus but only if  there 
has been a severe injury. If  there is only a mild APH then CT will  most l ikely 
be normal. On MRI there will  be high T2 signal and possibly low T1 signal 
from about 3 months onwards. There may be free diffusion in areas of cystic 
change which may affect the most severely damaged regions.  The more 
severe the injury then the more structures that will  be damaged i ncluding 
the hippocampi, head of caudate nucleus, globus pall idus, subthalamic 
nucleus and anterior lobule of the cerebellar vermis. In infants with very 
severe injury last ing over 25 minutes then all  areas of the brain may be 






Anatomical substrate for disability with reference to the vermis and subthalamic nucleus 
 
APH will  damage the most metabolically active regions of the brain which 
are those which are myelinated and most functional. The normal t iming of 
myelination includes the ventral postero- lateral thalamic nuclei and pall ido -
thalamic f ibres at 25gw, the lent iform nuclei and pre and post central gyri at 
35gw, the optic radiations at 37gw and the PLIC at 40gw (Martin and 
Barkovich).  
 
The PLIC has long been a focus for report ing radiologists in acute profound 
asphyxia and absence of the normal high T1 signal of the PLIC at term is 
considered to be a marker for poor outcome (Martin and Barkovich). 
However, this cannot be an anatomical marker of primary injury,  or all  
children injured by APH would have a spastic quadriplegia as the 
corticospinal tracts would be dam aged. Rather I  consider this to represent 
increased T1 signal in the adjacent thalami / putamen and low T1 signal in 
the PLIC due to oedema. Also, on T2 imaging the PLIC is normally low signal 
and the loss of the normal low T2 signal is probably more l ikel y a 
representation of high T2 signal and oedema centred on the ventral 
posterolateral thalamus and the posterior putamen. Similarly , diffuse white 
matter high T2 signal (DEHSI) was a marker of APH but is more l ikely just 
normal white matter incomplete myel ination. Despite this whit ematte rhigh 
T2 signal  but was found to have use in prediction of outcome  (Hart, Smith et 
al) .  Diffusion tensor imaging with artif icial intell igence interpolation of data 
to estimate white matter tract volumes is starting to be e mployed by some 




The pattern of brain injury seen on MRI is  not l imited to the regions of the 
brain described above by Myers. The medial temporal lobes and head of 
caudate nucleus have also been demonstrated to be affected by APH 
injuries. Damage to the posterior putamen and the ventral postero-lateral 
thalamus should not produce a dyskinetic cerebral palsy as can easily be 
appreciated when reviewing the numerous adult brain imaging acq uisit ions 
which demonstrate vascular injury to the head of caudate nucleus, putamen, 
and thalamus. We discussed this anatomical conundrum with Alan Crossman 
(Professor of neuroanatomy, University of Manchester) an internationally 
recognised expert on basal  ganglia funct ion, who suggested other 
anatomical targets for injury from APH which could better explain the 
clinical effect of APH. We then tailored our imaging protocol to better 
appreciate these regions by producing coronal high resolution and high grey -
white matter differentiation images to show focal injury to the subthalamic 
nucleus (Radon). This area of injury had not previously been described in the 
APH literature. Injury from APH to this nucleus far better explains the 
subsequent development of a d yskinetic movement disorder as injury to the 
putamen and antero-lateral thalamus do not frequently cause a movement 
disorder.  
 
Sargent et al .  demonstrated that the anterior lobule of the cerebellar vermis 
was another area of the brain which could be damage d following an episode 
of APH. We published one paper demonstrating that damage to the anterior 
lobule tended to be associated with more severe APH (Connolly). We have 
recently demonstrated that APH can produce isolated brain injury to the 
cerebel lar vermis and clinical ly this can produce an ataxic cerebral palsy 
rather than the usual dyskinetic or spastic cerebral palsy associated with 
APH (Joshi). This pattern of radiological and clinical isolated injury to the 
vermis from APH had not previously been repo rted and indeed some experts 




Imaging and prediction of outcome 
 
There have been many attempts over the years to predict cl in ical outcome 
from the early and late MRI appearances.  Weeke et al have produced a 
recent version but it  requires the use of MR spectroscopy DWI and includes 
reference to many areas of the brain. It  also requires evaluation of many 
image sequences including DWI, T1w and T2w imaging (Weeke et al) .  The 
scoring system has been shown to be reliable with high inter -rater scoring 
and to predict outcome well (Machie). However, I  am not convinced about 
its capacity for widespread implementation given the complexity of the 
scoring system. As I wil l  discuss later an easier to implement s coring system 
based on a l imited number of anatomical  locations and requir ing 
abnormality in any one of the image sequences would be far more l ikely to 









Perinatal asphyxia refers to the condition characterised by hypoxaemia, 
hypercapnia and insufficient blood perfusion of the fetal and newborn brain. 
The incidence is rated at between 2 and 9 % in term neonates and is higher 
in premature infants. Cl inically  the fetal heart rate will  be decreased, there 
may be meconium-stained amniotic f luid,  low Apgar scores, low scalp and 
cord pH or cl inical s igns of neurological depression. Al l  of these are poor 
predictors of neurodevelopmental outcome. Chronic partial asp hyxia is often 
diff icult to accurately t ime in terms of when it  happened and how long the 
asphyxia went on for. CPH is commonly considered to be due to intermittent 
cord events with spasm or intermittent occlusion.  
 
Clinical discussion with reference to impact on outcome 
 
Neurons are especial ly vulnerable to hypoxia and glucose def iciency both 
separately and in combination. Cell  injury is either due to the direct effect 
of hypoxia or can develop during recovery when excitatory aminoacids such 
as glutamate, free radicals and  calcium ions have a destructive role.  
 
Chronic partial hypoxia (CPH) induces the ‘diving reflex’ in the fetal brain. 
This means that the most important and most metabolically active areas of 
the brain are priorit ised for oxygenation and blood supply, wit h 
redistribution of the fetal blood supply. The areas of the fetal brain which 
are protected include the cortex around the central sulcus, the brainstem, 
the occipital cortex, the basal ganglia and the thalami. This means that the 
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vascular watershed territory of the mature or term brain, the region of the 
brain both deep in the white matter and extending up to the cortex between 
the middle cerebral artery and the anterior/posterior cerebral arteries, is at 
risk.  
 
Injury to this region therefore affects the white matter of the frontal lobes 
and parieto-occipital  lobes, together with the cortex. Clinical ly it  produces 
reduced intellect, spastic quadriplegia, seizures and possibly visual 
impairment. The chi ldren most severely affected cannot care for themselves  
and often have severe microcephaly.  
 
Ikeda et al produced a CPH in 17 near term fetal lambs who then survived 72 
hours after birth ( Ikeda et al) .  The most common mechanism for inducing 
CPH in vivo is a partial or intermittent complete cord occlusion which  
produces a slowly escalat ing fetal hypoxia unlike the rapid onset fetal 
hypoxia of APH. Asphyxia in the Ikeda et  al work was produced by umbilical 
cord occlusion lasting for approximately 60 minutes until  fetal pH was < 6.9 
and the base excess was > -20 mEq/l. Neuropathology changes varied hugely 
from case to case and ranged from extremely subtle and patchy white 
matter vacuolation to increased cellularity at the cerebral cortical grey / 
white matter junction up to extensive necrosis of grey and white matt er. 
Even the fetuses that showed full  recovery on EEG and all  physiological 
parameters demonstrated subtle but dist inct white matter lesions. 
Unfortunately, in the Ikeda study there was no neuro -imaging correlation 
with the histology, but this work does su pport the premise that CPH can 
auto-recover in utero, but that there is l ikely to be some neurological injury 
to white matter, due to the sensitivity of oligodendroglia, even if  the 






MR scans in the f irst few days demonstrate restricted diffusion in the deep 
and/or cortical watershed zones with high T2 signal and loss of cortical grey -
white matter differentiation also termed discontinuous cortex. T1 signal may 
be low. 
 
After four or f ive days high T1 signal in the cortex with underlying low T1 
signal may start to develop but normally occurs after 10 days.  This persists 
for a variable period but is normally present for at least 4 weeks and 
possibly up to 10 weeks (Martin and Barkovich). This cortical highlighting is 
the same radiologically as the described cortical laminar necrosis in adult 
strokes. Low T2 signal slowly develops during the f irst 4 weeks and persists 
up to 3 months. This low T2 and high T1 signal is potentially due to 
microhaemorrhage with secondary dystrophic calcif ication.  
 
DWI may demonstrate acute restr icted diffusion (high b700 and low ADC) in 
the deep white matter or cortex where there is cortical high T2 signal. After 
5 to 7 days the areas of primary injury will  pseudo -normalise on DWI, with 
high b700 and normal ADC. However, areas of secondary atrophy such as the 
corpus callosum, sensory nuclei of the thalamus and spino -thalamic tracts 
may start to demonstrate high T2 signal and restricted diffusion, depending 
on the areas of white matter and cortex which suffered the primary injury.  
 
Late / follow up radiology 
 
In the long term damaged white matter regions are diff icult  to demonstrate 
on T2 weighted images before myelination is complete. As white matter 
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matures areas of high T2 signal become more evident and are most obvious 
in the subcortical white matter at the  deep bases of cortical sulci .  There is 
also potential ly some volume loss in these regions producing mushroom 
shaped gyri;  with wide outer cortex and a narrow base to the gyrus with 
widening of the deep sulci giving an appearance known as ulegyria. There 
may be thinning of the corpus callosum, microcephaly and widening of the 
ventricles (Stivaros) .  The thalami may have sl ightly high T2 signal and 
volume loss.  
 
Imaging and prediction of outcome 
 
This is a relatively under reported and investigated subject, e specially given 
the huge interest in evaluating MRI for APH, but it  is r ipe for future research 
as I  wil l  discuss later.  
 
3.5 White matter injury to the term brain 
 
Li et al and subsequently Hayman et al have demonstrated that focal non -
cystic white matter injury can be demonstrated in populations of term 
neonates (Li  et al,  Hayman et al) .  Li  looked at 48 term neonates with HIE 
studied with MRI at 72 hours and found that 11 had white matter lesions 
(high T1 and low T2 signal,  with 10/11 associated wit h restricted diffusion). 
The restricted diffusion implied  (when extrapolating adult stroke DWI data) 
that the injury occurred in the week before the imaging rather than being a 
late manifestat ion of injury occurring prior to 34 gw. Li et al also 
demonstrated that the presence of white matter lesions was associated with 
reduced gestational age but not with lower birth weight. The white matter 
injuries were also demonstrated in neonates with milder encephalopathy 
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and fewer seizures. This suggests that an earlier stage of brain maturation 
rather than IUGR is a greater risk factor for white matter injury at term. 
Therefore, it  would follow that those comorbidities that impede brain 
maturation would also be risk factors for white matter injury from HIE in the 
term brain. 2/11 also has strokes and 1/11 had basal ganglia injury.  
 
Hayman et al in their later work demonstrated, in 42 near term neonates 
with punctate white matter lesions, that lesion load does not correlate with 
outcome (Hayman et  al) .  The study exclud ed children with perinatal arterial 
ischaemic stroke (PAIS), congenital heart disease or who had neonatal 
surgery. The 42 cases were poorly selected and included neonates with 
various conditions including tuberous sclerosis and venous sinus thrombosis. 
19/42 had HIE, 11/42 had a pathological genetic diagnosis, 10/42 had 
seizures and 1/42 had parechovirus infection. The 42 cases were selected 
from 2 tertiary centres over a more than ten -year period during which both 
centres imaged all  children with HIE, al l  neonates with seizures, or other 
neurological symptoms, and al l  neonates with suspected white matter 
lesions on ultrasound. In Sheffield most neonates imaged with MRI have HIE 
and therefore it  is not surprising that 45% of children with PWMI have HIE. 
There is no mention of a control group.  
 
Hayman et al showed that the children with less than three lesions were all  
neurological ly and developmental ly normal at follow -up and that lesion load 
alone does not appear to be a good predictor of outcome. The worst 
outcome group also had a genetic disorder and over-all  the study concluded 
that underlying cause was more important to outcome than lesion load.  
5/42 had irreversible white matter lesions on follow -up MRI performed due 
to clinical concern at  18-24 months.  DWI abnormality in the PLIC seen in 
8/42 was not associated with a higher rate of motor impairment, suggesting 
that the restricted diffusion in the PLIC alone is a poor predictor of motor 
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outcome. It  does not appear from this paper that white matter abnor mality 
on ultrasound was a major predictor of PWMI.  
 
Merhar et al demonstrated with MR that punctate white matter lesions were 
found in 8/20 term neonates with prenatal opioid exposure, but no punctate 
white matter lesions were found in 20 controls (Merhar  et al) .  All  children 
were imaged at week 4-8 post-delivery.  Merhar et al also found 2/20 in the 
prenatal opioid group had septo -preoptic fusion anomaly. Therefore, a 
comprehensive prenatal and perinatal history with good neuro -







3.6 Optimising imaging of the neonate 
 
Imaging modalities used in the neonate 
 
There are three commonly avai lable radiological technologies by which a 
radiologist may assist in the assessment of the neonatal brain. The three 
imaging modalit ies are cranial ultrasound (CrUS), computed tomography (CT) 
and magnetic resonance imaging (MRI).  
 
Cranial ultrasound  (CrUS) is the most used brain imaging technique in 
neonates as it  is readily avai lable at the neonatal cot  s ide and does not 
util ise radiation. CrUS can therefore be used repeatedly to mark the 
evolution of appearances and at short notice if  there is cl inical 
deterioration. There are no confirmed side effects to using this imaging 
technique. Ultrasound is used for demonstrating focal brain pathology such 
as haemorrhage or cysts within the brain substance. CrUS can also clearly 
demonstrate ventricular dilatation either due to enlargement of the 
ventricles fol lowing accumulation of CSF within the brain (hydroceph alus) or 
loss of brain volume (brain atrophy). The weaknesses of the technique are 
the complete dependence of the image acquisit ion and interpretation on the 
skil l  and experience of the operator acquiring the images and the diff iculty 
of demonstrating subt le brain parenchymal pathologies and symmetrical 
abnormalit ies.   
 
CrUS is a useful adjunct to MRI in helping to time the insult to the brain. 
There should be a t imeline of evolving CrUS appearances that can be 




The brain will  demonstrate early brain swelling with effacement of the sulci 
and ventricles. There may be increased echogenicity of the brain either in 
the basal ganglia and thalami if  there has been an acute profound asphyxia, 
or in the white matter of both cerebral hemispheres if  there has been 
chronic partial asphyxia. The brain swelling will  tend to start to regress 
about f ive days after the insult and there may go on to be some later brain 
volume loss. The regions of increased echogenicity may underg o cystic 
degeneration. Cysts tend not to appear after a hypoxic insult to the brain for 
at least ten days.  
 
Computed Tomography  (CT) is not frequently used in neonates due to its 
high radiation dose and its l imitations in demonstrating parenchymal 
pathology. CT is an X-ray derived imaging modality. As with ultrasound, CT is 
very good at demonstrating acute haemorrhage, large focal brain 
parenchymal lesions and enlargement of the ventricular system of the brain. 
CT is also extremely useful when investigatin g for possible bone injury or 
congenital anomalies (Ref Mohan et al) .  
 
CT is actual ly very sensitive to perinatal brain asphyxia particularly between 
days two and four after the insult (Mohan et al).  The CT wil l  demonstrate 
acute low attenuation in either the basal gangl ia and thalami with acute 
profound asphyxia or in the cortical mature vascular watershed territories in 
chronic partial asphyxia. After a week the areas of low attenuation may 
become high density due to cortical laminar necrosis and luxury p erfusion. 
In the long term these regions of injury will  demonstrate low attenuation 




Magnetic Resonance Imaging  (MRI) is the most modern imaging modality  of 
the three and is  commonly used for the investigation of complex neonatal 
brain pathology.  
MRI is a complex technology which has evolved signif icantly over the last 25 
years and involves a strong magnetic f ield (commonly 1.5 or 3 Tesla), energy 
applicat ion to the neonatal brain with radiofrequency (RF) waves and then 
the detection of very low energy emitted RF energy from the neonatal brain. 
The detection of the emitted RF energy allows local isation of the pathology 
and characterisation of the pathology. The neonatal brain is placed in a 
high-quality RF detector coil  to enhance detection of the emitted energy , to 
optimise both spatial resolution and signal to noise rat io. Coi l  technology 
development has had a huge impact on improved MR imaging of the 
neonatal brain.  
 
MRI has several advantages over both CT and CrUS as it  can demonstrate 
subtle and symmetrical brain pathologies which may have previously not 
been appreciated until  the child’s brain had matured or myelinated 
completely (beyond at least two years of  age). The chi ld may also have had a 
neurological and cognitive developmental outcome which was diff icult  to 
predict or assess in the f irst few years of l ife. The clear superiority of MRI of 
the neonatal brain is  mitigated by the dif f iculties experienced when 
monitoring for the safety of the neonate in the MRI scanner and the 
challenge of bringing the neonate to the scanner unit (which may require 
ambulance transport  to attend the MRI scanner if  they are not co -located) 






Development of new hardware and technology to support neonatal brain MRI 
 
A signif icant amount of work over the past years in Sheffield and elsewhere 
has focussed on the development of MRI scanners which can be housed in a 
neonatal unit environment. Init ial work focussed on an in -house 
construction with a low field strength (0.2T) system (Whitby et al 2004). This 
scanner had the advantage of being housed in a side room on NICU itself .  
There was no development of monitoring equipment but r ather a parent or 
other carer would hold the neonate in the scanner. That ‘Niche’ scanner had 
the marked disadvantage of l imited sequences which could be used to image 
the neonatal brain. Imaging was almost entirely T1 spin echo with no FSE T2 
or DWI echo planar imaging possible. The lack of monitoring meant that the 
neonate had to be stable and thus unwell  and particularly premature infants 
could not be assessed before they were at least 40gw. A lot of  the early 
l iterature in neonatal imaging therefore inv olved delayed imaging at term 
equivalent or later and focussed on appearances on T1 images when the 
pathology was often ≥ 10 days matured (Rutherford, Pennock et al) .  This 
delayed imaging was often l imited by motion artefact and l imited image 
sequences (often simply spin echo T1 and sometimes fast spin echo T2) and 
would have no impact on early decision -making regarding care and prognosis 
of the neonate.  
 
More recent work focussed on the development of new rapid acquisit ion MR 
sequences for use in neonatal and fetal MR imaging with a higher f ield 
strength(3T) MRI scanner (Firefly) housed on a NICU which would allow 
complete sets of images including single shot (ss)T2, SWI, DWI, FSE T2, T1 
volume images, MR spectroscopy, MRA of  the Circle of Will is and MRV 
(Griff iths et al  2013 and Griff iths et al  2018). The Firefly scanner produced 
exquisite images equivalent to those which would be acquired on a main MR 
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unit scanner, but the scanner was housed just 5 yards from the Sheffield 
NICU in a small room footprint. T he small  scanner was developed from 
animal / peripheral l imb MR scanners and could allow a transport table 
holding the monitored neonate to transfer directly from the NICU cot -side 
into the scanner. The environment was well  received by NICU senior staff  
and parents. However, the costs of the scanner versus the number of 
potential patients to be scanned (even on a large NICU this averages 
approximately two patients per week in Sheffield –  one of the three largest 
NICU in the country) meant that the developin g manufacturer was unwill ing 
to continue to fund the next stage of development. However increased use 
and applications would have made a scanner most cost effective.  
 
When it  becoame apparent that there were severe l imitations to appplying 
the niche scanner to routine clinical work we started to explore ways to 
facil itate MR scanning of neonates in departmental cl inical canners. Our 
work in Sheffield then evolved to develop methods of transporting neonates 
from the NICU to the MR scanner table with the mini mum amount of 
disturbance of the neonate and whilst maintaining a safe ecosystem for the 
child (Whitby et al  2004). Despite the improved incubators and increased 
acceptance of the need for MR imaging of  neonates, safety concerns and 
staffing issues, such as the need for a senior neonatal nurse and a doctor 
having to accompany the neonate in the incubator to the imaging 
department imaging is not as frequently performed as it  could or should be. 
Finally, we have worked on a 3 Tesla MR scanner to be housed in the 
neonatal unit,  the Firefly project , which achieved departmental standard 3T 
neonatal imaging within a neonatal unit  (Griff iths et al  2018).   
 
There have been three different incubators developed which have the 
capacity to take the neonate from the cot -side on NICU after transfer to the 
incubator which can then be directly placed into the MR scanner. The 
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incubators have improved in the quality of images produced as the coi ls 
integral to the incubators have improved. The incubators have also improved 
the visibi l ity of the neonate for the accompanying advanced neonatal nurse 
practit ioner or neonatologist and the quality of data for monitoring their 
well-being. I  have been involved in reviewing image quality from the 
acquired MR scans and in the assessment o f the most useful imaging 
protocols.  
 
The improved neonate safety and improved image qual ity with greater range 
of MR sequences has allowed for greater clar ity in the reports issued and in 
better and earlier prognostic information to the clinical team and to the 
family.  The imaging interpretation of neonates with HIE has recently been 
made more complex due to the widespread use of therapeutic cooling. 
Cooling may or may not produce clinical effect in an individual neonate and 
the extent of the impact cannot  be predicted or estimated.  
 
Therapeutic cooling and the impact of new interventions for the term neonate with HIE 
 
The TOBY cool ing study demonstrated that therapeutic cooling (reducing 
core body temperature to below 32 oC) of the HIE neonate signif icantly  
reduced the level of damage manifested both clinically and radiological ly 
(Azzopardi et al) .  Quantif ication of this beneficial effect is not possible with 
the current knowledge base though cooling has been shown to be effective 
in reducing the r isk and th e severity of permanent neurological injury 
following neonatal hypoxic -ischaemic encephalopathy, but it  does not 




Therapeutic hypothermia (cooling) is offered as a neuroprotective measure 
to term/near term infants with symptoms of neonatal encephalopathy after 
perinatal hypoxia. Treatment needs to be commenced within six hours of 
delivery for maximum effect. The criteria for init iating cool ing in UK practice 
are derived from those used in the TOBY tr ial of therapeutic hypothermia 
(Azzopardi et al  2009). The target temperature for therapeutic cooling is 
33.5 (33-34 degrees centrigrade) as a study has shown no benefit  of cooling 
to 32 degrees or lower (Shankaran  et al).  There was also a suggestion of 
increased mortality with the combination of deeper and longer cool ing.  
 
The primary effect of cooling is reduction of delayed neuronal loss / 
apoptosis (also known as secondary neuronal injury following recovery and 
reperfusion –  (Drury et al) following an acute profound hypoxic ischaemic 
insult and early init iation of cooling following an acute insult is most l ikely 
to be of benefit. Secondary energy fai lure is not just Wallerian degeneration 
but is a combination of oxidative stress, excitotoxicity (free radicals, Fe2 + ,  
low antioxidants, high glutamate) and inflammation exacerbated by 
reperfusion and reoxygenation.  
 
Although the extent of the benefit  of cooling in an individual case cannot be 
determined it  is l ikely to have a mitigating effect (Drury et al) .  In my 
experience therapeutic cooling has a greater benefit  in terms of reducing 
physical disabil ity rather than cognitive disabil ity after HIE. In  individual 
cases it  is impossible to state the extent of be nefit,  if  any, that the baby 
received from the intervention, though some authors have tried to estimate 
the benefit  at 12.5% in an individual. This is based on the need to treat 8 for 
benefit  in one individual (Edwards et al).  Statistically this conclusion  (not 




The TOBY-Xe trial (Azzopardi et al 2016) used 24 hours of adjunctive 
treatment with inhaled xenon alongside the standard 72 hours of 
therapeutic cooling showed that the treatment was fea sible and deliverable. 
However, the study demonstrated no additional benefit,  based on MRS 
lactate to N-acetyl aspartate performed as single voxel over the thalamus 
and posterior l imb of internal capsule. The TOBY -Xe study also demonstrated 
similar mortali ty rates between the two groups and an increase in adverse 
events in the xenon with hypothermia arm of the trial.  
 
 
Interpreting brain MR imaging in acute profound asphyxia after the use of therapeutic 
cooling 
 
Within the spectrum of dyskinetic CP pat ients  with GMFCS 1 and 2 outcome 
subtle injury may not be detected with long term traditional structural brain 
MRI though the use of DTI may provide information in cl inical applications in 
the future (Salas et al) .  As cool ing improves outcome then subtle perman ent 
brain injury may no longer be recognised either at MR imaging either in the 
neonatal period or when re-imaged after 2 years of age.  
Yokochi et al reported 16 children with asphyxia related dyskinetic CP who 
underwent MR imaging. 2 children had no abno rmality on scan. Population 
studies of chi ldren with cerebral palsy (CP -  a permanent and non-
progressive disorder of movement and posture attributed to injury to or 
maldevelopment of the fetal or infant brain) have shown that there is 
commonly a 10-20% incidence of normal MRI reports amongst  children with 
cerebral palsy. It  has also been reported that there is a trend towards 
normality of MRI f indings amongst the more mildly affected cases (Reid SM 
et al) .  In relation to normal MRI f indings in CP Reid et a l  state “the reported 
proportions of normal imaging for children with dyskinetic CP were mixed, 
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with high rates reported from Quebec and Victoria but low rates from 
Sweden. There was a trend towards lower rates of normal imaging for 
GMFCS levels IV and V. Roll ins and col leagues reported that cooled neonates 
who experienced an encephalopathy following HIE, discharged with normal 
MR scans are sti l l  at risk of learning impairment (Roll ins et al) .  It  has even 
been described that although signif icant motor delay  is not probable that 
the risk of mild to moderate learning impairment may be as high as 50% 




3.7 Clinical and radiological mimics of HIE in the term neonate.  
 
When reporting imaging in an encephalopathic neonate or reporting t he 
follow up imaging years later the radiologist must understand the clinical 
mimics of APH/CPH, acutely and in the long term. The other insults may have 
occurred in utero, at  and around the time of delivery, or in the days weeks 
and years following.  
 
What are the other causes of encephalopathy in neonates? 
 
Most children who are exposed to a period of hypoxia and then go on to 
develop encephalopathy will  not go on to have cerebral palsy. The reporting 
radiologist must be aware of the other clinical causes of encephalopathy in a 
neonate. In utero acquired pathologies such as global hypoxia and stroke 
may produce encephalopathy whilst a chi ld with a genetic epi lepsy syndrome 
and a congenital brain malformation causing seizures may present as 
neonates. Kernicterus, neonatal hypoglycaemia, perinatal arterial ischaemic 
stroke, dural venous sinus thrombosis and birth trauma with intracerebral 
haemorrhage, contusion or other parenchymal injury may present with 
encephalopathy and other specif ic features which may he lp the clinician to 
suspect the diagnosis. Genetic and metabolic disorders, such as non -ketotic 
hyperglycinaemia and maple syrup urine disease may present with neonatal 
encephalopathy within hours of delivery. Meningo -encephal it is,  c lassically 
due to HSV type 2 or group B streptococcus, may present with in hours / days 
of delivery and whilst there may be clinical markers of these causes of 
encephalopathy the radiology often has signif icant overlap with HIE. I  wil l  
expand upon all  of these pathologies in the following sections of the thesis 
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to describe their cl in ical and radiological presentations together with their 
impact on long term development of the child.  
 
When do they occur and why? 
 
When reviewing these other causes of neonatal encephalopathy, I  wi l l  
describe their early and late radiological  appearances. I t  is important when 
reporting to understand the timing of the brain imaging appearances on 
MRI, the overlap of the pathology with HIE, and how to differentiate or not 
the impact on development. For instance, a chi ld with HIE who has a 
cardiorespiratory col lapse on day seven from group B Streptococcal 
meningitis may have brain injury due to any one of or a combination of; the 
complications of meningitis (such as arterial stroke, cortical vein thrombosis 
and cerebrit is secondary to empyema), peripheral perfus ion injury to the 
brain due to cardio-respiratory dysfunction or acute profound and/or 
chronic partial asphyxia .  
 
If  one images this child at four years and discovers a structural brain 
malformation and is informed of a genetic chromosomal microdeletion th en 
ascribing clin ical features to anyone of these pathologies may be very 
diff icult. Very clear description of the acquired pathology may assist as may 
good contemporaneous information about the delivery and neonatal status. 
An MRI performed before the day  seven collapse with DWI will  al low the 
reporter to suggest prenatal chronic partial injury with auto -recovery in 
utero (if  there is no restriction and some volume loss on day 5). 
Alternatively, no volume loss and cortical watershed restr iction, with 
restriction in the posterior t ips of the putamen on day 4 would suggest a 
perinatal hypoxic injury with some injury on going at the time of delivery. If  
imaging is repeated at day 11 and there is restriction in the watershed 
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territories with no cystic change an d no volume loss then the reporter may 
confidently suggest that there was no perinatal injury and that all  disabil ity, 
epilepsy and brain volume loss is l ikely to be due to the late collapse due to 
meningitis. Contemporaneous CrUS imaging demonstrating the  evolution of 
cerebral swell ing and parenchymal cyst formation will  provide further 
helpful information to the reporter.  
 
Therefore, early MRI with DWI is the cornerstone of neonatal  MRI reporting 
particularly if  one applies a forensic eye to the timing and nature of the 
encephalopathy and brain injury.  
 
In the term infant neonatal hypoglycaemia will  tend to occur in the f irst 72 
hours of l ife as the neonate adapts to supporting its own blood glucose 
level. Kernicterus will  tend to occur between da ys four and eight as the 
neonatal bil irubin level escalates often in the home environment. PAIS will  
tend to present either in the f irst 48 hours of l ife with focal neurology and 
seizures, or much later as an incidental f inding. Dural venous sinus 
thrombosis often presents in the f irst 72 hour of l ife or in the presence of 
post-natal infection and/or dehydration. Bacterial meningitis may present 
from a couple of days to several weeks after delivery. Viral encephalit is due 
to in utero, perinatal or post -natal acquisit ion has a very variable t ime of 
symptom onset. Brain injury due to birth trauma should be suspected from 
soon after delivery when the neonate is f irst assessed and examined. 
Punctate white matter injury is often an incidental f inding, whilst meta bolic 
disorders may present in the f irst hours or days of l ife.  
 
When reporting an acute  term neonatal HIE MR scan there is  multi -
parametric MR data  and multi-modality imaging data together with 
extensive clinical information with high levels of complexity  that produces a 
44 
 
signif icant barrier to accurate interpretat ion of the MR findings for those 
radiologists who do not report these studies regularly. Our work had been 
based at one of the UK’s three largest neonatal units  together with research 
work and interpretat ion of many MR scans for medico -legal work. DWI 
restriction, the early presence of high or later low signal on T2, the delayed 
evolution of signal change on T1, lactate levels on MRS, the presence of 
cerebral swell ing and/or volume loss and the tem poral evolut ion of CrUS 
changes must al l  be taken together with the history and other clinical 
features to establish the most l ikely t iming of the insult or insults which 
have contributed to the acute presentation and to predict the subsequent 
neuro-cognit ive developmental impairment.  
 
DWI is the most useful in terms of t iming as restr icted diffusion should be 
present for a maximum of just seven days after the acute injury in the 
regions of primary injury. For example, we demonstrated MRS and DWI 
imaging appearance stogether in a case of neonatal hypoglycaemia for the 
f irst t ime and demonstrated that DWI had the greatest importance in 
predicting permanent injury and clinical outcome (Musson et  al) .  Restricted 
diffusion may persist  in areas of secondary Wall erian degeneration for much 
longer as cells in white matter pathways extending from areas of primary 
injury involute. For example, after a chronic partial asphyxia affecting the 
posterior watershed territories, there may be restr icted diffusion in the 
splenium and posterior body of the corpus callosum and posterior thalamus 
with high T2 signal for a few weeks as these white matter extensions from 
the primary area of cortical injury involute.  
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Congenita l CMV infection (Gabriell i  et al)  produces varying patterns of 
damage to the fetal brain depending upon the fetal age, t issue viral load, 
inflammatory response, placental function and extramedullary 
haematopoesis. Severe placental involvement and subsequen t fetal brain 
hypoxia together with viral load were most closely correlated with poor 
outcome and severity of brain damage. Up to 1% of children born in the USA 
shed CMV in urine or saliva consistent with congenital infection. 10% of 
those children will  have clinical features of CMV infection (Barkovich and 
Raybaud). The chi ldren may present clin ically with jaundice, 
hepatosplenomegaly, microcephaly, sensorineural hearing loss, 
chorioret init is or a purpuric rash. Treatment with ganciclovir may improve 
neurodevelopmental  outcome.  
 
Early in utero  infection will  l ikely lead to termination of the pregnancy due 
to severe brain damage. Infection at 14 -16 gw will  often produce cortical 
malformations, such as agyria or l issencephaly with periventricular 
calcif ication, ventriculomegaly, anterior temporal and germinal zone cysts 
and cerebellar hypoplasia. Infection at 16 -20gw most often produces 
polymicrogyria. Late in utero infection will  produce mild ventriculomegaly, 
with damage to the deep or peripheral white matte r, and scattered white 
matter calcif icat ion, which may be in the periventricular white matter 
though more diffuse calcif ication may also be seen. Mild late in utero 
infection produces minor scattered white matter high T2 and low T1 signal 
on MRI or low attenuation on CT. The extent of damage depends upon a 
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combination of viral load, genetic predisposition, fetal well -being at the 
time of exposure and maternal health / immunity.   
 
Congenital brain malformations 
 
Neonates may present with symptoms which may be confused with HIE, but 
which are not due to a perinatal acquired pathology. A small cohort of 
children may present with symptoms due to a genetically determined 
epilepsy syndrome (e.g Aicardi syndrome or DiGeorge syndrome)  producing 
seizures, encephalopathy,  and neurology but without clinical or radiological 
evidence of HIE or other perinatal injury.  Someof these children may have a 
congenital brain malformation such as polymicrogyria (Robin et al,  Kuzniecky 
et al) .  
 
Neonates may present with symptoms consistent with HIE , but which are in 
fact due to an injury to the brain which occurred some days or weeks prior 
to delivery. For example, Marciano et al  described five cases of feto -
maternal haemorrhage (FMH) with characterist ics of both acute and  chronic 
anaemia (Marciano et al) .  FMH can be diagnosed by checking for the 
presence of fetal red blood cells with one of the Kleihauer -Betke test, f low 
cytometry and Rosette tests. Outcome is affected by fetal age, rate of 
haemorrhage and volume of haemor rhage. In this series four out of the f ive 
children were discharged by day 15 in good condition and the f ifth child 
expired at 7 hours of  l ife despite aggressive resuscitation and red cell  
transfusions. Early cranial ultrasound brain imaging in this neonat e 
demonstrated mild to moderate frontal and basal ganglia increased 
echogenicity. This implies that FMH is most l ikely to either lead to a 
catastrophic (and l ikely not survivable) brain injury –  with probable multi -




Neonates may also present with encephalopathy symptoms due to either 
congenital brain malformations or brain pathology acquired in utero several 
weeks prior to delivery. Congenital brain malformations may be due to one 
of, or a combination of, genetic, hypoxic/ ischaemic,  and infective 
aetiologies. Since the 1960’s assessment of the fetal brain has been 
performed with antenatal ultrasound. Recent work from the MERIDIAN study 
has demonstrated the superiority of fetal  MRI compared to ultra sound in 
evaluation of the fetal brain. This superiority of MRI is not just in the 
confidence of diagnosis of fetal brain pathology but also in the prediction of 
long term neurological and cognitive outcome.  
 
The long-term outcome and effect from a congeni tal brain structural 
malformation cannot beaccurately predicted from MR imaging and one must 
also consider the clinical evidence. Nevertheless, more accurate diagnosis of 
a structural brain abnormality by in utero MRI al lows the supervising clinical 
obstetric and midwifery team to provide far more valuable information for 
the family, often with direct input from paediatric neurology, neurosurgery,  
and neuroradiology. I  was f irst author of the paper looking at acquired fetal 
pathologies affecting the fetal b rain in the MERIDIAN cohort .  This was one 
of the f irst papers to look at the incidence of such pathologies rather than 
focussing on case series or case reports of individual pathologies  and I 
reviewed al l  the raw data and all  of the fetal MR studies for th e cases 
included in the paper  (Connolly et al).  This paper is included as one of the 











Prematurity and intrauterine growth retardation are both recognised to 
independently predispose the fetus to spastic, often diplegic,  cerebral palsy 
(Stanley). Khwaja and Volpe described the pathogenesis of cerebral white 
matter injury of prematurity. The injury is characterised by loss of pre -
myelinating ol igodendrocytes. The physiology and anatomy of the preterm 
(prior to 34 gw) brain predisposes the periventricular white matter to 
damage. Ischaemia (including postnatal hypoxia or hypocarbia, necrotising 
enterocolit is,  pneumothoraces , etc.) and inflammation (such as in utero 
infection or postnatal infection) either individually or in combination lead to 
activation of excitotoxicity and free radical injury in the presence of reactive 
oxygen and nitrogen species. The pre-myelinating ol igodendrocytes have 
immature antioxidant  enzyme systems and are also vulnerable to iron 
accumulation. Ischaemia and inflammation also directly trigger glutamate 
receptor mediated injury leading to cell  death.  
 
Prematurity in the presence of ischaemia and inflammation also predisposes 
to germinal matrix and intraventricular haemorrhage with possible 
subsequent iron accumulation. It  has been demonstrated in laboratory 
models that IVH related blood products could have a directly dam aging 
effect upon subependymal pre-myelinating oligodendrocytes,  but this effect 
is not reproduced in clinical practice as evidenced by the absence of PVL in 




Miller et al  reviewed a single-centre, small population of 12 term chi ldren 
with PVL demonstrated on subsequent brain CT and MR imaging (Mil ler et 
al) .  The chi ldren had presented variously with seizures, developmental 
delay, and attention-deficit-hyperactivity. When they were subsequently 
clinically examined by an experienced paediatric neurologist;  3/12 had 
normal motor examinations, three were hypotonic,  three had spastic 
diplegia, two had spastic quadriplegia and one had fine motor diff iculties. 
Nine had developmental delay and two had epilepsy. Four of the eight 
children with global developmental delay also had enlarged cerebral sulci as 
well  as the PVL. This suggests that a child born at term with PVL on scan may 
have a wide range of  cl inical presentations not just  the classic spastic 
diplegia.  
 
It  is known that antenatal administration of steroids to the mother and 
delayed del ivery to 39 weeks can protect fetuses from the risk of admission 
following delivery to special care baby units with respiratory distress 
syndrome (Stutchfield et al).  The incidence of PVL can also be signif icantly 




Germinal matrix haemorrhage is the result  of a complex set of stimuli and 
vulnerabi l it ies affect ing the germinal matrix. Very low birth weight, extreme 
prematurity, chorioamnionitis and perinatal stress such as hypoxia may all  
increase the risk to the fetus / neonate of developing a GMH. The more 
severe / extensive the GMH then the greater is the chance of extension of 




The Papil le classif ication of supratentorial GMH / IVH is used as the basis for 
grading the severity of GMH / IVH (1 -4) and therefore predict ing outcome 
(Papil le et al).  The higher the grade then the worse the outcome. Grade 2 
IVH is often subdivided in to type a and type b where type b has a cast of 
blood fi l l ing over 50% of the ventricular volume and type a does not. There 
is a recognised difference in predicted outcome between the grade 2 
subgrades which is used in regular practice by ne onatologists and 
radiologists who perform CrUS.  
 
A group of children with GMH/IVH wil l  go on to become shunt dependent 
and they will  tend to have a worse outcome due to the problems associated 
with shunt failure or infection. Those children that did not r equire shunt 
insertion wil l  have a better long -term outcome, even if  they required an 
external ventricular drain or repeated CSF drainage in the neonatal or early 
infant periods. Late follow up MRI in these chi ldren may not demonstrate 
blood products such as haemosiderin as CSF macrophages may have mopped 
up and digested the blood. Alternatively,  some children will  have 
susceptibil ity artefact due to haemosiderin and / or calcif ication especially 
prominent in the occipital horns of the lateral ventricles or  in  the thalamo-
caudate notch. The thalamo-caudate notch is the most common primary site 
of GMH. 
 
Tam et al demonstrated that supratentorial IVH was associated with reduced 
cerebel lar growth but could not deduce if  this was due to contemporaneous 
cerebel lar injury or due to a direct effect of IVH on cerebellar development. 
They did not discuss the potential role of Wallerian type reduced stimulation 








Haemorrhage in the cerebel lum is increasingly recognised as an injury 
pattern demonstrated in the premature brain. It  is often found in 
association with supratentorial germinal matrix haemorrhage and 
periventricular haemorrhage. Neonatal CrUS routinely now includes views of 
the posterior fossa to look for this pathology.  
 
Given that the haemorrhages are often small they may easi ly be overlooked 
by the inexperienced neuro-radiologist when reviewing delayed MR and CT 
imaging of the brain.  Blood sensitive brai n imaging sequences may 
underestimate the presence of blood products in the cerebellum due to 
macrophage activity .  There may be artefact from the tentorium cerebel l i  
which masks subtle haemorrhage. The long -term volume loss and 
destruction of cerebellar parenchyma may be subtle even when there has 
been a known previous injury  or encephalit is .   
 
Most commonly in my experience injury to the premature infant’s 
cerebel lum affects the inferior -paramedian, superior and lateral aspects of 
the cerebellum with relat ive sparing of the midline structures. It  is 
increasingly recognised from fMRI projects that different parts of the 
cerebel lar cortex are involved in higher functional processes including 
language, working memory, social processing,  and emotion processing (Guell  
et al) .  Therefore, future work should look to assess acute cerebellar and 





Limperopoulos et al studied 40 ex -preterm infants with isolated cerebellar 
injury using MRI. This study demonstrated that injury to the premature 
cerebel lum was associated with secondary impairment of remote contra -
lateral cerebral cortical growth and functional disabil it ies in survivors. There 
was highly signif icant association between early  signs of autism and 
dorsolateral prefrontal cortical volume, gross motor scores and 
sensorimotor cortical volumes and finally between cognitive and expressive 
language scores and premotor and mid -temporal cortical volumes. They 
demonstrated by multivarian t analysis that each unit increase in the 
corresponding regional cerebral volume was associated with lower odds of 
abnormal outcome score, adjusted for age, and contralateral cerebel lar 
volume. 
 
The relationship between the cerebellum and supratentorial br ain is not a 
simple one-way process with injury to the supratentorial brain causing brain 
volume loss and / or haemorrhage secondarily producing reduced cerebellar 
volume and functionality, but rather it  is a two -way process with possible 
supratentorial reduced volume and funct ion related to a primary cerebel lar 
insult.  This cerebellum-cerebrum inter-relationship is ripe for further 










Bil irubin is a breakdown product of haemoglobin. There are several 
conditions which can predispose the neonate to breakdown more blood cells 
and produce higher bil irubin levels such as blood group incompatibil ity with 
the mother, Rhesus factor disease (whe re the mother has Rhesus negative 
blood, and the baby is Rhesus positive) and an inherited enzyme deficiency 
such as glucose 6 phosphate dehydrogenase.  
 
Bil irubin is transported around the body in the blood either free or bound 
(conjugated) to the serum protein albumin. The level of albumin in the 
blood, which is partly age dependent, therefore affects the proportion of 
bil irubin which is free or unconjugated in the blood (Le Pichon et al).   
Kernicterus is due to deposition of bil irubin in the brain and is a cause of 
both acute neonatal encephalopathy and chronic neuro -disabi l ity because 
free, unconjugated bil irubin is neurotoxic.  
 
Uptake of bi l irubin into the brain may also be modified by several factors 
such as hypoxia and/or sepsis which damage the blood -brain barrier and 
facil itate uptake of bil irubin. Genetic factors, excretion and metabolic 
function may all  a lso affect bil irubin uptake into the brain and/or 
susceptibil ity to neurotoxicity from brain intracel lular bi l irubin. Bi l irubin is 
predominantly deposited in the subthalamic nucleus and the globus pal l idus, 
but the brainstem nuclei of the VIII th  cranial nerve and the VIII th  nerve itself  




In the acute phase there may be clinical evidence of jaundice (yellow 
colouration of the sclera and skin) opisthotonus (arching of the back) and a 
high-pitched cry. These acute clin ical features do not predict outcome. In 
the acute setting clinicians should attempt to reduce the serum bil irubin 
level as a matter of urgency with the us e of phototherapy, ‘bi l i -blankets’ 
and, in the most severe cases, exchange transfusion.  
 
Some reports suggest that mildly abnormal movements at 1 year of age may 
result without overt perinatal kernicterus if  the bil irubin level  is above 340 
mmol/l (Soorani-Lunsing et al ) but long term follow up was not provided in 
their cohorts.  
 
Chronic bil irubin encephalopathy  (CBE), kernicterus and bil irubin induced 
Neurological Dysfunction (BIND) al l  refer to the effect of the uptake of 
bil irubin to the long-term neurological outcome of the child. Predominantly 
the children have motor and/or audiological disabi l it ies (Olds and Oghalai) .  
The child with kernicterus may have any or all  the classic tetrad of cl inical 
features; sensori -neural hearing loss, fai lure of u pwards gaze, dyskinetic 
cerebral palsy and bi l irubin staining producing dysplasia of the dental 
enamel of the deciduous teeth. Chi ldren might also have subtle neuro -
cognitive developmental impairment if  they have only been mildly affected, 
whilst other affected children might have seizures, gastro -oesophageal 
reflux, scoliosis,  and hip dysplasia. There is evidence from a systematic 
review that in term (rather than premature ) infants BIND is associated with 
later development of autistic spectrum disorder.  
 
Brain MR imaging can help to confirm the diagnosis of kernicterus if  there is 
focal T1 and or T2 signal abnormality in the globus pal l idus and/or 
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subthalamic nucleus.  Imaging of the VIIIth cranial nerve will  not 
demonstrate abnormality. Acute MR imaging in the f irst 5-7 days after the 
insult may demonstrate restricted diffusion in the globus pall idus. The 
imaging features after the f irst week of l ife may be subtle as the globus 
pall idus demonstrates high T2 signal in normal infants for the f irst year of 
l ife and in my clinical experience MR scans are often normal beyond one 





The normal term infant can mount a physiological response to 
hypoglycaemia after delivery by mobilisi ng alternative energy substrates 
from fat and carbohydrate stores until  b lood glucose levels are restored 
following establishment of feeding. Infants with an impaired abil ity to 
mount this physiological ketogenic response after delivery are at risk of 
potentially damaging neuro-glycopenia due to an inabil ity to maintain an 
adequate supply of energy substrate for brain metabolism.  
 
Infants at increased risk for hypoglycaemia include growth restricted infants 
(lack of energy substrate stores), preterm infants  (lack of energy substrate 
stores), intrapartum hypoxic stress (depletion of energy substrate stores and 
possible transient secondary hyperinsulinism) and infants of diabetic 
mothers (hyperinsulinism).  
 
Infants with hyperinsulinism (infants of diabetic mot hers or infants with 
primary hyperinsulinism) are at r isk of neuro -glycopenia because insulin 
antagonises the normal catabolic ketogenic response and actively lowers 
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blood glucose levels.  Children can be identif ied to have growth restriction 
from their birth weight and head circumference. Normally birth weight and 
head circumference are roughly on the same centile. If  there is intra -uterine 
growth retardation, then the birth weight will  tend to fall  across the centi les 
before the head circumference (OFC).  
 
Vannucci and Vannucci described the accepted lower threshold blood 
glucose level of 2.6 mmol/l for infants at risk from hypoglycaemia for later 
reduced mental and motor developmental outcome based on the work of 
Lucas (Lucas, and Vannucci and Vannucci).  H ussain suggested that neonates 
with transient hyper -insulinaemic hypoglycaemia should have their glucose 
maintained at above 3.5 mmol/l during management to avoid recurrent / 
persistent brain injury as prolonged mildly reduced blood glucose levels are 
thought to potentially have the same long -term adverse effect on outcome 
as a short-term profoundly reduced blood glucose level (Hussain et al) .  
Therefore, cl inical teams must regularly monitor the at -risk infant’s blood 
glucose and provide early treatment, wh ether by increased feeds (e.g.,  naso 
gastric feeds, bottle top ups), by dextrose infusions or by glucagon 
injections.  
 
Barkovich et al f irst described the classic paramedian occipital subcortical 
and cortical volume loss with subcortical high T2 signal pat tern of brain 
damage from neuro-glycopenia and this was later updated to include other 
potential areas of injury including the thalamic nuclei and many other areas 
of the brain (Barkovich et al,  Caksen et al  and Burns et al) .  If  the neonatal 
hypoglycaemia is associated with any cause of periventricular leukomalacia 
or a cardio-respiratory collapse with peripheral perfusion fai lure,  then it  
may be very diff icult  radiologically to categorically ascribe al l  or even some 
of the injury to hypoglycaemia given the  anatomical overlap in the 




Whipple’s Triad is a collection of three criteria suggesting that a patient’s 
symptoms result from neonatal hypoglycaemia; (1) cl inical features are 
typical of hypoglycaemia and (2) a low plasma glucose concentration is 
documented concurrently using accurate and precise methods and (3) that 
clinical features resolve within minutes to hours after normo -glycaemia is 
restored unless brain injury has already occurred. T in suggested that both 
Whipple’s tr iad should be satisf ied and that the pattern of brain injury 
revealed by diagnost ic imaging is characteristic of that described in the 
neuropathological l iterature to attribute later disabil ity to hypoglycaemia in 
the neonatal period (Tin ). This injury may be most eloquently demonstrated 
with DWI images obtained within 5 days after the ictus (Musson et al ) .  Even 
extensive DWI change may produce very subtle changes on follow up MRI 
after 2 years of age, despite signif icant neurodisabi l ity. Tin’s suggestion  
followed on from previous work describing proposed diagnostic criteria for 
neonatal hypoglycaemic brain injury (Wang et al and Mao et al) .  These later 
proposals suggested that the blood glucose laboratory measurement should 
be below 2 mmol/l (rather than 2.6) and that there also should be 
contemporaneous cl inical manifestations of symptomatic hypoglycaemia 
such as paroxysmal cyanosis, tremors, convulsions, apnoea, and decreased 
responsiveness.  
 
Vannucci and Vannucci together with Yager et al .  suggested that asphyxia 
and hypoglycaemia acting together (at the same time) exacerbate brain 
damage which individually would not be sufficient to cause brain damage i.e. 
reduction in overall  energy supplies from many s ources makes the brain 
more vulnerable to a specif ic energy depleting insult  (Vannucci and Vannucci 
1978, Yager et al)  Their animal studies demonstrate that resistance of the 
animal neonatal brain during asphyxia is decreased in the presence of 
hypoglycaemia. Insul in dependent hypoglycaemia depletes lactate , which 
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may be util ised by the brain as an alternative energy metabolite to glucose,  
and therefore makes brain injury even more l ikely.  
 
The at-risk territories for damage from hypoglycaemia and chronic partial 
asphyxia overlap posteriorly within the brain as the posterior vascular 
watershed extends from the parietal to the occipital lobes and the 
hypoglycaemia vulnerable regions extends supero -laterally from the medial 
occipital lobes towards the parieta l lobes.  This produces a radiological 
conundrum in the late follow up period. Brain MR is most l ikely to be able to 
apportion injury to one or both mechanisms (CPH and / or hypoglycaemia) in 
the acute phase, due to the DWI pattern and distribution of restr ict ion, 
rather than at late follow up when there is gl iosis and volume loss in the 




Perinatal arterial ischaemic stroke (PAIS) is defined as a group of 
heterogenous conditions (usually primari ly ischaemic in nature, though 
secondary haemorrhage may occur) in which there is a focal disruption of 
cerebral blood flow secondary to cerebral ar terial or venous 
thrombosis/embolization, between 20 weeks fetal l ife through to the 28 th  
post-natal day, confirmed by neuroimaging or neuropathological studies. 
Arterial ischaemic stroke accounts for approximately 80% of perinatal stroke 
with the rest caused by parenchymal primary haemorrhage or dural venous 
sinus thrombosis (Ferreiro et al ) .  
 
Stroke can occur in utero  (Connolly et al  2019). The causes of  PAIS are 
usually unknown and therefore the invest igation, imaging,  and treatment of 
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PAIS are different  from the older paediatric and adult populat ions. Outcome 
is often good but around 30% of cases develop cerebral palsy, 15 -20% 
develop epilepsy and cognitive problems may also occur. Recurrent stroke is 
rare (1.2% - Fullerton et al)  
 
PAIS is estimated to affect between 1;2300 and 1;4000 l ive births. The 
neonate may be asymptomatic or only have mild symptoms that settle 
spontaneously in the neonatal period. Outcome can be entirely normal 
following PAIS and therefore it  is probable that several  children and adults 
that have experienced a PAIS episode have never received a diagnosis or 
that the diagnosis is made several years after delivery (Hart et al) .   
 
The exact cause of a PAIS is often unknown. The commonest explanation is 
of a clot forming in the ageing p lacenta, entering the fetal circulation, via 
the umbilical vein and entering the cranial circulation after passing through 
a patent foramen ovale. The commonest site for the embolus to lodge is the 
left middle cerebral artery (MCA) or its branches, which o ccurs in 80% of 
neonates with PAIS  as reported by my group in our published review (Johns 
et al) .  
 
There are numerous associations and perhaps risk factors (maternal and 
fetal) for PAIS including primiparity, prolonged second stage of labour, a 
non-reassur ing CTG trace, obstetric intervention at delivery, maternal 
smoking, pre-eclampsia, neonatal meningitis,  IUGR and many more (Cheong 
and Cowan, Harteman et al,  Lehman and Rivkin). Kiserud suggested that a 
preferential increase in the shunting of blood from the umbilical vein 
through the ductus venosus  to the IVC and right atrium in response to fetal 
hypoxia thus increased the magnitude of the right to left shunt across the 
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foramen ovale and it  was suggested that his may increase the l ikelihood of 
embolization from the placental bed (Kiserud).  
 
Neonates may also have risk factors for PAIS such as thrombophilia, 
infection, coagulopathy, cardiac lesions,  and trauma. Genetic disorders such 
as mutations affecting COL4A1 and COL4A2, subunits of type IV collagen 
involved in angiogenesis, are now recognised as r isk factors for in utero 
stroke (Ferreiro et al ).  These mutations are particularly associated with 
primary haemorrhagic stroke and shoul d be considered once a vascular 
abnormality such as an arteriovenous malformation (AVM) or aneurysm has 
been excluded. AVMs and aneurysm are extremely rare in neonates, but 
both must be excluded before surgery is considered and extensive genetic 
testing commenced. The potential of a genetic mutation should be especially 
considered if  there is evidence of glaucoma or cataract. Haemorrhagic 
disease of the newborn is sti l l  prevalent in regions of the world where 
vitamin K is not administered as routine to neon ates.  
 
PAIS is rare following uncomplicated vaginal delivery or elect ive Caesarean 
section without labour. Freud , who first trained and worked as an 
obstetrician before transferring to psychoanalysis,  is reported to have 
suggested that delivery of a health y chi ld required both the efforts of 
mother and child. Therefore, one could suggest that if  the fetus cannot 
move and assist in the process due to a PAIS then this may predispose to a 
diff icult  delivery with maternal injury and hypoxic injury for the neona te. 
The l iterature is often interpreted as PAIS being the result of a causative 
hypoxic insult rather than reflecting the potential that in utero PAIS may 




PAIS commonly presents with seizures, characteristical ly (94%  of cases) 
unilateral l imb motor seizures, typical ly within the f irst few days fol lowing 
delivery, but PAIS is often asymptomatic during the newborn period. The 
lack of symptoms in the neonate may reflect the distant t ime of the event 
from delivery (Hart  et al  2018). PAIS is a common cause of chi ldhood 
hemiplegia, but that clinical presentation may take years to be recognised 
(Rutherford et al  2012). Therapy is usual ly supportive (oxygen, f luids, anti -
epileptics etc) in the neonatal period.  
 
Imaging in the neonatal period wil l  demonstrate restr icted diffusion for 5 -7 
days in the affected region of the brain and possible early Wallerian 
degeneration in the connected white matter tracts which may last for longer 
as reported by Tony Hart in one of the papers fr om his PhD work (Hart et al).  
For instance, a left MCA infarct may produce Wallerian degeneration in the 
corpus callosal f ibres connecting the affected cortex to the opposite 
hemisphere and may also affect the corticospinal tracts extending down to 
the same side cerebral peduncle and then the brainstem. There will  be acute 
loss of grey-white matter differentiation on T1 and T2 weighted images in 
the affected cortex with subjacent white matter high T2 and low T1 signal. 
There is subsequent focal cystic encep halomalacia in the distr ibution of the 
infarcted tissue. There may be transient cortical laminar necrosis (high T1 
signal and mild low T2 signal) before volume loss and marginal gliosis if  the 
PAIS occurs after 28 gw as we have demonstrated in our group’s papers 
based on our cl inical  experience (Johns et al) .  If  the infarct occurs earlier, 
before glial cells have matured and thus can attempt to produce a reparative 
process then there will  be no marginal gliosis and imaging follow -up will  







Cerebral  dural venous sinus thrombosis  (DVST) is a common cause of 
intraventricular haemorrhage and/or parenchymal haemorrhage  at term (Wu 
et al) .  DVST can be a clinical mimic of HIE and is more l ikely to oocur in 
encephalopathic neo nates who have been stressed due to HIE and possibly 
other causes such as hypoglycaemia and kernicterus. Reduced feeding can 
produce a prothrombotic tendency as can an inflammatory response. DVST 
can also radiological ly mimic HIE due to intracranail  haemor rhage and brain 
swelling and oedema due to venous hypertension and / or ischaemia. 
Straight s inus thrombosis is commonly associated with thalamic 
haemorrhage (often bilateral) with possible subsequent intraventricular 
extension. Presentation is often non -specif ic with lethargy, irritabil ity,  or 
seizures (Ferreiro et al) .   
 
If  DVST is diagnosed, then a thrombophilia screen could be performed to 
assess for r isk factors (Ramenghi et al).  Thrombophilia can be transient, for 
instance if  there is dehydration or i f  there is a transient protein -C deficiency 
in an infant of a diabetic mother (Carvalho et al,  Vielhaber et al) .  DVST is 
also common in neonates with meningo -encephalit is (Hughes et al) but no 
cause is found in the majority of cases of neonatal DVST.  
 
Following DVST venous pressure escalates in the vessels and parenchyma 
drained by the occluded vein and haemorrhagic infarction can develop in 
this region due to venous congestion, vasogenic oedema and increased 
capil lary hydrostatic pressure. IVH can also ens ue by direct extension of 




Treatment options include supportive measures with rehydration, treatment 
of infection or other causes, treatment of seizures and treatment of iron 
deficiency if  present. Anticoagulat ion is surprisingly (until  one assesses the 
lack of signif icant supportive l iterature) more controversial amongst 
physicians and various treatment regimens are employed, especial ly varying 
if  there is evidence of intracranial haemorrhage.  
 
Ventricular enlargement can follow intraventricular haemorrhage, this is 
then followed by raised intraventricular pressure due to obstructed CSF 
circulation that can lead to trans -ependymal CSF f low with periventricular 
white matter damage especially at the an terior t ips of the frontal horns and 
the posterior t ips of the occipital horns. Clinically the neonatologist should 
suspect raised intraventricular / intracranial pressure when there is a head 
circumference which enlarges beyond the 99 th  centile and in the presence of 
sunsetting pupils. Neurodevelopmental outcome is often poor, with or 
without the development of hydrocephalus (Moharir et al).  Recurrence rates 




Punctate white matter (PWMI) lesions demonstrate high T1 and low T2 
signal at neonatal brain MRI. They have traditionally been associated with 
injury to the preterm brain but are now reported in term brains at beyond 
36 gw when they can present with DWI ch anges. The lesions can completely 
disappeara at followup MR imaging or they may manifest as areas of 
persistent gliosis (Logitharajah et al,  Kersbergen et al,  Hayman et al).  In a 
population of 42 infants PWMI are associated with perinatal asphyxia 
(19/42) and genetic mutations (though cause and effect of the mutations is 
inconclusive). 5/42 had hypoglycaemia, with one metabolic disorder 
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diagnosis and one parecho-virus infection (Hayman et al) .  However, over 
half  of the children in the population would have been imaged for perinatal 
asphyxia, thereby cause and effect cannot be attributed to the asphyxia.  
 
Most lesions in this term (36 gw or older at delivery) group were described 
as appearing in clusters and are predominantly found in the parietal region  
(Hayman et al) .  30/42 in the Hayman paper had more than 6 lesions which is 
a predictor of poor outcome in premature infants with PWMI.  Description of 
lesions as being either l inear or cluster in distribution is based on previous 
work in 112 preterm infants fro m the Utrecht group and the images in the 
paper only weakly support such a subgroup distribution of lesions 
(Kersbergen et al) .  The Kersbergen paper suggests that associated DWI 
rather than SWI changes may be associated with increased r isk of developing 
CP. CP was diagnosed in 9/112 but 6/9 had new/extra lesions at a term 
equivalent MRI. Associated risk factors such as clotting factors and cardiac 
anomalies were not clearly excluded  and so this evidence is weak .  
 
Clinically they may present with seizures ( 24%). In those pat ients in the 
study who had a follow up MRI at 18 -24 months for evaluation of cl inical 
concerns then irreversible white matter injury was demonstrated (Hayman et 
al).  However, 2/9 infants who had a follow up MRI at less than 3 months no 
longer had evidence of PWMI with no gliosis or white matter volume loss. 
The case in f igure 4 in the Hayman paper where they state that there is 
evidence of white matter volume loss is unconvincing at best and was in a 
patient with coexistent DVST and where an intermediate time point MRI 
demonstrated ischemic brain lesions appearing at day 8 follow up MRI. Most 
children (32/37) had unremarkable clinical follow up. Neurodevelopmental 







Birth trauma may mimic HIE with encephalopathy in neonates and is more 
l ikely to occur in neonates that experienced a diff icult  or instrumental 
delivery (ventouse, forceps, manual disimpaction etc). The pattern of injury 
will  rarely if  ever overlap, but a signif icant traumatic birth injury might 
produce a reduction in blood volume (subgaleal haematomas, extradural 
haematomes etc) sufficient to induce a peripheral perfusion injury to the 
brain or even a cardio-respiratory collapse with injury to the basal gangl ia.  
 
It  is amazing that most or all  children do not go on to suffer from a 
traumatic injury to the head and/or brain following vaginal or instrumental 
delivery, but clinically signif icant intracranial injury is rare. Soft t issue injury 
to the scalp with haematoma formation is  relatively common but does not 
produce subsequent neuro-developmental problems. The percentage of 
children who suffer from fractures of the skul l  vault is very small as the skull  
can remodel with overlapping of the su tures and bone plates.  
 
Extradural haematomas and/or subdural  haematomas requiring evacuation 
are very rare though small subdural haematomas are present in a large 
proportion of neonates, with increased detection rates as neonatal MR scan 
quality improves (Whitby et al  2004). Small volume subarachnoid blood is 
relatively rarely demonstrated and of no clinical concern in isolation. 
Contusion and tear of the brain cortex is rare.  
 
There is an increasingly recognised group of children injured at delivery who 
are born to mothers with small pelvic outlets or to obese mothers. The 
mothers often have labour augmented by syntocinon (synthetic oxytocin) 
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with the fetal head becoming wedged in the true pelvis above the ischial 
spines. Ventouse cap and/or forceps del ivery cannot be achi eved as the head 
is so high in the true pelvis and therefore extraction via a Caesarean section 
is required. The fetal head is so wedged in the bony pelvis that manual 
manipulation of the fetal head is required,  either from above by the 
obstetrician, possibly with use of forceps blades, or from below with 
transvaginal manual pressure on the palpable head. In this group extra -axial 
haematomas requiring evacuation, and tears / contusions to the brain are 
far more common.  
 
Further research is required to asse ss for imaging features which may help 
to predict which fetuses will  struggle to descend through the birth canal and 










In older children meningo-encephal it is is  a rare but potentially l ife -
threatening condition. Bacterial meningit is can either be the result of blood 
born bacterial infect ion or direct spread from either the petro -mastoid air 
cells or the paranasal air s inuses. Blood born infection is more l ikely in the 
immunocompromised, those with congenital cardiac problems and those 
with poor nutrit ion. Direct spread from the local petro -mastoid air cells or 
paranasal air sinuses is rare (less than 1 %) but is more l ikely  with chronic 
infection (De Oliveira Penido et al) .  Bacterial meningitis can be associated 
with a wide range of  direct or indirect complications including 
hypoperfusion, hydrocephalus, abscess, cerebrit is,  thrombosis, infarction, 
ventriculit is and empyema (Hughes et al).  In the long term there is an 
increased risk that the children wil l  develop a shunt dependent 
hydrocephalus, though this is reducing with improved antibiotic regimens 
(Cole et al).  Neuro-surgical intervention with burr hole aspiration, and o r 
craniotomy is sometimes required.  
 
Viral meningo-encephalit is is rare in older children in the UK and is most 
often due to the Herpes Simplex type 1 virus (HSV 1). Herpes zoster can also 
cause a meningo-encephalit is as well  as rarer viruses ( e.g.,  Japanese B 
virus). The outcome is poorer with any delay in init iating anti -viral therapy.  
 
In neonates, bacterial meningitis often presents in the f irst few days of l ife, 
though presentation can be delayed for a few weeks. The presentation is 
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often non-specif ic with low grade pyrexia, grunting, chest infection, poor 
feeding and irritabil ity. White cel l  count and inflammatory markers such as 
CRP are not necessarily raised at presentation. As the disease progresses 
focal seizures, increasing head circumference and focal weakness may 
become manifest as blood tests become increasingly abnormal. Infection is 
usually acquired in utero or as the fetus descends through the birth canal.  
 
Infection is most common in those whose mother suffered from 
chorioamnionitis / funicu lit is during the latter stages of pregnancy, those 
whose mothers had prolonged rupture of membranes (PROM) and/or 
maternal pyrexia, and those whose mothers had colonisation of the lower 
uro-genital tract. Foul smell ing infected meconium may be present at 
delivery. High vaginal swab culture growth, maternal or neonatal blood 
cultures and placental histology / culture may al l  give clues to the 
pathogenic organism. Group B Streptococci is the commonest bacterium 
acquired in the neonatal period, but there are m any other pathogens which 
can be the cause of sepsis and meningitis ( e.g. ,  Listeria, Serratia, Candida 
etc). The complications of neonatal bacterial meningitis are the same as 
those in older children. Meningitis and intraventricular haemorrhage are the 
commonest causes of a neonate developing a shunt dependent 
hydrocephalus.  
 
Bacterial infection (for instance in older children from prior asymptomatic 
carr iage of pneumococcus in the nasopharynx) f irst invades the blood 
stream, there follows multiplication of  the bacteria in the blood stream 
causing symptomatic infection (sepsis). There is then spread from the blood 
stream to the meninges, in it ial ly without specif ic meningeal symptoms, but 
with continuing symptomatic blood stream infection. The time interval 
between blood stream infection and meningeal invasion varies between 
different organisms and within organism strains. It  may be that a threshold 
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number of organisms for an individual must be present in the bloodstream 
before meningeal invasion can take plac e. The threshold can be determined 
by host immunity, concomitant viral ( Influenza especially) infection and 
bacterial virulence.  
 
Once meningitis becomes symptomatic cl inically there can also be 
involvement of the petrous bone labyrinth and subsequently s ensorineural 
deafness can ensue. The probable mechanism of hearing loss is the spread of 
bacteria and / or toxins and / or inflammatory mediators to the cochlea via 
the cochlear aqueducts (Tsuprun et al).  Imaging of the petrous bones may 
remain normal despite the sensorineural deafness. Gentamicin may cause 
sensorineural deafness if  blood levels are raised due to direct toxicity on the 
eighth cranial nerve.  
 
In adults earlier antibiotic administrat ion has been demonstrated to improve 
outcome (Aronin et al) .  At the time of presentation hypotension, altered 
mental status and seizures were independently associated with poor clinical 
outcome. Therefore,  early antibiotic treatment following LP and blood 
cultures are advised for suspected bacterial meningitis,  esp ecially if  there 
are seizures and/or altered mental status.  
 
Neonatal viral meningo-encephal it is is extremely rare and is most commonly 
due to the acquisit ion of a Herpes Simplex type 2 (HSV 2) viral  infection as 
the fetus passes through the birth canal of  an infected mother (genital 
herpes). It  can also be acquired after del ivery.  
 
There are three potential cl inical manifestations (Anzivino et al ,  James and 
Kimberl in). 45% present with vesicular skin rash, eye keratit is  / 
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conjunctivit is and mucous membran e involvement which has a high risk of 
progressing to nervous system infection. 30% present with CNS infection 
which may be non-specif ic with lethargy, poor feeding, irritabil ity,  and 
seizures. 2/3 also have a vesicular rash. 25% present with disseminated 
infection affect ing multiple organs ( e.g.,  l iver, lungs, adrenals)  and often 
there is CNS infection. A vesicular rash is  not always present in this last 
group. Therefore, identif ication of a vesicular skin rash is the most valuable 
sign for early identif ication and treatment of HSV-2 before there is CNS 
involvement.  
 
Early instigation of anti -viral treatment with high dose intravenous acyclovir 
can lead to a good outcome. The diagnosis is often confirmed following 
lumbar puncture and then laboratory PCR (po lymerase chain reaction) 
assessment for HSV 2 (Anzivino et al and James & Kimberlin).  
 
Neonatal parecho-virus and enterovirus infection can both produce diffuse 
white matter injury which can mimic PVL as the distribution of injury is 
similar. However, the branching candlest ick appearance near to the trigones 
and frontal horns is characteristic of these increasingly diagnosed viral 





Metabolic disorders are genetically acquired but may present in the 
vulnerable neonate. For instance, mitochondrial disorders, urea cycle 
disorders, nonketotic hyperglycinaemia, molybdenum co -factor deficiency 
and maple syrup urine disease are just a few o f the more common metabolic 
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disorders presenting in the f irst days of l i fe. The neonate is often well at 
delivery but then presents soon afterwards once they must metabolise their 
own abnormal biochemistry (rather than the maternal circulation performing 
this function via the placenta) or as increased metabolic demand arises as 
metabolites have not been provided by the mother.  
 
Some of the metabolic disorders may be confused with HIE by the unwary or 
inexperienced report ing radiologist,  but HIE should be e asily excluded by 
analysis of the distribution of lesions and restricted diffusion, and 
interrogation of the clinical history and biochemistry. MR spectroscopy may 
be very useful in diagnosing some of these conditions, for example non -
ketotic hyperglycinaemia has a specif ic extra glycine peak visible at 3.5 ppm.  
 
Further investigation of children with normal MRI f indings in CP has been 
suggested but the screening of such children for neuro -metabolic diagnoses 
(i .e.,  non-CP) rarely produces an alternative dia gnosis. Leonard et al 
reported 23 cases in which dyskinetic CP cases with normal MRI scans were 




Early cardiac dysfunction  in the post-natal period, whether due to electrical 
or physical dysfunction may lead to brain injury. The injury tends to affect 
the deep vascular watershed territories of the cerebral hemispheres 
(Peyvandi et al ,  Kel ly et al) .  There may be  acute encephalopathy, seizures,  
and focal neurology.  The early MRI features will  be of restricted diffusion (if  
imaged within the f irst 5 days after the insult) with high T1 and low T2 signal 
in the centrum semi-ovale. There wil l  be long term gl iosis and white matter 
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volume loss. The patient may develop spastic hemiplegia or quadriplegia 
(depending on the degree of asymmetry of the injured brain).  
 
Early respiratory dysfunction will  tend to cause a watershed injury (Ri ley et 
al) as demonstrated in our case report of  RSV bronchiolit is in a neonate. 
Early onset encephalopathy will  be present,  and the child may go on to 
develop cognitive disabil ity and spasticity.  
 
These cardio-respiratory disorders may be impossible to differentiate 
clinically and radiologically from chron ic partial asphyxia. If  a  child suffers 
from a col lapse in the postnatal period, then MRI within f ive days of the 
ictus, accompanied by DWI, will  a l low the reporter to better inform the 





3.12 Developmental impairment  
 
Clinical assessment and grading 
 
Developmental impairment in a child often prompts cl inical investigation 
with genetic, biochemical and MR imaging. Developmental impairment may 
have motor, speech, behaviour,  and cognitive components. Developmental 
impairment wil l  also often prompt a forensic invest igation to look through 
the entire clinical history from before birth to the time of diagnosis and the 
radiologist wil l  often be asked to define when any brain injury occurred, by 
what mechanism and how the injury manifest on imaging has produced the 
clinical constellation present in each child.  
 
Early developmental  impairment (EDI) occurs when a child’s developmental 
skil ls fall  two standard deviations or more below the population m ean in two 
or more developmental domains. The developmental domains are speech, 
f ine motor, gross motor, cognition,  and behaviour. 10-12% of children have 
a developmental impairment, and 1 -3% of  children have EDI. The causes of 
EDI include genetic, metabol ic, antenatal ,  endocrine,  and infective 
conditions, amongst others. Good quality clinical paediatric assessment is 
required to assess and classify the child’s developmental impairment.  
 
Poor birth outcome, malnutrit ion, chronic i l l  health, inadequate stimulation, 
and other environmental factors may impede development. Early 
identif ication and prediction of developmental impairment should promote 
clinical teams to commence timely intervent ions which may go on to prevent 
delay in achieving milestones and promote competencies. With HIE in the 
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term infant the neuroradiologist report ing the neonatal MRI may assist with 
early identif ication of expected cognitive and motor function impairment, 
which may then prompt specialist  services with therapy and assisted devices 
and special education with planning for assistance and support to impact 




The number of recommended invest igations ha s increased over the last 20 
years, although opinion varies on whether children with EDI are invest igated 
appropriately, and the usefulness of specif ic investigations. The reasons why 
families wish to know the aetiology include : validat ion, i .e. proof of a  
credible problem and to help explain the problem to the affected child or 
siblings and others , to provide prognostic information and help set real istic 
expectat ions / plans ,  for any potential treatment , to allows better access to 
educational support,  to provide the opportunity for early intervention ,  to 
provide support opportunities , the “need to know”  and for prenatal testing 
and recurrence risk .  
 
We asked clinicians who subscribe to the email l ists of the Brit ish Paediatric 
Neurology Association (BPNA) and Brit ish Academy of Chi ldhood Disabil ity 
(BACD) to complete an online questionnaire on their views and approach to 
children with EDI (Hughes et al).  Our aim was to assess the degree in 
variat ion and attitude towards the invest igative approa ch of children with 





107 clinicians repl ied. 93  (86.9%) were consultants, 6 (5.61%) were associate 
specialists, 3 (2.8%) staff  grades, 2 (1.9%) special ity doctors, with a single 
ST4-8 trainee, all ied health professional and nurse practit ioner. Al l  saw 
children with EDI as part of their work. 67 (62.6%) responders worked in a 
child development centre (CDC), 37 (34.6%) in paediatric neuro -disabil ity, 21 
(19.6%) in general p aediatrics, 17% (15.9%) in community paediatrics,  and 
11 (10.3%) in paediatric neurology. The overlap in f igures is explained by 
responders who work across more than one department. 65 (61.9%) of 
responders said their department had a protocol for the inve stigation of EDI, 
36 (34.2%) did not and 4 (3.8%) did not know.   
 
The most commonly reported additional cl inical factors to increase the 
l ikelihood of a clinician requesting investigations were increasing severity of 
disordered development, dysmorphia, fa mily history of i l lness or disordered 
development, microcephaly and epileptic seizure disorder. Overall,  55/89 
(61.8%) of responders felt  children with EDI and additional cl inical features 
were investigated the appropriate amount, 21 (23.6%) felt  these chi ldren 
were under investigated, and 6 (6.7%) felt  they were over -investigated.  
 
75/89 (84.3%) of responders investigated children with isolated EDI, 11 
(12.4%) did not. The investigations thought to be most l ikely to determine 
the aetiology in isolated EDI were CGH microarray, audiology referral,  
creatinine kinase, ophthalmology referral  and fragile X 33/89 (37.1%) 
respondents said parental wishes affected their decision on which 
investigations to perform in children with isolated EDI, and 41/89 (46.1%) 




31/89 (34.8%) of responders thought children with isolated EDI were 
investigated the right amount, 18 (20.2%) felt  they were under investigated, 
and 34 (38/2%) over -investigated.  
 
In Sheffield we reviewed the cost of investigating chi ldren with early 
developmental impairment (EDI) using both our local guidelines of the time 
and previous guidelines  (Hart et al) .  Costs ranged from £380 per patient in 
1997, assuming that microarray rather than karyotype was perfor med, to 
£567.28 locally for f irst l ine investigations. MRI head under general 
anaesthetic is charged at £932 per patient as a second line investigation in 
Sheffield. 3% of chi ldren have EDI , with a UK birth rate of 777 000 per 
annum. If  f irst l ine tests were completed, then charges would vary from £8.9 
to £13.2 mil l ion per year. If  MRI was added for 55% of cases, then costs rise 
to £20.8 to £35.0 mil l ion per annum . Therefore, we suggested that a 
prospective study of children with EDI was required to streamline and 
optimise the investigative pathway for EDI with cost effectiveness analysis.  
 
It  may of course be argued that earlier and more accurate diagnosis of the 
cause of EDI may facil itate more individualised early treatment and reduce 
unnecessary, expensive,  and late investigations. Early focussed treatment 
may improve outcome and reduce further long -term care and therapy costs.  
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4 Current practice for HIE imaging and 
reporting 
 
When to image to assist with outcome prediction  
 
Early imaging guidelines for imaging of neonates based their MR protocols 
on the available l iterature. The early l iterature was based on l imited imaging 
sequences performed in more mature neonates in whom imaging was 
performed after day 10 when the neonate was cl inically mor e stable after 
their perinatal insult  (such as HIE) because there was not the avai lable 
technology in terms of MR compatible incubators and NICU sited MR 
scanners. That work suggested that diagnosis should be based on T1 imaging 
features (high T1 signal in  areas of pathological damage is presumed to 
appear after day 10, although adult stroke MR imaging experience advises 
that not all  damaged brain demonstrates high T1 signal –  cortical laminar 
necrosis –  after injury) rather than the more acute pathology se nsitive DWI 
appearances and the acute brain swelling / oedema sensitive T2 sequences. 
Imaging was also performed without the use of blood sensitive sequences 
(e.g. ,  SWI) and without the use of biochem ical / physiological  sequences 
(e.g. ,  MR spectroscopy).  
 
The Brit ish Association of Perinatal  Medicine (BAPM) has published a 
framework document for fetal and neonatal brain MRI (BAPM 2016).  The 
guideline suggests that all  neonates who have suffered from 
encephalopathy, and those with seizures but no encephalo pathy, should 
have an MRI between days 5 and 14. The guideline mentions preterm infants 
and advises that they should be imaged at term equivalent if  the CrUS was 
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grossly abnormal (including focal increased echo -density persisting for more 
than 3-4 weeks) or with unexplained abnormal neurology. Al l  scans should 
be double read, but by whom is not specif ied.  
 
As MR scanner and MR compatible technology has evolved the l iterature has 
expanded with more papers describing imaging features of perinatal 
pathology in the f irst 5 -7 days after del ivery (Weeke et al).  We have 
reported imaging features resulting from damage from HIE in fully 
myelinated brains (Griff iths et al  2010, Connolly et al  2007) and clinically 
have been performing our imaging in neonates between days 3 and 5 after 
delivery for many years. This early imaging and accurate double reporting of 
the MR scans has produced more useful and robust early prognostic and 
diagnostic information.  
 
Medicolegal impact of ENS  
 
The NHA lit igation authority (NHSLA) has recently introduced an early 
notif ication scheme whereby any child who is admitted to NICU 
unexpectedly has a midwifery, obstetric and neuro -radiology preliminary 
opinion. A neonata l opinion may also be requested. The opinions are 
presented to the family with the hope that either they will  be reassured or 
that an easy path to a settlement may be adopted. If  the family are 
reassured, then routine clin ical follow up will  ensue as stand ard. If  there is 
evidence of brain injury and there is substandard midwifery or obstetric 
care, then the NHSLA and their legal advisors will  attempt to mediate an 




Working in this medicoleg al milieu has prompted investigation of imaging 
for HIE and other causes of neonatal encephalopathy with a view to 
improving the prognostic and diagnostic information which can be provided 
to clinicians and the legal system. We have focussed on imaging the  
neonate, improving access to high quality MRI, and thus improving the 
quality of the radiology report ing of these cases.  
 
The paediatric neuroradiologist wil l  often be asked three questions in the 
early notif icat ion scheme cases; what the nature of the pathology / 
pathologies is ,  what is l ike l ikely impact on long term prognosis, what was 
the t iming of the insult / insults  causing the neurological injury.  
 
It  is the question of t iming which necessitates early neonatal brain MRI. DWI 
at about day 5 will  a l low the radiologist to exclude later brain injury from a 
late hypoglycaemia, meningitis/encephalit is,  peripheral perfusion injury 
from RSV bronchiol it is or a hypoxic injury from a cardiorespiratory collapse.  
 
An MRI at about day 5 with DWI will  reveal pseud o-normalisation of an in 
utero chronic partial  asphyxia with auto -recovery 3 days prior to admission 
to hospital far better than CrUS would be able to narrow down the time 
window for the insult.  
 
New technologies  
 
To assist the reporting radiologist with prediction of outcome following HIE 
using MRI various groups have util ised advanced imaging, with computer 




Lally and colleagues in the MARBLE study used thalamic MR spectroscopy at 
days 4 to 14 to evaluate children that received  therapeutic hypothermia for 
HIE and correlated with outcome at 18 -24 months (Lally et al).  Imaging had 
to be done at 3 Tesla (making it  impractical in all  acute care settings) and 
the MRS protocol was over 20 minutes for a single sequence so 
unsurprisingly over half  of cases could not be evaluated. NAA concentration 
could be calculated from the software applied to the MRS and independently 
accurately predicted outcome. Single voxel MRS over the thalamus will  also 
evaluate injury from both CPH and APH so th e pattern of injury from HE may 
not be so easily predicted from the MRS NAA concentration.  
 
In Sheffield and Manchester, we evaluated computer analysis (Stivaros et al) 
to quantify structural changes in the corpus cal losum in children with APH. 
This used segmentation of the corpus cal losum and demonstrate good 
correlation with focal thinning of the corpus cal losum related to the 
transcallosal f ibres extending from the cortex of the central sulcus to long 
term outcome 
 
Diffusion tensor imaging (DTI) has been  used extensively for research into 
outcome from HIE and systematic reviews have now establ ished that in a 
tertiary centre FA values and evidence of  restricted diffusion in the 
posterior l imb of internal capsule, corpus callosum and hippocampus may 
find correlation with outcome (Salas et al ,  Dibble et al).  Application of this 
technology in the acute care setting of a DGH is diff icult  to envisage without 
centralisation of imaging and data processing / review to a l imited number 




5 MRI Report scoring systems  
 
Machie et al have shown that using a scoring system to grade the extent of 
injury from HIE on MRI in infants with mild HIE and subtle brain 
abnormalit ies was most often detected with a more complex or detailed 
scoring system, but that there was greater inter -rater rel iabil i ty with a 
simpler scoring system (Machie  et al ).  They compared the Barkovich, NICHD 
NRN and Weeke scoring systems in 42 newborns with moderate to severe 
HIE who received therapeutic hypothermia. The Weeke scoring system is the 
most complex using a scoring system up to 57 and uses MRS, DWI and 
several subtle anatomical markers and detected abnormality in 24/42 
newborns whilst the simplest system from Barkovich only detected 
abnormality in 3/42 (Martin and Barkovich) . At least two readers (not a 
constant number) reached agreement levels of k = 0.9 for the simplest 
scoring system to 1.0 for the Weeke system. There was however no 
correlation in this paper of reporting agreement and prediction of outcome  
We need to test an achievable scoring system in the UK and compare with 
outcome. 
 
How I report neonatal MRI 
 
For medicolegal reporting, when late MRI has been obtained after two years 
of age corrected, I  use an amalgamated scoring system devised from the STN 
(Griff iths et al 2010) and the vermis APH (Connolly et al  2007) papers. This is 
my personal adapted severity scoring system for MR evidence of brain injury 




I  expect that axial T2 TSE/FSE, FLAIR imaging (preferably 3D), SWI or GRE 
T2*, T1 volume imaging and coronal T2 TSE imaging with a short ETL (8 or 
less) wil l  be included in the MR scan protocol  (Radon et al) .  
 
The table is a very subjective measure of the extent of brain damage and the 
duration of the period of damaging APH,  but it  has been trial led over many 
years and correlated with expert perinatal obstetric and neonatal case 
review and also with subsequent long term paediatric neurology follow -up, 
often with CP motor disabil ity classif ication by an expert and with a GMFCS  
classif ication.  
 
By convention, based on the Myers model, people have described a period of 
10 or more minutes of non-brain damaging acute profound asphyxia before 
immediately and subsequently being followed by brain damaging acute 
profound asphyxia (Myers 1971). The brain damaging acute profound 
asphyxia has been subdivided in to 3 f ive -minute aliquots (10+0-5, 10+5-10, 
10+10-15) and any brain injury beyond those 15 minutes of brain damaging 
asphyxia has been considered to not be survivable.  
 
*The duration of the non-brain damaging APH can be reduced below 10 
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Long term impact of HIE and how to link imaging to outcome? 
 
HIE at term may produce neuro -cognitive disabil ity in the neonates who 
suffer from APH and / or CPH. The GMFCS grading system al lows the clinician 
to score motor impairment. Cognitive disabil ity can be compared to 
expected level of function from parental  a nd sibling attainment.  
 
The APH scoring system for long term MRI ( table 5.1) tends to produce 
robust correlation with outcome. The mild MRI changes group have GMFCS 
level 1 or 2 outcome with preserved cognition. The moderate MRI changes 
group have GMFCS level 2 to 4 outcome with good cognit ion. The severe MRI 
changes group have GMFCS level 4 or 5 outcome with poor cognition.  
 
APH will  tend to produce a dyskinetic choreoathetoid cerebral palsy with 
variable dystonia, spasticity, bulbar palsy and rarely a co gnitive impairment 
affecting the most severely affected group only. MRI assessment tools to 
predict outcome from long-term fol low up MRI and acute MRI have been 
tested by several groups with often increasingly complicated and impractical 
scoring algorithms and imaging protocols. The GMFCS clinical score for 
cerebral palsy is used but cognitive impairment is now more diff icult to 
predict as therapeutic cooling appears to signif icantly improve motor 
outcome and imaging appearances but to overlook APH impact o n cognition. 
The scoring system for HIE which we will  evaluate wil l  also have a simplif ied 
scoring algorithm for APH.  
 
CPH will  tend to produce a spastic quadriplegic cerebral palsy with 
microcephaly, seizures,  and cognitive impairment. There have been few  
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attempts to l ink acute MRI f indings in CPH to long -term outcome. This is 
even though CPH is probably more common than APH. However, the easier 
l inking of APH to a CTG terminal bradycardia and less variable clinical 
features and aetiology al low easier corr elation with aetiology and outcome 
for doctors and lawyers. In my section on future research, I  wi l l  attempt to 
evaluate an MRI assessment tool for acute neonatal MRI to predict long term 
cognitive outcome in CPH and with GMFCS grading.  
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6 Future research  
 
Future work and how this will  be important for the NHS and medicolegal 
work. How can this be applied to suggestions for improved imaging and 
imaging interpretation?  
 
The work that I  have been involved in over the last 17 years in Sheffield has 
focussed on the assessment with MR imaging for the brain and spine of the 
fetus, neonate and child. Imaging technology development has allowed 
improved MR assessment of the neuro -axis. I  have been involved in the 
assessment of new imaging techniques, MR scanners and  MR compatible 
neonatal transport PODS which have al lowed better and more complete MR 
imaging assessment of the neonatal brain.  We have used the scan data to 
better assess the pathologies which go on to produce cerebral  palsy and 
early developmental  impairment.  
 
We have investigated neonatal HIE and its mimics. We have demonstrated in 
utero acquired pathologies which may mimic cl inically and radiological ly 
brain injury from HIE.  
 
We have demonstrated new anatomical substrates for subsequent clinical 
presentations in HIE and assessed the clinical severity of the neonatal insult 
and long-term neurological impairment. The ventrolateral nucleus is the 
region of the thalamus most often described in association with damage 
from APH. However, in a histo -pathological correlate study in six piglets 
Martin et al found that the ventral postero -lateral thalamic nucleus (a 
somato-sensory nucleus) is in fact the nucleus that is consistently damag ed. 
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On axial MRI studies the antero -lateral aspect of the thalamus is the region 
classical ly involved, but the reporter should appreciate that the orientation 
of the thalamus is oblique not AP to the MRI axial scan plane (the AC -PC l ine 
drawn from the anterior to the posterior commissure on a sagittal image 
defines the axial plane for MRI imaging).  The nucleus of the thalamus most 
often damaged by APH is the ventral postero -lateral nucleus though other 
nuclei including motor nuclei such as the anterolateral  nucleus may be 
damaged in more severe APH.  
 
I  have emphasised the importance f inancial ly and in clin ical resources to the 
NHS of these pathologies. By improving diagnosis, prognostication and then 
supporting early targeted interventions outcomes for these  children and 
their families may be changed for the better.  
 
Routine neonatal imaging with achievable imaging protocols (not just in 
tertiary and quaternary centres l ike Sheffield) should become attainable for 
all  UK NICUs. The image protocols should then be optimised and simplif ied 
so that reliable image interpretation can be produced, probably with 
specialist  centre secondary reporting / support.  
 
The radiologist must  also consider and exclude the HIE mimics which I have 
detailed previously. I  would sugg est the adoption of the Sheffield neonatal 
MRI brain request form with answers to the 18 specif ic questions on the 
request card available to the reporting radiologist. The radiologist must be 
able to interpret the clinical data supplied and thus inform the ir report. I  
would add that clinical details regarding therapeutic cooling including time 
of commencement after delivery should be avai lable to the radiologist.  
Congenital brain, orbit,  spine, and petrous bone malformations must be 
excluded. The acute f ind ings on MRI related to kernicterus, birth trauma, 
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dural venous sinus thrombosis, PWMI, perinatal viral infection, in utero 
pathologies, acute and chronic metabolic decompensation, PAIS, neonatal 
hypoglycaemia cardiorespiratory insufficiency, and bacterial meningitis must 
be considered and hopefully excluded prior to confirming brain injury from 
HIE.  
 
The Utrecht MR scoring system for neonatal HIE is too complicated for 
widespread application in the UK with a f inal score calculated out of 57 
(Weeke et al) .  For instance, many UK neonate imaging centres do not even 
perform MR spectroscopy, let alone employ it  as part of their routine 
neonatal imaging protocol despite the recent MARBLE study outcome 
suggesting that MRS at 3T is the best predictor of outcome foll owing HIE 
(Lally et al) .   
 
Therefore, one of my next projects will  focus on refining the Utrecht 
neonatal MR protocol to allow rel iable and widespread application of brain 
MR to invest igation of neonatal HIE in the UK.  
 
A l imited set of images are essential and should be priorit ised in the imaging 
protocol. Axial ssFSE T2, Axial DWI, Axial FSE T2, axial GRE T2* and PRESS 
MRS on one side over the basal ganglia and thalamus. MRS normal ranges for 
NAA/Cr and lactate peak hei ght should be obtained.  
 
Coronal T1 volume may then be acquired. There is no requirement for FLAIR 




I  suggest two simple scoring systems to be used in conjunction when 
reporting al l  scans for neonatal encep halopathy, one each for APH and CPH, 
which both are much simpler to use tha n the Utrecht scoring system.  
 
 
Adapted APH scoring system for neonatal brain MRI 
 
Signal change in the structures may be high on T2w, high on T1w or they 
may demonstrate restricted  diffusion (high b700 with low ADC).  
Signal change may be unilateral or bilateral. The more signif icant side of 
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T a b l e  6 . 1  P r o p o s e d  M RI  s co r i n g  s y s t em  o f  n e o n a t a l  b r a i n  M RI  in  A P H  
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Adapted CPH scoring system for neonatal brain MRI 
Signal change in the cortex may be represented by high T2w signal with loss 
of cortical grey-white matter differentiat ion, cortical high T1w signal 
(highl ighting), or the cortex and subcort ical white matter may demonstrate 
restricted diffusion (high b700 with low ADC). Cortical highlighting is often 
accompanied by subcortical low T1w signal.  I  ignore deep white matter 
signal change and restricted diffusion as I  am uncertain if  this  is primary 
pathology, artefact,  or secondary early Wallerian degeneration.  The extent 
of cortical s ignal change may be measured with a chord to the brain surface 
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MRI in the neonate new technologies and timing of imaging 
 
I  suggest that early MR imaging by 120 hours of l ife (after therapeutic 
cooling and then rewarming has been completed) should be achieved in all  
encephalopathic neonates. The f irst advantage is that DWI and MRS data can 
be evaluated and that there is a narrow window for the imaging appearances 
of the pathology to evolve. All  readers would then be able to ‘get their eye 
in’ to images produced in a smaller t ime window after the presumed 
pathology.  
 
The DWI would also allow the radiologist to suggest that an insult had 
occurred prior to del ivery if  there was no restricted diffusion 120 hours 
after delivery. Neonatal hypoglycaemia, which can mimic and exacerbate HIE 
encephalopathy and then brain injury, is best appreciated wi th DWI in the 
f ive days after the insult and may be very diff icult  to appreciate later. I  
suspect anecdotal ly that kernicterus wil l  have a s imilar diagnostic 
enhancement with early MRI.   
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8 List of abbreviations 
 
 
Apgar    The name of the author of the paper describing the 
neonatal level of neurological function in f ive domains 
which can all  score 0 -2 with a total score out of 10.  
BIND Bil irubin induced neurological dysfunct ion  
bpm Beats per minute  
CBE Chronic bil irubin encephalopathy  
CFAM Cerebral function monitoring  
CMV Cytomegalovirus  
CNS Central nervous system 
CP Cerebral palsy  
CSF Cerebrospinal f luid –  the f luid that surrounds the brain 
and spinal cord and that l ies within the brain in the 
ventricular system 
CT Computed tomography 
CTG Cardiotocograph –  a measure of the fetal heart rate  
CrUS Cranial ultrasound 
DVST Dural venous sinus thrombosis  
EDH Extra dural haematoma 
126 
 
EEG Electroencephalography –  a formal measure of brain 
electrical activity  
FHR Fetal heart rate  
GMH Germinal matrix haemorrhage  
gw Gestational weeks –  age of the fetus  
HIE Hypoxic ischaemic encephalopathy  
HSV Herpes Simplex virus  
IVH Intra-ventricular haemorrhage  
MCA Middle cerebral artery  
MRI Magnetic resonance imaging  
NHSLA National Health Service Lit igation Authority  
NICU  Neonatal Intensive Care Unit  
OFC Occipito-frontal head circumference –  a measure of 
head size  
PAIS Perinatal Arterial Ischaemic Stroke  
PCR Polymerase chain reaction  
SAH Sub-arachnoid haemorrhage  







9 Papers for inclusion in thesis 
 
9.1 Initial experience of an investigational 3T MR scanner designed for use on 
neonatal wards 
Griff iths PD, Jarvis D, Armstrong L, Connolly DJA, Bayl iss P, Cook J,  Hart AR, 
Pil l ing E, Will iams T and Paley MNJ  




The Firefly project was a collaboration between Harvard Medical School, 
General Electr ic and the University of Sheffield. The plan was to produce a 
small f ield MR scanner with a small foo tprint which could be easily housed 
adjacent to or in a neonatal unit. Safety as always would be of premium 
importance,  and we were focussed on a system which would be accepted by 
the neonatal cl in ical  nursing and medical  teams.  
 
Image quality was to be judged compared to a standard 3 Tesla MR system 
and all  imaging sequences which might be required for assessment of an 
encephalopathic neonate would be optimised for clinical appl ication. The 
sequences included T1, T2, T2*, FLAIR, DWI, SWI, MR spectroscopy (PRESS), 




Magnetic resonance (MR) imaging has revolutionised the assessment of the 
brain in cl inical practice,  and it  is the most accurate method of detecting 
most brain pathologies in most age groups. In addition, the abil ity of MR 
imaging to produce high spatial a nd high contrast resolution images without 
exposure to ionising radiation has ensured rapid clin ical uptake. One group 
that has not benefited from MR imaging as much as others is neonates, in 
whom MR imaging of  the brain is fundamentally diff icult  on sever al levels. 
There is inherently poor contrast resolution in the neonatal brain due to its 
pre-myelinated state and obtaining high quality MR images in a non -
sedated/non-anaesthetised baby is challenging because of movement.  
 
A further and substantial problem is ensuring safe transfer of the baby from 
the neonatal intensive care (NICU) or special care baby units (SCBU) to the 
MR scanner. Many neonates who may benefit  from MR imaging of their brain 
have unstable cardiovascular and respiratory function and tra nsfer to the 
MR scanners (usually in a different part of the hospital or at a different 
hospital) introduces extra risk. The decision to perform a cl inical procedure, 
including a diagnostic test, should be considered based on a risk/benefit  
analysis and, for neonates, the decision is often not to perform MR imaging.  
In such cases, trans-fontanelle cranial ultrasound scanning (CrUS) is often 
performed as it  can be done on the NICU/SCBU and has been used to good 
effect over many years. MR imaging is being us ed increasingly in a targeted 
fashion with cl inicians evaluating the risk/benefit  equation on an individual 
basis. These factors are well  i l lustrated in a short educational video made at 
Sheffield Teaching Hospital by the Welcome Trust. 1  It  has been a long-term 
aim of our group to improve access to MR imaging of the brain in neonates 
and in this paper we describe our init ial experience of using a physical ly 






The Firefly 3T MR scanner  
‘Firefly’ is a prototype, high f ield (3T) MR system built  by GE Healthcare, 
Milwaukee and is l ight enough at just 500 kg to be sited on normal, non -
reinforced office f loors, in an area of approximately 6 x 6m (including scan 
control and equipment rooms) is designed to have the full  capability of a 
current clinical MR system but customised to scan neonatal brains. The 3T 
static magnet is a closed loop cryogenic system with a low helium volume 
(30L), which maintains the magnet at 4. 2 Kelvin. The 5 Gauss (0.5mT) fr inge 
f ield of the static magnetic f ield is contained within the scanner room 
(dimensions 2.0m x 1.3m) and has a f ield uniformity of 15 ppm within a 
15cm diameter sphere at iso -centre. The maximum gradient strength of the 
system is 70mT/m and dB/dt is kept below the FDA guidelines of 
300mT/m/ms by strict software and hardware control. The RF power of the 
transmitter is set at 4Kw to allow maximum SAR levels in the range of 2W/Kg 
for babies weighing up to 6kg. The internal clea r magnet bore is 28.0cm, the 
gradient bore is 21.8cm and the internal diameter of the quadrature 
transmit-receive RF coil  is 17.9cm. The magnet, gradients and RF systems are 
l inked to a standard GE ‘front -end’ running software at release level DV25.0. 
The installed system is shown in f igure 1a and the site plan in f igure 1b.  
 
Ethical approval  
Firefly currently has neither FDA approval nor CE marking so its use in this 
f irst stage of our programme is governed by the Medicines and Healthcare 
products Regulatory Agency (MHRA), which is an executive agency of the 
Department of Health of the United Kingdom. The MHRA specif ied that the 
system could not be used for primary diagnostic purposes at this stage and 
that the manufacturer (GE Healthcare) should be the sp onsor of the study 
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and obtain ethics approval.  Approval was provided by a specialist  paediatric 
Research Ethics Committee, which allowed the researchers to approach  
 
F i g u r e  9 . 1 . 1 .  T h e  F i r e f l y  3 T  M R  s y s t e m  i n s t a l l e d  a t  S h e f f i e l d  T e a c h i n g  H o s p i t a l  a n d  a  p l a n  o f  t h e  M R  s u i t e  
s h o w i n g  t h e  p r o x i m i t y  t o  t h e  n e o n a t a l  i n t e n s i v e  c a r e  u n i t  a n d  d e l i v e r y  s u i t e .  T h e  s c a n n e r  c o n t r o l ,  s c a n  r o o m  
a n d  e q u i p m e n t  r o o m  o c c u p y  a  f l o o r  s p a c e  o f  6 . 0 m  x  6 . 5 m .  
 
families of two groups of neonates with a view to recruitment into the study 
as a volunteer:  Group 1.  Completely normal babies born at or close to term 
whose parents agreed to have an MR study before the baby went home. 
Group 2. Premature babies that were about to go home at term -corrected 
age and had had cl inical neuroimaging studies performed at an earlier date  
All  parents provided written, informed consent after reading the approved 
information sheet and had  the opportunity to ask questions, with a target to 





Safety issues and patient handling  
Safety considerations are paramount when designing and using an MR 
system for neonates.  The pre-checks and preparation for the MR scan were 
carr ied out by one of two special ist  research nurses associated with study 
(PB, JC).  The scan events were scheduled to be within one hour of the baby 
being fed and the safety checks commenced by confirming that the head of 
the baby would f it  into the scanner before going to the scan room, hence 
saving unnecessary exposure. This was done by attempting to place a soft 
template with the same diameter as the coil  around the neonate’s head 
before bringing them to the scan room in order to ensure that they would f it  
into the relatively small bore. None of the recruited babies were excluded 
on the basis of head size and there w ere no scan fai lures because of head 
size.  
There are no specif ic safety concerns about exposing a neonate to a 3T 
static magnetic f ield, 2  although the strong f ield gradient at the entry to this 
magnet (39.8 T/m) requires a str ict protocol to prevent ferro magnetic 
materials from entering the scan room. Parents completed MR safety 
screening forms for their baby and themselves, as one parent was allowed to 
accompany their baby in the scan room. Any monitoring device or other 
equipment not compatible with MR s canning was removed, and the baby 
changed from their usual clothing into a Velcro -fastened vest provided by 
the researchers to ensure there were no metal fastenings. Screening for 
metal prior to scanning was completed on arrival at the MR unit by the 
radiographer (DJ). The radiographer also ensured all  ferromagnetic personal 
items were removed from each adult and further visual inspection of the 
baby was supplemented by the use of a hand -held metal detector.  
Each baby’s temperature was monitored and recorde d in order to ensure the 
thermoregulat ion of the baby was not compromised during transfer and 
scanning. Temperature was f irst measured whilst the baby was sti l l  on the 
ward using a handheld electronic thermometer (Filac 3000, Covidien,  
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Mansfield, MA). A di sposable temperature probe was then attached to the 
baby’s axi l la using DuoDerm Extra Thin, hydrocolloid dressing  before 
transfer to the scanner suite. On arr ival,  temperature was recorded again 
using the handheld thermometer but once the baby was on the s canner the 
probe was connected to an MR-compatible monitoring system with a free -
standing monitor in the scan room and a table top slave monitor in the 
control room ( Invivo Expression MR400, Phil ips Healthcare, Eindhoven, 
Netherlands). Temperature was monitored continuously during scanning 
along with heart rate and blood oxygen level of the baby.  The f inal 
temperature was recorded on return to the ward.  A further issue for close 
consideration is the acoustic noise created by the scanner, which can have 
equivalent continuous sound levels of around 102 db(A) for some of the 
sequences we planned to use. As such, noise reduction of at least 22dB was 
required, in order to comply with IEC 60601 -2-33 standards. This was 
achieved by using a combination of earplugs a nd ear protectors. Mack’s® 
mouldable earplugs (McKeon Products, Inc. Warren, MI) gave a noise 
reduction rating of 22 dB (manufacturer’s  data) and the additional use of 
MiniMuffs® (Natus Medical Inc. Pleasanton, CA) provide an extra 7 dB noise 
reduction (manufacturer’s data). These were applied just before entrance to 
the scan room. 
Babies were transferred from the ward to the MR suite in their standard -
care cot by the specialist  research nurse accompanied by the parent(s). The 
baby was placed in a disposable sl ing, which swaddled them closely in order 
to minimise motion, help maintain body temperature and provided a secure 
method of transfer into the cradle of the scanner. The scan cradle is built  
into the scan table, which is detached from the scanner and b rought into the 
control room. The scan table holding the baby was then taken into the scan 
room and manually docked with the scanner. A sl ide system with dual rulers 
on the bed and scan cradle were used to position the baby’s head at the iso -
centre of the scanner without the need for electr ical drives for the table or 
positioning lasers. The whole transfer process is shown in f igure 2. In the 
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event of an emergency or subject distress, the bed can be rapidly detached 
from the scanner and brought into the sca n control room, where appropriate 
care can be provided.  
 
MR methods 
Exposure to the magnetic f ield was l imited to one hour, including time 
allowed for accl imatisation to the scan room, monitoring at the start and  
end of scanning, positioning of the baby in  the scanner, and pacifying when 




F i g u r e  9 . 1 . 2 .  P r e p a r a t i o n  o f  a  b a b y  f o r  M R  s c a n n i n g  o n  F i r e f l y  i l l u s t r a t e d  b y  a  ‘ m o c k ’  c a s e  u s i n g  a  m a n n e q u i n  
a n d  r e s e a r c h  s t a f f  ( s e e  t e x t  f o r  f u l l  d e t a i l s ) .   T h e  b a b y  i s  c h a n g e d  i n t o  c l o t h e s  w i t h  n o  f e r r o - m a g n e t i c  
c o m p o n e n t s  o n  t h e  w a r d  a n d  a n  a x i l l a r y  t e m p e r a t u r e  p r o b e  i s  a t t a c h e d  ( 2 a ) .  A f t e r  t r a n s f e r  t o  t h e  a t r i u m  i n  t h e  
M R  s u i t e  t h e  b a b y  i s  r e - c h e c k e d  f o r  a b s e n c e  o f  f e r r o - m a g n e t i c  i t e m s  a n d  e a r  p l u g s ,  e a r  d e f e n d e r s  a n d  a  v i t a l  
s i g n s  m o n i t o r  a r e  a p p l i e d  ( 2 b ) .  T h e  b a b y  i s  p l a c e d  i n  a  t r a n s p o r t  s l i n g  ( 2 c )  a n d  t r a n s f e r r e d  o n  t o  t h e  s c a n  
c r a d l e  o f  t h e  t a b l e t o p ,  w h i c h  h a s  b e e n  d e t a c h e d  f r o m  t h e  M R  s c a n n e r  ( 2 d ) .  T h e  t a b l e  a n d  b a b y  a r e  p u s h e d  i n t o  
t h e  s c a n n e r  r o o m  ( 2 e ) ,  t h e  t a b l e  i s  d o c k e d  w i t h  s c a n n e r  a n d  t h e  c r a d l e  m a n u a l l y  s l i d  i n t o  t h e  b o r e  o f  t h e  M R  
s c a n n e r  ( 2 f ) .  
 
research nurse was satisf ied that the baby was settled and the init ial 
monitoring adequate. The research nurse stayed with the baby during 
scanning in order to monitor the baby visually and stop the scan if  there was 
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any concern. Approximately 40 minutes of image acquisit ion time was 
avai lable during an uneventful scan event. We wished to optimise a full  
range of imaging sequences on Firefly which paralleled our current clin ical 
MR imaging protocol  on a 1.5T scanner as shown in table 1. We a lso wanted 
to develop MR arteriography and venography sequences that would be used 
in relevant cases.  
Development of the MR protocol involved refining and trial l ing a single 
sequence before focusing on the next sequence. To begin with the imaging 
parameters for the T2 weighted imaging were modified until  optimal 
contrast, resolution and scan time were achieved for both ultrafast single 
shot fast spin echo (ssFSE) and T2 FSE imaging. The best sequences were 
acquired in all  subsequent cases. Long TE single v oxel proton spectroscopy  
and T1-volume imaging sequences were added and trialled in cases 6 -11, 
with diffusion weighted imaging and susceptibil ity weighted imaging 
(gradient echo T2* and sensitivity -weighted imaging) added in cases 9 -13. 
Cases 13-18 were used to evaluate and refine MR arteriography and 
venography sequences. All  sequences were acquired in cases 20 -49 with 
further f ine-tunings being made to the sequences for full  optimisation. The 
last f ive cases were scanned with a protocol provided by the s ponsor of the 
research study in order to provide the data suitable for appl ication for CE 
marking.  
In accordance with Ethics Committee approval,  all  of the images were 
reviewed soon after the study by one or both of the two experienced 
paediatric neuroradiologists involved in the study (DJAC, PDG). This f irst 
review was made in order to report any unexpected intracranial f indings to 
the neonatologist caring for the baby. Two to three weeks later the images 
were formally reviewed by both reporters by consens us in order to assess 
the quality of the imaging and recommend any changes to the sequence 
parameters for future scanning. The neuroradiology reporters were asked to 
rate the overal l  qual ity of the imaging dataset as either i) ful ly evaluable .  
136 
 



























10 6262 600 7000 57.5 1500 21 35 




60 15 124 23 144 3.4 5 
Flip Angle 90 8 110 15 142 25 90  20 10 
Bandwidth(KHz) 31.25 15.6 50 15.6 15.6 31.3   27.8 21 
PREP TIME - 900 - - - - - - - 
Echo Train Length  - 20 - 16 5 - - - 
NEX 0.55 0.75 2 2 2 0.7   1 0.63 
Slice Thickness/ 
Slice Gap (mm) 
3/0 1.0/0 4/0 
3.0/
0.3 
3/0 3/0 15 1/0 2.4/0 



























  384/224 
320/
192 
b Value -  - 1000 - - - - - - 
Scan Time (Secs) 29 264 192 180 231 173 140 240 364 
Additional    
ZIP512 
ZIP2 
















 (each sequence is of  diagnostic quality),  i i)  part ially evaluable (some 
sequences degraded but a clinical report would have been possible) or i i i)  
Not evaluable i .e. a cl inical report could not have been made. The assessors 
were also asked to compare a number o f aspects of image quality against 
the current reference standard at our institution, namely MR imaging at 
1.5T. ‘Poor’ was used if  the quality measures were worse than the current 
clinical standard, ‘Average’ if  comparable and ‘Good’ if  better than curren t  







54 families provided consent for their baby to come into the study but in 
one case consent was withdrawn before the MR study was performed. In 
another case, we attempted to scan a baby but no diagnostic images were 
obtained because of equipment failure, th erefore 52 babies had successful 
MR imaging. Approximately 60% of the babies scanned were born at term, 
defined as more than 37 gestational weeks (gw) and approximately 40% 
were born before 37gw. The median corrected gestat ional age at the time of 
the MR study was 39gw (interquarti le range 36 -40gw, full  range 34-43gw), 
median weight was 2.8kg ( interquartile range 2.4 -3.4kg, full  range 1.3-4.5kg) 
and median head circumference 34.0cm (interquartile range 32.6 -35.8cm, 
full  range 28.3-39.0cm). There was one rep ortable adverse event –  a term 
baby in whom a baseline bradycardia was detected during scanning but on 
investigation this had also been noted before MR imaging and so it  was not 
thought to be attributable to the procedure. The ECG was normal and the 
baby went home the same day and the neonatologist judged that no follow 
up was required.   
 
The MR imaging studies from Firefly were considered to be evaluable in 
52/52 (100%) of the babies scanned, of which 22/52 (42%) were fully 
evaluable and 30/52 (58%) were partial ly evaluable. Examples of MR images 































F i g u r e  9 . 1 . 3 .  R e p r e s e n t a t i v e  i m a g e s  f r o m  a  n o r m a l  b a b y  b o r n  a t  T e r m  s h o w i n g  t h e  r a n g e  o f  r o u t i n e  s e q u e n c e s  



















F i g u r e  9 . 1 . 4 .  R e p r e s e n t a t i v e  i m a g e s  f r o m  a  n o r m a l  b a b y  b o r n  a t  T e r m  s h o w i n g  M R  a r t e r i o g r a p h y  a n d  M R  
v e n o g r a p h y  i m a g e s  s e q u e n c e s  o p t i m i s e d  i n  c a s e s  1 3 - 1 8  i n  t h i s  s t u d y .  
 
The assessors judged the overall  image quality to be at least comparable to 
the quality on the cl inical 1.5T scanner in 47/52 (90%) of cases and better 
than 1.5T in  34/52 (65%). Similar results were found for image contrast, 
signal to noise rat io,  t issue contrast and homogeneity. The worst results 
were for artefacts, which were thought to be worse than on 1.5T in 13/52 












5 13 34 90% 
Image contrast 4 8 40 92% 
Presence of 
artefacts 
13 20 19 75% 
Signal to noise 
ratio (SNR) 
7 7 38 87% 
Tissue contrast 2 9 41 96% 
Fat/water 
homogeneity 
0 22 30 100% 
T a b l e  9 . 1 . 2 .  I m a g i n g  q u a l i t y  a s s e s s m e n t s  m a d e  b y  t h e  p a e d i a t r i c  n e u r o r a d i o l o g y  e x p e r t s .  
 
Two babies had unexpected intracranial f indings on their MR examinations 
that required discussion and cl inical input from the neonatology staff:   
 
 
Case A (f igure 9.1.5) .  A boy born at 37gw (weight 2.59kg and head 
circumference 34.0cm) and scanned on day 1  with no cl inical concerns. 
Haemosiderin staining of the ependyma was shown in both occipital horns 
and in both caudate-thalamic notches consistent with earl ier haemorrhage. 
Clinical review was made the day after the MR examination after the 
f indings had been discussed and the baby was allowed home with no need 













F i g u r e  9 . 1 . 5 .  R e p r e s e n t a t i v e  a x i a l  g r a d i e n t  e c h o  T 2 *  i m a g e s  f r o m  c a s e  A  d e s c r i b e d  i n  t h e  t e x t  s h o w i n g  s m a l l  
a r e a s  o f  h a e m o s i d e r i n  s t a i n i n g  i n  t h e  c a u d a t e - t h a l a m i c  n o t c h e s  b i l a t e r a l l y  c o n s i s t e n t  w i t h  p r e v i o u s  
h a e m o r r h a g e  i n t o  t h e  r e m n a n t s  o f  t h e  g e r m i n a l  m a t r i x  ( a r r o w e d  –  5 c ) .  
 
Case B (f igure 9.1.6).  A boy born at 37w and scanned on FIREFLY on day 2. 
His weight was 2.7kg and his head circumference was 34.0cm. There was a 
small volume of intra-ventricular haemorrhage in both occipital horns and a 
developmental venous anomaly in right frontal lobe. Cl inical review was 
made the following day after the f indings had been discussed and the baby 



























F i g u r e  9 . 1 . 6 .  R e p r e s e n t a t i v e  a x i a l  F S E  T 2 *  i m a g e s  f r o m  c a s e  B  d e s c r i b e d  i n  t h e  t e x t  s h o w i n g  a  s m a l l  v o l u m e  o f  
i n t r a v e n t r i c u l a r  b l o o d  i n  t h e  g r a v i t y  d e p e n d a n t  p a r t s  o f  t h e  o c c i p i t a l  h o r n s  o f  t h e  l a t e r a l  v e n t r i c l e s  ( a r r o w e d  -  
6 a )  a n d  a  t u b u l a r  s t r u c t u r e  r u n n i n g  t h r o u g h  t h e  r i g h t  f r o n t a l  l o b e  a n d  t e r m i n a t i n g  i n  t h e  s u p e r i o r  s a g i t t a l  s i n u s  






The work reported in this paper is the f irst part of a wider study designed to 
improve access to MR scanning facil it ies for newborn babies and 
subsequently attempt to quantify the diagnostic and cl inical impact of 
making MR more widely available. We have t aken the approach of instal l ing 
a high-field MR scanner on the neonatal unit at our Institution in order to 
reduce the risks of transferring babies to MR imaging facil it ies. This is not 
the only possible approach and another method is the use of  an MR -
compatible transport incubator, which reduces the number of  t imes the 
baby has to be handled during transportation and provides a controlled 
physical environment during scanning. If  a baby is transferred from the ward 
to the MR scanner without a transport incu bator he/she must be handled 
four t imes, twice of the ward (in and out of the cot/incubator) and twice in 
MR scan room (on and off the scanner). The MR compatible transport 
incubator has a built  in MR receiver coi l  so the baby goes into the scanner in 
the incubator reducing the number of handling events to two, both of which 
occur on the ward where neonatal staff  are available if  there is cl inical 
deterioration during handling. Our group was involved in the early prototype 
trials of one such system that is commercially available 3  and we have 
designed and built  our own MR-compatible incubator, 4  which we use for 
clinical purposes at present.  
 
Although the use of MR-compatible incubators works well ,  we maintain that 
an MR scanner on the neonatal unit is a fund amentally safer approach. It  is 
generally not practicable to instal l  whole body MR scanners on the neonatal 
unit in most hospitals because of the space required and the f loor loading 
constraints due to the heavy weight ( in the order of 12 tonnes) of whole -
body MR scanners. The hospitals that have created that type of facil ity have 
done so mainly because they have designed new departments with the 
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express intention of accommodating a whole -body MR scanner. Other 
centres have approached the problem by develop ing MR services optimised 
to meet the needs of imaging neonates on standard cl inical MR scanners 
(1.5T and 3T) by using tailored equipment and/or care measures. 5 , 6   
 
There have also been several other attempts to construct small foot -print 
systems for neonatal  imaging. Our group previously reported experience of 
using a 0.2T permanent magnet system, which had CE marking for neonatal 
imaging.7   There have also been more recent developments using low field 
MR systems for neonatal scanning (0.023T), 8  and the FDA has recently 
approved the f irst commercially avai lable small ,  1.0T neonatal  MR system 
designed to accommodate the needs of the neonate. 9  In spite of those 
developments, we came to the conclusion based on our experience of 
neonatal imaging at 0 .2T that the highly detailed requirements for neonatal 
brain imaging (e.g. spectroscopy, diffusion imaging, MR angiography) require 
MR imaging at 1.5T or higher f ield strength. Considerable steps forward have 
been made by Tkach and colleagues who successfu lly developed a small -
footprint 1.5T system which they sited on a neonatal unit and have 
successfully imaged several anatomical areas 1 0 .  They have subsequently 
reported their experience of 492 premature neonates. 1 1  In this paper, we 
have demonstrated that a physical ly small,  3T MR scanner is a feasible 
option for imaging the neonatal brain and its smaller s ize/ low weight allows 
placement above ground level and on the neonatal unit without the need for 
additional major structural alterations. This is becaus e for safety reasons 
neonatal units should not be housed at ground level so that the risk of theft 
of babies is reduced. We believe that the theoretical improvements in signal 
to noise ratio provided by imaging at 3T offer the best potential imaging for 
the neonatal brain because of the requirements of high-quality multi-
sequence imaging and spectroscopy in as short a t ime as possible. It  should 
be noted that the FDA guidelines confirm that MR devices with main static 
magnetic f ields of ≤4.0T should be clas sif ied as a ‘non -signif icant risk’ for 
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neonates.1 2  There are disadvantages of scanning at 3T, however, such as 
increased SAR, increased acoustic noise and more artefacts arising from for 
example susceptibil i ty effects and field homogeneity problems. The pr oblem 
with artefacts is compounded by the small size of the Firefly scanner and the 
clinical raters considered MR artefacts to be a concern in 25% of cases 
(although all  cases were considered reportable). This issue wil l  require 
further work in future stud ies.  
 
The safety of the babies taking part in this study was of paramount 
importance and a close col laboration between the MR imaging and neonatal 
unit staff  was vital.  The neonatal staff  involved in the transfer and scanning, 
coupled with the location of the MR scanner allowed good access, rapid 
assessment and transfer of babies back to the wards. The involvement of 
neonatologists in the study facil itated specialist  medical care and 
intervention if  required. This was not required in any of the 52 babies 
scanned in this study, although a consultant opinion was sought in three 
cases (one baby with a bradycardia and two babies with unexpected intra -
cranial f indings). The increased acoustic noise associated with using Firefly 
was successfully managed by the use  of two types of ear protection. In 
addition, one of the major factors that influence image quality in neonatal 
imaging is movement of the baby and we have taken a feed and swaddle 
approach which appears highly beneficial for settl ing the babies. 1 in 52 
scans stopped early due to movement but the study was partially evaluable. 
Close physiological monitoring of the babies did not reveal any adverse 
effects leading to problems with desaturation or thermoregulation. 
Thermoregulation is particularly important because of two competing 
factors. The scan room is kept at 22 -24°C but the increased radiofrequency 
strength at 3T can potentially cause heating, particularly in a neonate whose 
abil ity to adapt to changes in external temperature are l imited. Our results 
showed no problems with temperature control and support the f indings of 
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Cawley et al .  who measured the core temperatures of neonates during 
scanning at 3T and found no signif icant effects. 1 3   
 
At the planning stage of this study, we were prepared to take i mage qual ity 
that was ‘no worse’ than that obtained on our routine clinical  scanning on a 
whole body 1.5T system as an acceptable outcome. This equivalence 
approach is justif ied by the extra advantages in terms of safety by having 
the Firefly scanner close  to the neonatal units. Our results show that the 
quality was at least equivalent to 1.5T in the majority of cases (90%) and 
were judged to be better than the 1.5T images in nearly two thirds of cases. 
We also have the ful l  range of MR sequences that we wo uld expect to be 
used in the clinical environment al l  of which produced high quality images. 
The next stage is to see if  this can be reproduced in babies that have or are 
expected to have acute brain pathology. At the time of writing this report an 
applicat ion for CE approval has been submitted. If  approval is  granted, then 
we will  start to perform cl inical cases on Firefly rather than on our whole 
body 1.5T in both premature and term babies that are fundamentally stable 
as we do not have the capacity to ha ndle ventilated babies at the present 
t ime. We will  judge whether the sequences developed so far allow Firefly to 
demonstrate pathology or if  further ref inements are necessary.  
 
In conclusion, we have described a new class of high f ield MR scanner that 
has been designed specif ically for imaging neonates and is small enough to 
be sited on neonatal  units. Our init ial assessments of safety and technical 
performance are favourable, and the next stage is to move on to evaluate 
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9.2 Involvement of the anterior lobe of the cerebellar vermis in perinatal profound 
hypoxia.   
 
Connolly DJA,  Widjaja E, Griff iths PD.  
 
American Journal of Neuroradiology (2007); 28: 16-19. 
 
The Vancouver group had previously reported the focal loss of volume and mild 
gliosis that affects the anterior lobule of  the cerebellar vermis in some children 
who have suffered an acute profound perinatal asphyxia at beyond 36gw 
(Sargent et al).  This focal injury to the vermis we considered to be most l ikel y 
to have occurred in the more severe cases of brain injury from acute profound 
HIE.  
 
We needed to develop an MR head scoring system to decide upon the severity 
of brain injury at follow up MR imaging beyond 2 years of age when myelination 
is complete. The scoring system was based upon a combination of the number 
of regions of the brain that were involved, extent of signal change in a 
structure and degree of volume loss in the brain structure. The regions of the 
brain assessed included the classical triad o f the posterior putamen, antero -
lateral thalamus and the Rolandic (paracentral) cortex and underlying white 
matter. The medial temporal lobes (hippocampi) and head of  caudate nucleus 
were also observed as it  was already acknowledged that these other region s of 
the brain could also be injured during acute profound HIE.  
 
We scored the brain insult as mild, moderate or severe and then demonstrated 
that it  was more l ikely that there would be involvement of the vermis if  there 




Background and Purpose.  We report abnormal high T2 signal in the anterior 
lobe of the cerebellar vermis, which we believe was the result  of profound 
hypoxic ischemic encephalopathy in the perinatal period in term infants. We 
tested the hypothesis that  this sign was associated with other signs of 
signif icant perinatal hypoxic damage.  
 
Methods. 30 patients with clin ically and radiologically  confirmed perinatal 
profound hypoxia close to term were included in the study. The cranial MR 
images were reviewed by two pediatric neuroradiologists and were scored for 
the presence and severity of hypoxia / ischaemia in the regions classically 
affected by profound hypoxia .  The presence or absence of high T2 signal in the 
vermis and other sites was correlated with the  extent of damage  in classical ly 
affected regions.  
Results. 18/30 patients had high T2 signal in the vermis. The presence of 
vermian damage correlated positively with radiological evidence of severe 
hypoxic damage and extremely poor (0 or 1) one -minute Apgar scores .  
Conclusion. High T2 signal in the anterior lobe of the vermis probably 
represents gliosis secondary to hypoxia/ischaemia and is related to the severity 




Introduction   
 
Perinatal hypoxic/ ischemic encephalopathy (HIE) in the term infant is a 
catastrophic clinical event and may have considerable long -term patient care 
implications.  The regions  of the brain damaged by HIE depend on several 
factors, but most importantly the degree and duration of the hypoxia and the 
maturity of the brain at the time of the insult.  Short periods of very severe HIE 
in children born at or close to term has been ter med ‘profound hypoxia’ in the 
past.  This produces a highly characterist ic pattern of gl iosis in the posterior 
putamen, ventrolateral thalamus, paracentral white matter and hippocampus 
(1). Another region of select ive vulnerabil ity, the anterior lobe of th e cerebellar 
vermis (ALV) is recognised and in this paper we describe the frequency and 





Materials and Methods  
 
Thirty consecutive patients were included in this study who had been referred 
to our institution for MR examinations to investigate possible HIE in the 
perinatal period. No patients were excluded from these consecutive referrals 
but patients with severe HIE who failed to survive the f irst nine months of l ife 
could not be included in this study population. Al l  patients had Apgar scores of 
6 or less one minute after birth (range 0 -6, median 1). Cord pH measurements 
had been made in 18/30 and all  were 7.1 or lower (15 below 7.0). Heart rate 
measurements were avai lable in 22/30. The heart rate was not recordable in  
eight patients, less than 100 beats per minute in thirteen patients and more 
than 100 beats per minute in one patient. All  these children had long -term 
static neurological deficits, either hemiplegia or quadriplegia,  and twenty 
children had dyskinesia. Al l  patients were born between 37 -42 weeks gestation 
as calculated from last menstrual period and fetal ultrasound imaging data and 
birth weights ranged from 2.3kg to 4.2kg.  None of the patients included in this 
group had a documented evidence of hyper -bil irubinaemia or hypoglycaemia.  
 
MR imaging showed patterns of damage distribution consistent with textbook 
descriptions of profound hypoxia and no patients had any suggestion of 
developmental brain pathology (1).  Al l  patients had an MR imaging at 1.5T 
(Eclipse or Infinion, Phil l ips Medi cal Systems) and ages at the time of scanning 
ranged from 1 to 24 years.  Imaging consisted of axial and coronal fast spin 
echo T2W, axial and sagittal spin echo T1 images and fast spin echo FLAIR 
images in either the axial or sagittal plane.  
 
Two experienced pediatric neuroradiologists (DJAC, PDG) reviewed the hard 
copy images and a consensus opinion was attained without knowledge of the 
clinical information at the time of image review. The posterior putamen, 
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ventrolateral thalamus and paracentral white m atter changes were graded 0 to 
3 (0 for no change, 1 for signal change but no volume loss, 2 for early volume 
loss and signal change and 3 for signif icant volume loss). A total score of these 
abnormalit ies was recorded. The presence of abnormal s ignal othe r regions was 
noted (e.g. hippocampus or caudate) as well  as the condition of the ALV.  
 
F i g u r e  9 . 2 . 1  F i v e  y . o .  g i r l  w i t h  a t h e t o i d  s p a s t i c  q u a d r i p l e g i a . a )  A x i a l  T 2 .  M i l d  s i g n a l  c h a n g e  i n  t h e  p e r i r o l a n d i c  w h i t e  
m a t t e r . b )  A x i a l  T 2 .  T y p i c a l  s i g n a l  c h a n g e  i n  t h e  p o s t e r i o r  p u t a m e n  a n d  t h e  v e n t r o l a t e r a l  t h a l a m u s  b i l a t e r a l l y . c )  
A x i a l  T 2 .  T y p i c a l  s i g n a l  c h a n g e  i n  t h e  a n t e r i o r  l o b e  o f  t h e  v e r m i s . d )  A x i a l  T 1 .  L o w  T 1  s i g n a l  c h a n g e  i n  t h e  v e r m i s . e )  
A x i a l  F L A I R .  H i g h  T 2  s i g n a l  a n d  c y s t i c  c h a n g e . f )  C o r o n a l  T 2 .  A n t e r i o r  l o b e  o f  v e r m i s  h i g h  T 2  s i g n a l  c h a n g e .  
 
 
The clinical information recorded included gestational age and birth weight, 1 - 
and 5-minute Apgar scores, lowest r ecordable heart rate in the perinatal period 
(normally a cardiotocograph or scalp electrode reading) or at  birth, age at MRI 
and clinical symptoms. The Apgar score at one minute was categorised into 
those with a score of 0 or 1 (clinically severe) and thos e with a score of 2 to 6 
(clinically moderate).  The total score of putamen, thalamus and paracentral 
white matter abnormality was also categorised into those with a combined 
score of 6 or more (radiologically severe) and those with a score of 5 or less 
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(radiologically moderate ) .  Chi-square analysis was performed between ALV 
signal change and one-minute Apgar, ALV signal change versus low and high 
total scores of putamen, thalamic and paracentral white matter, ALV and 
hippocampal signal change, and hippocamp al signal change and total score.  
 






In the 30 patients 97% had putaminal, 90% thalamic and 87% paracentral white matter changes 
(Table 9.2.1). 18/30 (60%) patients demonstrated high T2 signal in the superior vermis.  
The total score of changes in the posterior putamen (0-3), ventrolateral thalamus (0-3) and 
paracentral white matter (0-3) was scored out of nine with 15 patients scoring 5/9 or less and 
15 scoring 6/9 or more. Those with high ALV T2 signal are more likely to have a high total score 
(p= 0.02). There was no association between high total score and hippocampal or caudate 





*Total score of the abnormalities seen in putamen, thalamus and paracentral white matter (PCWM)  **bpm – beats per minute 
Table 9.2.1 Individual case data for assessment of brain injury from acute profound asphyxia including vermian injury 
Case  Age  
yrs  
Apg ar  
1  m in  
Apg ar  
5  m in  
Heart  rat e  
bp m  
pu tame n  tha la mu s  PCWM  Tot a l  
sc ore  
vermis  ot hers  
1  4  6  6  >1 0 0  2  2  1  5  0  0  
2  2  1  3  8 0  3  3  2  8  1  H ip p o c a m p u s ,  
ca u d a t e  
3  3  0  2  7 0  2  3  2  7  1  0  
4  1 5  0  1  u n r ec o r d a b l e  1  3  2  6  1  0  
5  4  1  7  6 0  3  3  3  9  1  H ip p o c a m p u s  
6  1  1  2  6 0  2  1  1  4  1  H ip p o c a m p u s  
7  1  1  5  <2 0  3  2  2  7  1  H ip p o c a m p u s  
8  1 4  1  2  U n r ec o r d a b le  2  2  2  6  1  H ip p o c a m p u s  
9  6  0  3  U n r ec o r d a b le  2  1  1  4  0  0  
1 0  7  6  9   2  1  2  5  0  0  
1 1  5  2    1  3  2  6  1  C a u d a te  
1 2  5  3  5   1  2  1  4  1  h ip p o ca m p u s  
1 3  5  0  4  U n r ec o r d a b le  3  3  2  8  1  0  
1 4  1 2  1  6   1  0  3  4  0  0  
1 5  3  1  5  4 0 - 6 0  2  2  1  5  1  h ip p o ca m p u s  
1 6  2 4  1  5   2  2  0  4  1  0  
1 7  1  3  5   3  0  2  5  0  C a u d a te  
1 8  5  1  0   3  3  3  9  1  0  
1 9  1  0  0  U n r ec o r d a b le  2  2  1  5  0  0  
2 0  2    U n r ec o r d a b le  2  2  0  4  1  H ip p o c a m p u s  
2 1  2  2  3  7 7 0  2  3  2  7  0  0  
2 2  2  5  6  8 0  3  3  3  9  1  0  
2 3  1  1  1  6 0 - 8 0  2  2  2  6  1  h ip p o ca m p u s  
2 4  4  4  8  7 0  0  0  2  2  0  C a u d a te  
2 5  2  4  6  6 0  2  1  3  6  0  C a u d a te  
2 6  2 2  0  2  U n r ec o r d a b le  1  2  0  3  1  0  
2 7  1 5  6  7  U n r ec o r d a b le  2  2  1  5  0  0  
28 4 6 8  2 2 2 6 1 hippocampus 
29 7 1 4 60 2 2 0 4 0 0 




17 of 30 infants had clinically severe HIE (1-minute Apgar of 0 or 1). There was a significant (p = 
0.020) association between low Apgar score (0 or 1) at 1-minute and the presence of ALV high 
T2 signal. There was however, no significant association between the 5-minute Apgar and high 
signal in the ALV (p>0.05). One-minute Apgar and total score were shown to have no direct 
association (p>0.05).  
 
 
Figure 9.2.3 S e v e n  y . o .  b o y  w i t h  s e v e r e  s p a s t i c  q u a d r i p l e g i a  a )  A x i a l  T 2 .  S e v e r e  s i g n a l  c h a n g e  a n d  v o l u m e  l o s s  i n  t h e  
p e r i r o l a n d i c  w h i t e  m a t t e r . b )  A x i a l  T 2 .  S e v e r e  p u t a m i n a l  a n d  t h a l a m i c  v o l u m e  l o s s  a n d  h i g h  T 2  s i g n a l  b i l a t e r a l l y . c )  







Cerebral palsy defines a group of neurological conditions involving motor 
disorders with neurological signs result ing from brain damage that is static and 
has occurred in early l ife (2). Patients with underlying metabolic disorders, 
hydrocephalus, brain tumours and various other disorders by convention are 
excluded from the cerebral palsies. HIE in the perinatal period contributes a  
signif icant proportion of the total number of cases and three ‘text -book’ cl inical 
and radiological patterns are recognised. Hypoxia/ischaemia severe enough to 
cause brain damage before the 35 th  week of gestation usually produces 
‘periventricular leukomalacia’ with the white matter immediately next to the 
ventricles being most affected. As the fetus matures, the pattern of 
involvement changes due to alterations in the site of the vascular watershed 
zones (1). For example, a 40-week fetus exposed to a long period of low-grade 
hypoxia will  cause damage to the parasagittal white matter. In contrast, a 40 -
week fetus exposed to acute severe hypoxia will  damage areas of the brain that 
are most metabolically active, including the putamen, thalamus and paracentral 
white matter.  
 
MR imaging has long been identif ied as the method that provides important 
information related to the timing and severity of HIE, with altering patterns of 
structural involvement depending on the age of the patient (3). Posterior 
putamen and ventrolateral thalamic gliosis is associated with extra -pyramidal 
symptoms in cerebral palsy (4) (f igures 1b and 3b). Paracentral lobule high T2 
signal change and volume loss is another site of involvement typical of HIE in a 
term infant (f igures 1a and 3a). The reason for the specif ic selection of these 
foci for damage in HIE is uncertain but some authors consider that they may be 
selected as they are areas of active myelination in the term infant (5). The 
reason why the vermis is selectively injured in pr ofound HIE may differ from the 
above active myelination (5a). The vermis is rich in Purkinje cells,  a group of 
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cells some of which may be deficient in aldolase C and EAAT4. Aldolase C is a 
fructose-bisphosphonate aldolase family enzyme expressed specif ical ly in the 
hippocampus and Purkinje cel ls of the brain and is a key enzyme in the 4 th  step 
of glycolysis and is therefore crucial in ATP synthesis. Excitatory amino acid 
transporter 4 is expressed specif ically in the cerebellum and has high affinity 
for excitatory amino acids such as L -aspartate and L-glutamate leading to 
chloride ion conduction. EAA4 is involved in regulation of membrane potential.  
Aldolase C and EAAT4 deficiency means that these cells are unlikely to survive 
intense synaptic input after th e restoration of blood flow.  
  
Recent studies have assessed the use of new MR techniques such as diffusion 
weighted imaging and MR spectroscopy in the investigation of patients with 
HIE. Diffusion weighted imaging has been shown to demonstrate abnormalit ie s 
in the thalami and internal capsule in the f irst day of HIBI,  when conventional 
MR imaging is normal (Barkovich 2001). Diffusion weighted imaging however, 
underestimated the extent of the long -term injury (Robertson 1999; Barkovich 
2001). Delayed neuronal and oligodendroglial cell  death due to apoptosis in 
areas with lower metabolic demand may explain the reason that diffusion 
weighted imaging underestimates the extent of injury (Robertson 1999).  
Diffusion weighted images obtained between the second and fourth day of l ife 
reflects the extent of injury more reliably. By the seventh day, diffusion MR is 
less sensitive to perinatal brain injury compared to conventional MR because of 
transient pseudonormalization of diffusion images (McKinstry 2002).  
 
Barkovich et al  used single voxel MR spectroscopy centred on the basal ganglia 
or watershed vascular region in asphyxiated term neonates to predict 
developmental status at 12 months (8). High lactate ( lactate/choline ratio) 
correlated with poor neuromotor outcome. Kuenzle et al  have demonstrated an 
association between changes seen in the f irst week post -delivery of signif icant 
brain injury on MRI ( including diffuse brain injury and basal ganglia/thalamic 
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signal changes) with poor developmental outcome (9). However, a normal CT or 
MRI performed in the f irst few weeks of l ife did not preclude later neurological 
dysfunction (10). The optimal t iming and technique for an MRI to assess for HIE 
is therefore uncertain. An MRI in the f irst  few days of l ife allows cli nicians to 
provide families with information on prognosis. An MRI after two years of age 
when myelination is complete wil l  al low more complete assessment of HIE 
related brain damage.  
 
We have described ALV high T2 signal for HIE in the term infant. ALV hig h T2 
signal is most easily seen on coronal image. In more severe cases there may be 
volume loss. This sign may assist in the correct diagnosis of HIE birth injury and 
should not be interpreted as showing second pathology. It  should be 
appreciated that spur ious high signal change can sometimes be seen in the 
cerebel lum on T2 weighted images if  there is loss of brain volume and CSF is 
partial volumed into the voxel. We are confident that this is not the case in our 
patients because the high signal is also see n on proton density and FLAIR 
images. It  is most l ikely that the T2 prolongation is due to gliosis as in the other 
regions of the brain affected by profound HIE.  
 
In adults, in jury to the vermis normally results in truncal ataxia. A larger study 
than this would be required to assess if  this radiological sign is associated with 
specif ic symptoms and signs that can be attributed to injury to the vermis in 
patients who often have signif icant neurological deficits. However, it  should be 
noted that the extensive  involvement of the other regions of the brain might 
make attributing functional implications of ALV damage diff icult or impossible.  
 
Levene et al  stated that severity of encephalopathy in HIE could be graded 
retrospect ively on the basis of a set of cl inic al signs (11, 12). MR changes of HIE 
in the pediatric population have been shown to correlate with neurological 
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outcome (13). There is an association in our study of ALV high T2 signal with 
both lower one-minute Apgar scores and with a higher overall  score  for 
radiological evidence of HIE. The ALV high T2 signal sign may therefore be an 
independent predictor of HIE associated with signif icant neurological disabi l ity. 
We must accept that  the classif ication of putaminal, thalamic and white matter 
HIE signal and volume changes into mild, moderate and severe may appear 
arbitrary but this was completed as a consensus opinion by two experienced 
neuroradiologists blinded to the clinical outcome data. The correlation of a high 
overal l  score for MRI change of HIE and  vermian high T2 signal marks this as a 





Conclusion .   
The ventrolateral thalamus, posterior putamen and paracentral white matter 
(perirolandic gyrus) are known areas of brain injury man ifest as loss of volume 
and high T2 signal in  term infants with profound HIE in the perinatal period.  
We have described ALV high T2 signal as a sign of profound HIE in the term 
infant. ALV high T2 signal is associated with radiological and clinical indicat ors 
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9.3 Anatomic localisation of dyskinesia in children with ‘profound’ perinatal hypoxic-
ischemic injury.  
 
Griff iths PD, Radon M, Crossland AR and Connolly DJ.  
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The classic triad of damage seen in acute profound HIE involves injury with 
signal change and possibly volume loss affecting the posterior putamen, the 
antero-lateral thalamus and the cortex and underlying white matter of the 
Rolandic region. The Rolandic cortex is the motor cortex of the brain and 
therefore focal injury would be expected to induce a spastic motor injury.  
The posterior putamen is often injured in adult stroke cases and does not 
induce a dyskinetic (choreo-athetoid) motor disorder. An insult to the antero -
lateral thalamus would be expected to produce a sensory deficit .  
 
The question to be answered was which bit  of the brain if  injured would 
produce a choreo-athetoid cerebral palsy as is commonly seen in a cute 
profound asphyxia. Discussion with Alan Crossman in Manchester led to the 
suggestion that the sub-thalamic nucleus (a t iny structure often not identif ied 
on brain MR) would be a suitable anatomical substrate to produce the clinical 
features if  damaged in an acute profound HIE.  
 
We therefore reviewed a cohort of chi ldren injured by perinatal acute profound 





Two conclusions could be drawn from this work. Firstly, if  coronal T2 imaging 
was optimised to increase signal -to-noise and to reduce voxel size then in a 
signif icant proportion of these cases high T2 signal could be identif ied in the 
subthalamic nuclei. Secondly, if  there was signif icant injury to the Rolandic 
cortex then there would be a spastic rather than a dyskinetic cerebral palsy 
induced despite subthalamic nucleus involvement. It  was deduced that this was 
due to the insufficient motor cortex signal for movement and therefore 





Abstract    
Objective.  Dyskinetic cerebral palsy is a common feature of perinatal hypoxic -
ischemic brain damage in the context of 'acute profound' injury. This frequently 
produces damage to the basal ganglia and thalamus, but it  is diff icult  to explain 
how dyskinesias arise from that injury based on current understanding of 
functional neuroanatomy.  Specif ically, focal destructive lesions in those 
locations rarely produce dyskinesia.  In this paper we have made a detailed 
assessment of the extent of brain injury in children with dyskinetic and spastic 
cerebral palsy arising from acute profound hypoxic ischemic injury in order to 
explain why some children develop movement disorders whilst others do not.  
 
  Methods.   MR imaging was used to study 40 consecutive children referred to 
our centre with cerebral palsy confirmed to be the result of acute profound 
hypoxic/ischemic injury.  All  children received the same high -resolution MR 
imaging protocol using the same 1.5T scanner.  Two pediatric neuroradiologists 
reviewed the imaging independently.  
 
  Results.  Of the 40 children with confirmed acute profound hypoxic/ischemic 
injury 20 had dyskinetic cerebral palsy and 20 had spastic cerebral palsy. 
Children with dyskinetic cerebal palsy had a higher prevalence of injury to the 
subthalmic nucleus, as manifest by increased T2 signal. Children with spastic 
cerebral palsy had more severe gl iosis and loss of volume of white matter in the 
vicinity of the paracentral lobule. Injury to the putamen or caudate nuclei were 
not signif icant predictors for dyskinetic cerebal palsy.  
 
Conclusion.  We believe that injury to the subthalamic nucleus following hypoxic 
ischemic injury is central to the development of cl inical ly apparent dyskinesia.  
We propose that in cases with subthalamic injury but without dy skinesia severe 
injury to descending cortical efferent pathways prevents the manifestation of 
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the dyskinesia.  We discuss this hypothesis in terms of the known functional 







Children who have suffered relatively short periods of severe hypoxic/ischemic 
brain damage (HIBD) and subsequently develop cerebral palsy (CP) often have 
similar distributions of brain damage.  These were f irst described in pathology 
studies1  and more recently in magnetic resonance  (MR) imaging studies of 
children who have survived the init ial damaging event. There appears to be a 
predilection for the ‘central’  structures of the forebrain including the putamen 
and thalamus, often with highly specif ic patterns of injury, namely the p osterior 
t ips of the putamen and the lateral aspects of the thalami. 2  Other parts of the 
brain that may be injured with high frequency include the paracentral white 
matter (PCWM), optic radiat ions, hippocampus and cerebellar vermis. 3  Many 
clinicians who work with patients with cerebral palsy consider the injury to the 
putamen and thalami to be the anatomical substrate of the hallmark clin ical 
sequelae of ‘acute profound’ HIBD –  dyskinetic CP, often accompanied by 
preservation of intel lectual capacity.   
 
On closer review, however, there are several problems with that theory.  
Firstly, many children with the typical putaminal and thalamic injury do not 
have dyskinetic CP, instead they develop spastic cerebral palsy. Secondly, the 
part of the thalamus that is most frequently involved is not thought to have a 
motor function. It  is the ventral posterolateral nucleus, a primary 
somatosensory relay nucleus, that is injured in HIBD rather than the anterior 
region of the lateral thalamus which has a major role in mot or function.4  It  is,  
therefore, diff icult  to explain how injury at this site could produce dyskinesia.  
 
There is no doubt that the putamen has a central role in planning vol it ional 
movement. Generalized, inflammatory lesions of the putamen can produce 
movement disorders e.g.,  Sydenham’s chorea. Discrete destructive lesions in 
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the putamen, however, rarely produce dyskinesia although a few case reports in 
human patients exist  in the published l iterature .  
 
The purpose of this study was to make a detailed review  of the MR imaging in 
children who survived ‘acute profound’ HIBD and to correlate those f indings 
with the type of CP that resulted. In the l ight of the information given above we 
have looked for evidence of damage at other sites of the basal ganglia not 
usually thought of as being primarily involved in HIBD, specif ically substantia 
nigra, caudate nucleus, globus pall idus and subthalamic nucleus (STN).  By 
doing this we hope to add to the understanding of the pathophysiology of 







This was a prospect ive study in which a high -resolution MR clinical protocol was 
put in place to allow for a subsequent detailed review of anatomical injury. The 
study consists of 40 consecutive children referred for MR imaging at Sheffield 
Children’s Hosp ital.   All  had confirmed CP resulting from acute profound HIBD 
around the time of birth as defined by expert obstetricians, neonatologists and 
pediatric neurologists.  Their summary details are shown in table 1.   
 
MR acquisition and analysis  
All chi ldren were examined on the same 1.5T superconducting system (Infinion, 
Phil ips Medical Systems) under general anaesthesia with identical imaging 
protocols over a four-year period in l ine with the existing radiological protocols 
at our institution.  The imaging p rotocol consisted of a high resolution, mult i -
planar, multisequence protocol.  The assessments used in this study were made 
primari ly on the axial and coronal fast spin echo T2 -weighted (TR 3169ms, TE 
100ms, echo train length 8, two acquisit ions, sl ice thi ckness 4mm, f ield of view 
240mm matrix s ize 352x512) and on axial  fast spin echo ‘T2’ FLAIR images (TR 
10000ms, TI 2200ms, TE 109.6ms, echo train length 8, s l ice thickness 4mm, f ield 
of view 210mm, matrix size 192x256).  Two experienced pediatric 
neuroradiologists (DJC, PDG) reviewed the images on the manufacturer 
proprietary workstat ions independently and without knowledge of the clinical 
information.  A sample case showing the location of the STN on coronal T2 -



























F i g u r e  9 . 3 . 1 .   L o c a t i o n  o f  t h e  s u b t h a l a m i c  n u c l e u s .   T h e  n o r m a l  s u b t h a l a m i c  n u c l e u s  i s  n o t  s e e n  o n  T 2 - w e i g h t e d  
i m a g e s  a t  1 . 5 T  b e c a u s e  o f  i t s  s m a l l  s i z e  a n d  s i g n a l  c h a r a c t e r i s t i c s  c l o s e  t o  t h e  s u r r o u n d i n g  w h i t e  m a t t e r  s t r u c t u r e s .   
F i g u r e  1 a  i s  a  c o r o n a l  T 2 - w e i g h t e d  i m a g e  f r o m  a  c h i l d  w i t h  d y s k i n e t i c  C P  a r i s i n g  f r o m  h y p o x i c  i s c h a e m i c  i n j u r y  i n  
w h i c h  t h e  s u b t h a l a m i c  n u c l e u s  i s  s h o w n  b e c a u s e  o f  g l i o s i s  w i t h i n  t h e  n u c l e u s .   1 b  i s  a  l i n e  d i a g r a m  d e t a i l i n g  t h e  
r e g i o n a l  a n a t o m y  o f  t h e  d i e n c e p h a l o n .   
174 
 
A four-point scoring system (0 to 3) was used for assessing the s everity of 
involvement for the putamen, thalamus and the paracentral white matter as 
used in a previous study 3  with some modifications outlined here. Zero implied 
no radiological evidence of damage to that brain region on any MR sequence.  A 
score of 1 for the putamen implied the typical text -book appearance of 
involvement of the posterior t ip of the putamen, 2 de scribed involvement of 
the posterior half  of the nucleus whilst 3 described involvement of all  of the 
putamen.   Scoring of the thalamus now concentrated on the extent of signal 
change rather than volume loss. A score of 1 for the thalamus implied the 
typical text-book appearance of involvement of the ventral postero -lateral 
nucleus only, 2 described involvement of the central 50% of the thalamus whilst 
3 described involvement of all  of the structure.   The PCWM was graded as 1 if  
there was minor signal change on T2 sequences but no volume loss. A score of 
two was given if  there was both signal change and some volume loss confined 
to the PCWM and 3 i f  there was severe volume loss and/or white matter change 
extending out of the PCWM. Representative examples o f the scoring system are 
shown in f igure 2. The scoring was completed separately for both sides of the 
brain. A total score was then calculated for brain damage with a range from a 












F i g u r e  9 . 3 . 2 .  C l a s s i f i c a t i o n  o f  s e v e r i t y  o f  i n v o l v e m e n t  u s e d  i n  t h i s  p a p e r  f o r  t h e  p u t a m e n  a n d  t h a l a m u s  o n  T 2 -
w e i g h t e d  i m a g e s  ( 3 a - 3 c )  a n d  f o r  t h e  p a r a c e n t r a l  w h i t e  m a t t e r  o n  F L A I R  i m a g e s  ( 3 d - 3 f ) .  F i g u r e  3 a  s h o w s  g r a d e  1  
c h a n g e s  i n  t h e  p u t a m e n  a n d  t h a l a m u s ,  3 b  g r a d e  2  c h a n g e s  i n  p u t a m e n  a n d  t h a l a m u s  a n d  3 c  g r a d e  3  c h a n g e s  i n  b o t h  
s t r u c t u r e s .   3 d  s h o w s  g r a d e  1  c h a n g e s  i n  t h e  p a r a c e n t r a l  w h i t e  m a t t e r ,  3 e  g r a d e  2  a n d  3 f  g r a d e  3 .  
 
Changes in other regions of the basal ganglia were looked for and recorded as 
present or not present (caudate nucleus, substantia nigra, globus pall idus, 
STN). When there was disagreement over involvement of the basal ganglia 






Statistical analysis  
 
MRI data and patient characterist ics were compared between patients with 
dyskinetic and spastic CP using the Student t-test for normally distributed 
variables such as gestational age and birth weight and the Wilcoxon rank -sum 
test for categorical data including putamen, thalamus and PCWM injury scores. 
Fisher's exact test was used to compare the two groups regarding presence of 
STN, caudate and globus pall idus injuries.  Multivariable logisit ic regression was 
applied in minimize confounding with the backward step -wise method to 
identify the independent predictors fo r differentiating the two CP groups with 
the l ikel ihood ratio chi -square test to assess s ignif icance and the odds ratio and 
95% confidence interval (CI) to measure the strength of association. Variables 
with P < .20 from the univariate analysis  were entere d into the multivariable 
model. Predicted probabilit ies of dyskinetic CP were derived by maximum 
likelihood est imation such that 100% minus these values would indicate the 
probability of spastic CP based on combinations of the signif icant predictors. 5  
Two-tailed values of P < .05 were considered statistical ly signif icant. Statistical 







20/40 (50%) of the children studied had spastic CP. 20 had dyskinetic CP. 
Comparison of patient characteristics and MR data indicate several differences 









(N = 20) 
Spastic CP 
(N = 20) 
 
P value 
Age at time of MRI, yrs 4.8 ± 3.7 6.0 ± 3.9 .35 
Gestational age, wks 40.0 ± 1.3 39.1 ± 2.0 .12 
Birth weight, kg 3.3 ± 0.5 3.3 ± 0.6 .78 
Apgar score 5-minute 3 (1 – 7) 4 (0 – 6) .27 
Cord blood pH at birth 6.92 ± 0.15 6.83 ± 0.20 .18 
Head circumference (centile) 53.5 ± 26.0 35.4 ± 20.5   .02* 
Age at onset of seizures (hrs) 3 (1 – 14) 3.5 (1 – 18) .17 
Putamen injury score (0-3) 
  Left 
  Right 
 
2 (1 – 3) 
1 (0 – 2) 
 
1.5 (0 – 3) 




Thalamus injury score (0-3) 
  Left 
  Right 
 
1 (1 – 3) 
1 (1 – 3) 
 
1.5 (0 – 3) 




PCWM severity score (0-3) 
  Left 
  Right 
 
1 (0 – 2) 
1 (0 – 2) 
 
2 (1 – 3) 
2 (0 – 3) 
 
  .01* 
.07 
Total injury score (0-18) 8.0 (4 – 14) 9.5 (4 – 18) .38 
STN injury, no. (%) 15 (75) 6 (30)   .01* 
Caudate injury, no. (%) 2 (10) 8 (40) .06 
Globus pallidus injury, no. (%) 2 (10) 6 (30) .24 
Plus-minus data are mean ± SD with groups compared by the Student t-test. All scores and age at onset of seizures are expressed as median with ranges 
in parentheses and compared by the Wilcoxon rank-sum test. Proportion of patients in each group with STN, caudate, and GP injuries were evaluated by 
Fisher’s exact test. 
 
*Statistically significant, P < .05.   
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Signif icantly larger head circumference  (P  = .02), lower PCWM left side scores 
(P  = .01) and a higher prevalence of STN injury ( P  = .01) were observed in the 
dyskinetic group. These associations were confirmed by multivariable logistic 
regression analysis (Table 9.3.2).  
 
Table 9.3.2. Results of Multivariable Stepwise Logistic Regression Analysis 
Predictor Variable LRT P value Odds Ratio* 95% CI 
PCWM left (0 – 3) 8.2 .004 0.2 0.1 – 0.7 
STN injury 11.1 .001 18.6 2.4 – 141.0 
Head circumference† 6.7 .010 3.0 1.2 – 7.3 
* Odds ratios and 95% CIs are with respect to dyskinetic CP, and can be reciprocated to estimate the odds of spastic CP. 
† Based on centiles (10th, 25th, 50th, 75th, 90th) for head circumference with 10th as the reference category.  
LRT = likelihood ratio test; CI = confidence interval. Cox and Snell model R2 = 63%, indicating good fit to the data.  
 
The f inal model containing head circumference ( P  = .01), presence of STN injury 
(P  = .004), and PCWM score on left (P  = .004) provided a good fit  to the data (R 2  
= 0.63). Logistic regression indicated that  children with STN injuries are 18 
times more l ikely to have dyskinesia as compared to spast icity, independent of 
birth weight, Apgar scores, cord pH, hours to onset of seizures, as well  as head 
circumference and presence of caudate or GP injuries. Furthermore, for each 
increase in centile for head circumference, the odds of dyskinetic CP compared 
to spastic CP are 3 t imes higher. With ea ch increasing score in PCWM on the 
left side, the odds of  dyskinetic CP decreases by 80% (95% CI:  30 -90%). 
Maximum likelihood estimation was applied to determine the probability of 






Table 9.3.3. Multivariable Algorithm for Differentiating Dyskinetic and Spastic CP*  
 STN Injury No STN Injury 
 PCWM Injury Score - Left PCWM Injury Score - Left 
HC (centile) 0 1 2 3 0 1 2 3 
10th 93 70 30 8 40 11 2 1 
25th 97 87 55 19 66 26 6 2 
50th 98 95 78 50 85 51 16 4 
75th 99 98 90 66 94 75 35 9 
90th 99 99 97 85 98 90 62 23 
* Values represent percent probability of dyskinetic cerebral palsy according to the combination of the three predictors in the logistic regression model. 
Children with dyskinetic CP have larger head circumference (HC), more commonly have STN injury compared to spastic CP, and have lower left side 
PCWM scores. Probability of spastic CP can be determined by taking 100 minus the value in the table.  If there is STN signal change with normal 50th C HC 
then even with severe PCWM volume loss, then 50% chance of dyskinesia 
But 95% chance of dyskinesia with minor PCWM injury 
If there is no evidence of STN injury with normal 50th C HC then severe PCWM injury gives 4% chance of dyskinesia  
but 51% chance of dyskinesia with minor PCWM injury 
Microcephaly increases the chance of spasticity 
Increased head C increases the chance of dyskinesia 
 
For example, a child with a head circumference at the 75 t h  centile with an STN 
injury and PCWM on the left of grade 2 (i .e.  moderately severe signal change 
and some volume loss) is estimated to have dyskinesia with 90% (10% 
probability of spastic CP), whereas with no STN injury the est imated probability 
of dyskinesia is 35% (65% probability of spastic CP). F igure 3 i l lustrates the 
relationship for children with a 75 th  centile head circumference between PCWM 
severity grade and the presence or absence of an STN injury in predicting 
dyskinetic CP. The probability of spastic CP for each combination is easily 100% 
minus the height of each bar (i .e. ,  the complementary probability). Clearly,  for 
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any given PCWM grade, the probability of dyskinetic CP is higher in children 
















F i g u r e  9 . 3 . 3 .  P r o b a b i l i t y  o f  a  c h i l d  h a v i n g  d y s k i n e t i c  C P  p l o t t e d  a s  a  f u n c t i o n  o f  S T N  a n d  P C W M  i n j u r y .  D a t a  f r o m  
c h i l d r e n  w i t h  h e a d  c i r c u m f e r e n c e  a t  t h e  7 5 t h  c e n t i l e .  
 
  












































The effects of hypoxia/ischemia on the fetal/neonatal brain are dependent on 
many factors such as severity, durat ion, amount of reserve and gestational 
maturity.  If  HIBD occurs at, or close to, term most textbooks describe two 
primary patterns of injury with discrete clinical sequelae.  If  the 
hypoxia/ischaemia event is severe but lasts for a short period of t ime  
(10 to 25 minutes is the often-quoted range) the pattern of damage is usually 
‘central ’.   This results in damage to the basal gangl ia and thalamus, although 
other areas are often damaged (e.g. PCWM, optic radiations, hippocampus).  
The typical cl inical description of a ch i ld with that type of injury includes 
dyskinetic cerebral palsy with relatively well -preserved intellect.  In contrast, a 
lower level of hypoxia/ischemia lasting for a longer period of t ime produces a 
‘peripheral ’  pattern of damage.  This is best described  as involving the vascular 
watershed territories of the cerebral hemispheres producing damage to grey 
and white matter structures in a ‘parasagittal’  distr ibution.  Children with this 
damage wil l  typical ly have spastic quadriplegic cerebral palsy, often wi th 
signif icant intel lectual impairment.  
The primary evidence for the two models of HIBD comes from carefully 
controlled animal experiments 6  and extrapolation to humans is diff icult  because 
the precise mechanism of injury is rarely known with certainty.  On e of the 
most diff icult  problems occurs when a baby is del ivered in a poor condition 
after a short-l ived emergency towards the end of pregnancy.  Is it  ever possible 
to say that the resulting HIBD was due solely to the events in the last minutes 
before birth?  Was the fetus suffering from a protracted low -grade 
hypoxic/ischaemic event in the hours before birth that became signif icantly 
worse during del ivery?  Overlapping ‘chronic partial’  and ‘acute profound’ HIBD 
is often advanced as a possible cause when imaging and cl inical features are 
not congruent, e.g. when a child has basal ganglia and thalamic damage on MR 
imaging but suffers from spast ic CP.  The simplest f inding from the results of 
our study underlines the increasing recognition that spastic CP is  a common 
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outcome in cases of acute profound hypoxia/ischaemia, not just those chi ldren 
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F i g u r e  9 . 3 . 4 .  T y p i c a l  a p p e a r a n c e s  o f  H I B D  c h a n g e s  i n  c h i l d r e n  w i t h  a c u t e  p r o f o u n d  H I B D .  F i g u r e s  4 a - 4 d  a x i a l  T 2  
i m a g e s  s h o w i n g  m i l d  i n v o l v e m e n t  o f  t h e  p u t a m e n ,  t h a l a m u s  a n d  p a r a c e n t r a l  w h i t e  m a t t e r  i n  a  c h i l d  w i t h  d y s k i n e t i c  
C P  ( 4 a ,  4 c )  a n d  s p a s t i c  C P  ( 4 b ,  4 d ) .  F i g u r e  4 e - 4 f  c o r o n a l  T 2 - w e i g h t e d  i m a g e s  s h o w  i n v o l v e m e n t  o f  t h e  S T N  i n  a  c h i l d  
w i t h  d y s k i n e t i c  C P  ( 4 e ) ,  b u t  n o  s i g n a l  a b n o r m a l i t y  i n  t h e  r e g i o n  o f  t h e  S T N  i n  a  c h i l d  w i t h  s p a s t i c  C P  ( 4 f )  
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To understand why acute profound HIBD produces dyskinetic CP in some 
children and spastic CP in others we need to review the anatomy and functional 
connectivity of the basal gangl ia and motor cortex in normality and in cases of 
movement disorders.  Origina l theories about the function of the basal ganglia 
came from observational studies in humans post mortem  but this has been 
refined in recent years by detai led studies of animal models of movement 
disorders.7 , 8  Here, we shall  concentrate on the basal gangli a and its role in 
controll ing voluntary movement and not direct our attention to the conscious 
mechanisms that instigate voluntary movement.   
 
When voluntary movement is undertaken, two neuronal activit ies are generated 
within the basal ganglia using anat omically discrete pathways. One promotes 
the primary movement whilst the other attempts to provide the stabil ity in 
other muscle groups required for the primary movement to act eff iciently, 
which is usually a combination of stimulation and inhibition of di fferent muscle 
groups.  Both the primary ‘direct pathway’ and the associated ‘indirect 
pathway’ of movement programming originate in the putamen (caudate nucleus 
to a lesser extent), albeit from different neuronal subtypes.   The direct 
pathway projects to  the medial globus pall idus (GP m) ,  and the indirect pathway 
to the lateral globus pall idus (Gp l) .  9  This is shown schematical ly in f igure 5 
(modified from references 7 and 10).   Some disorders selectively affect the 
activity of these pathways preferential ly and this results in different types of 
cl inical symptomatology.  Abnormalit ies that reduce the activity of the direct 
pathway are expected to produce hypokinesia, whilst reducing the activity of 
the indirect pathway should produce hyperkinetic syndromes  such as chorea or 
dystonia.  
 
Early, untreated Parkinson’s disease provides a good example of a hypokinetic 
syndrome and there is good evidence that the lack of dopamine caused by 
neuronal degeneration in the substantia nigra, pars compacta causes reduced  
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activity of the neurons of the  direct pathway.1 1   In contrast, the striatal 
degeneration associated with Huntington’s disease, init ial ly affects the neurons 
of the indirect pathway and causes chorea. 1 2   It  should be appreciated that the 
two neuronal subtypes in the putamen are closely intermingled and focal 
lesions (either infarctions in humans or destructive lesions in animal models) do 
not affect one particular subtype specif ically.  This may explain why focal 
lesions of the putamen rarely produce movement disorders of any type.  By 
implication, it  is unlikely that the focal putaminal damage seen in profound 
HIBD is responsible for the dyskinesia associated with the cerebral palsy.  
Likewise, the site of predilection for damage in the thalamus is a sensory region 








F i g u r e  9 . 3 . 5 .   L i n e  d i a g r a m  t o  s h o w  t h e  d i r e c t  a n d  i n d i r e c t  p a t h w a y s  f r o m  t h e  p u t a m e n  t o  t h e  t h a l a m u s  a n d  h e n c e  
t o  t h e  m o t o r  c o r t e x .   D a s h e d  l i n e s  i n d i c a t e  t h e  n e u r o n s  o f  t h e  i n d i r e c t  p a t h w a y  t r a v e l i n g  v i a  t h e  s u b t h a l a m i c  
n u c l e u s  ( m o d i f i e d  f r o m  r e f e r e n c e s  6  a n d  9 ) .   A n a t o m i c a l  a b b r e v i a t i o n s  u s e d  –  V A - V L ,  v e n t r a l  a n t e r i o r  a n d  v e n t r a l  
l a t e r a l  n u c l e i  o f  t h e  t h a l a m u s ;  S T N ,  s u b t h a l a m i c  n u c l e u s ;  G P m ,  m e d i a l  g l o b u s  p a l l i d u s ;  G P l ,  l a t e r a l  g l o b u s  p a l l i d u s .   
N e u r o t r a n s m i t t e r  a b b r e v i a t i o n s  –  G A B A ,  g a m m a  a m i n o  b u t y r i c  a c i d ;  G L U ,  g l u t a m a t e ;  E N K ,  e n k e p h a l i n ;  S P ,  
S u b s t a n c e - P .  
 
The indirect pathway from the GP l  f irst projects to a small diencephalic nucleus, 
the STN, using GABA as the neurotransmitter.  The STN neurons then project to 
the GPm  using glutamatergic neurons.  It  has been shown that the indirect 
pathway has faster neuronal transmission rates when compared with the highly 
somatotopic direct pathway and this feature is responsible for the fast 
suppression of unwanted movements. 1 3  It  has been known for a long time that 
injury to the STN and its associated tra cts can produce hyperkinetic syndromes. 
In this situat ion, reduced activity in the STN leads to under -suppression of 
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unwanted movements, hence dyskinesia. The purported underlying mechanism 
is interruption of the excitatory glutamate -mediated project ion from the STN to 
the GPm  which, subsequently, is expressed via altered function of the 
thalamocortical and corticospinal pathways.   
 
In one series of adults with hemichorea following stroke, radiological evidence 
of STN damage was reported in 30%, and globus pal l idus damage in 7%. 1 4  That 
series also reported a high frequency of striatal and cortical injuries which are 
not classical sites associated with dyskinesia. However, those patients with 
radiologically apparent STN damage had the worst prognosis.  In infants, a 
similar pattern of radiological ly detectable STN damage has been shown in 
kernicterus.1 5  Pathologically, kernicterus results from deposition of bil irubin in 
the globus pall idus and STN and produces a clinical syndrome of dyskinetic 
cerebral palsy. To summarize the clinical observat ions and work from animal 
models, it  is diff icult  to support focal injuries to the putamen as the anatomical 
substrate for dyskinesia.  If  a focal injury is to cause a dyskinesia it  is much 
more l ikely to be in, or close to, the STN.  
 
The normal STN is diff icult/impossible to visualize directly on MR imaging on 
standard scanners operating at 1.5T (as in our cases) because of the small s ize 
of the nucleus and the lack of contrast between the nucleus and surrounding 
structures.  MR imaging of adults at 3.0T does allow direct visualization 1 7  as a 
small b iconvex hypointense structure on T2 -weighted images.   This is 
presumably due to the susceptibil ity effects of high iron content in the STN as 
is also seen in the adjacent  red nucleus and substantia nigra.  Our cases were 
not imaged at 3.0T but we predict that even if  they were, the STN in normal 
brains would not be visualized directly because the pediatr ic brain is virtual ly 
devoid of iron at al l  sites as there is an age -dependent accumulation. 1 8  As 
shown in this study, the STN can be seen directly on T2 -weighted MR at 1.5T 
when there is gliosis  produced by ischemic injury. It  should be noted that not 
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all  children with dyskinetic CP showed radiological ly apparent STN abnorm ality. 
Possible explanations include the small size of the STN, and that an injury may 
not be sufficiently great to be visualized. Although, all  the cases in this series 
were imaged using the same protocol, it  has been our experience that high -
resolution sequences are required. In particular, injury to the STN is more 
apparent on relatively short echo -train length (ETL) sequences (8 echos) than 
on longer ETL sequences.  
 
Previous reviews of MR findings in HIBD have l inked dyskinetic symptoms to 
less severe patterns of injury. 1 9  Our study has provided support for that theory 
as chi ldren with spastic CP tended to have more severe signal  changes and 
volume loss on MR imaging, particularly in the PCWM.  We have also shown that 
injury to the STN as a common findin g in dyskinetic CP (15/20) and uncommon 
in spastic CP (6/20). In 3/6 children with spastic CP and abnormal STN there was 
also severe damage to the PCWM and the dominance of spasticity in the clinical 
symptomatology may be explained by the injury to PCWM.  It  is l ikely damage 
to the descending corticospinal tracts masks the aberrant neuronal output from 
the injured basal ganglia and dyskinesia cannot be manifest cl inically for that 
reason. None of the children with dyskinetic CP had severe volume loss or 
signal change in the PCWM suggest ing that some function in the corticospinal 
tracts is necessary for dyskinesia to be clinically apparent.   
 
The injury commonly seen in the ventral postero -lateral thalamus is a 
somatosensory relay nucleus and should not have  a major role on motor 
function, however we have demonstrated that more severe forms of HIBD tend 
to involve the thalamus more general ly.  It  is possible that this could have 
further deleterious effect on motor function if  the damage extends anteriorly 
into the ventral lateral and ventral anterior thalamic nuclei through abnormal 





In summary, we found that spastic CP is a frequent outcome of acute profound 
HIBD in some chi ldren as well  as the more extensively reported cases of 
dyskinetic CP.   In this paper we have attempted to explore why some children 
have spastic CP whilst others have dyskinetic CP by making detailed anatomical 
studies by way of MR imaging. The main f indi ng was frequent injury to the STN 
in children with dyskinetic CP, a f inding that was uncommon in children with 
spastic CP.  Those children with STN damage and spastic CP always had severely 
damaged PCWM. We have explained those f indings on the basis of the  known 
connectivity and function of the basal ganglia and have generated a new 
hypothesis. Specif ically, dyskinetic CP arises from abnormal activity of the 
indirect putamen/GP pathway (by way of injury to the STN) and requires a 
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9.4 Isolated superior cerebellar vermis injury: a consequence of hypoxic ischemic injury 
 
Joshi H, Mordekar SR, Connolly DJA and Griff iths PD  
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Ataxic cerebral palsy due to isolated injury to the anterior lobule of the 
cerebel lar vermis was  described in the medical l iterature for the f irst t ime in 
this paper.  
 
Sargent et al f irst described the focal injury to the anterior lobule of the 
cerebel lar vermis seen in children who had suffered neonatal  acute profound 
hypoxia at term (Sargent et al) .  We had previously described a series of term 
neonates with acute profound hypoxic injury in whom the more severely injured 
were more l ikely to also demonstrate injury to the superior vermis (Connolly, 
Widjaja and Griff iths).  
 
Many paediatric neurology experts suggest that ataxic cerebral palsy does not 
exist as a separate cl inical entity, and indeed the original descriptions  of 
cerebral palsy did not include an ataxic subtype. However, since that t ime the 
papers describing injury to the vermis and now isolated injury to the vermis 
have been published. Therefore, we suggest th at, though rare , isolated ataxic 
cerebral palsy does exist .  However, these two cases demonstrate no evidence 
of injury to the STN, ventral postero -lateral thalamus or posterior putamen, but 




The lack of correlat ion between focal brain injury as demonstrated 
pathologically and with brain MR imaging is perhaps best appreciated by the 
dyskinetic cerebral palsy described and witnessed frequently after acute 
profound hypoxia at term. Th e classic regions of the brain affected are the 
posterior putamen, antero-lateral thalamus and paracentral  white matter. 
Damage to these regions does not explain the subsequent movement disorder. 
We demonstrated for the f irst t ime that injury to the subtha lamic nucleus in 
acute profound asphyxia and described how this focal injury does explain the 











Hypoxic ischemic insult (HII) in early childhood can have a varied cl inical 
presentation depending on the timing and severity of the insult and magnetic 
resonance imaging (MRI) plays a key role in identifying injury patterns.  
Dyskinetic cerebral palsy is commonly associated with injury to the basal 
gangl ia and thalamus.  We report tw o cases presenting in early childhood with 
signs and symptoms of dyskinetic cerebral palsy attributed to focal damage to 
the superior cerebellar vermis secondary to a hypoxic insult in  the perinatal 
period in term infants.  
 
Keywords 
Dyskinetic cerebral palsy, Hypoxic ischemic insult,  Superior cerebellar vermis, 










Cerebral palsy is a group of permanent disorders of development of movement 
and posture causing activity l imitation that is attributable to a non -progressive 
disturbance that occurred in a developing fetus or an infant brain.  Motor 
disorders of cerebral  palsy are often accompanied by disturbance of sensation, 
perception, cognition, communication, behaviour, epilepsy, recurrent chest 
infections and secondary musculoskeletal  problems. Hypoxic ischaemic injury 
(HII) to the brain in the peri -natal period is one of the causes of cerebral palsy 
and its cl inical presentation depends upon the timing and severity of injury 
sustained. There are well  described manif estations of HII;  both periventricular 
white matter injury and acute profound injury may occur in the preterm (less 
than 34 weeks gestation) brain and both parasagittal watershed injury and 
acute profound injury in term neonates. There are rare exceptions which are 
acknowledged to occur such as white matter injury due to HII in a term infant 
(1).  
We describe 2 children with dyskinetic cerebral palsy who were found to have 
an isolated injury to the superior cerebellar vermis (SCV). Clinical history 
revealed these chi ldren had sustained a period of hypoxia in the peri -natal 
period.   
 
Case 1  
Following an uneventful pregnancy, a female was born at ful l  term by 
emergency caesarean section due to reduced fetal movements. Apgar scores 
were 1, 5 and 6 at 1,  5 and 10 minutes respectively and the umbilical cord 
arterial pH was 7.11. There were featur es of neonatal encephalopathy with 
neonatal seizures. Extensive neurometabolic invest igations and infection 
screens were negative. At 2 years of age , she presented with a developmental 
impairment, bulbar dysfunction and axial hypotonia with dyskinetic movem ents. 
She was diagnosed with dyskinetic cerebral palsy (DCP). She was diagnosed to 
have a developmental co-ordination disorder by her Paediatrician at 5 years of 
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age. At 5 years of age, she was reviewed by Paediatric Neurologist,  who 
diagnosed her to have ataxia.  
She continues to make slow progress and has independent mobility with 
diff iculty in f ine motor skil ls due to her ataxia. She can self -feed herself  orally 






F i g u r e  9 . 4 . 1 .  S e l e c t e d  i m a g e s  o f  C h i l d  1 .  A  a x i a l  T 2  i m a g e  t h r o u g h  n o r m a l  b a s a l  g a n g l i a .  B  a n d  C  a x i a l  a n d  c o r o n a l  T 2  
i m a g e s  t h r o u g h  t h e  s u p e r i o r  c e r e b e l l a r  d e m o n s t r a t e s  i n c r e a s e d  T 2  s i g n a l  i n  t h e  s u p e r i o r  v e r m i s .  D  S a g i t t a l  T 1  i n  t h e  





Following an uneventful pregnancy, a female was born by normal delivery at full  
term for reduced fetal movements. Apgar scores were 1, 3 and 8 at 1, 5 and 10 
minutes respectively. There were features of neonatal encephalopathy and al l  
neurometabolic investigations and infect ion screens were negative. At  3 years 
of age she was referred with developmental impairment, bulbar dysfunct ion, 
axial hypotonia with ataxia and dyskinetic movements. She was diagnosed with 
DCP. She is under regular review by a Paediatric Neurologist and at 6 years of 
age continues to  make slow progress with independent mobility and is orally 
fed. 
Subsequent MRI brain imaging in both chi ldren demonstrated focal damage to 
the superior cerebellar vermis, with normal imaging of the remaining neural -









F i g u r e  9 . 4 . 2 .  S e l e c t e d  i m a g e s  o f  C h i l d  2 .  A  a x i a l  T 2  i m a g e  t h r o u g h  n o r m a l  b a s a l  g a n g l i a .  B  a x i a l  T 2  i m a g e  t h r o u g h  
t h e  s u p e r i o r  c e r e b e l l a r  d e m o n s t r a t e s  i n c r e a s e d  T 2  s i g n a l  i n  t h e  s u p e r i o r  v e r m i s .  C  C o r o n a l  T 2 - F L A I R  i m a g e  t h r o u g h  
t h e  v e r m i s  d e m o n s t r a t i n g  i n c r e a s e d  s i g n a l  i n  t h e  v e r m i s .  D  S a g i t t a l  T 1  i n  t h e  m i d l i n e  d e m o n s t r a t i n g  l o s s  o f  v o l u m e  






Cerebral palsy is the most common cause of physical disabil ity in chi ldren 
occurring in 2 to 3 per 1000 l ive births (2) and is characterised by a non -
progressive motor impairment (3), secondary to an insult that has occurred in 
early l ife.  Patients with cerebral palsy have an increased association with other 
conditions including visual and hearing impairment and epilepsy (4).  In full  
term neonates, there are two types of HII :  acute profound injury and chronic 
partial injury.  
Neuro-imaging has played a vital role in the management of cerebral palsy by 
identifying patterns of brain insult attributed to different gestational age (with 
associated varied brain maturation) duration  of insult and severity of insult 
sustained (5) along with other structural  abnormalit ies and is  recommended in 
all  cases of cerebral palsy of unknown origin (6).  
The pattern of subsequent disabil it ies in children has also been helpful in 
inferring causat ion in babies who have suffered neonatal encephalopathy. 
There are two cl inical paradigms of survivors. In chronic part ial hypoxic injury, 
the fetus suffers a more prolonged but a less severe episode of hypoxia due to 
the perfusion failure in the brain and the watershed area or the parasagittal 
cortex are damaged. The clinical features in such cases commonly include a 
spastic quadriplegic cerebral palsy with acquired microcephaly. In acute 
profound hypoxic injury, the fetus suffers a total or a near total hy poxia over a 
brief period. In this case the damage affects the most metabolically act ive parts 
of the brain called the basal ganglia and the thalami.   The characteristic cl inical 
features in these chi ldren is of a dyskinetic type of cerebral palsy with an  
impaired motor development with oromotor diff iculties which our children had.  
Dyskinetic cerebral palsy (DCP) is the second most common form of cerebral 
palsy (7) and is often associated with lesions involving the basal ganglia or the 
thalamus secondary to an acute profound hypoxic ischaemic insult,  commonly 
in the term infant (8).  Studies have shown the lentiform nuclei is the most 
frequent area to sustain damage (9).  Anatomical studies have suggested the 
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subthalamic nucleus as a s ite of focal damage as sociated with later dyskinesia 
(10).  
The underlying process leading to cerebral palsy can be multi -factorial including 
congenital brain malformations, toxins and in utero infection (11).  HII can be 
indicated as the cause in a small proport ion of cases.  
There are three well recognised distinct patterns that can occur; insult before 
28 weeks of gestation leading to hydranencephaly and porencephaly.  An insult 
between 28 and 36 weeks of gestation is  often associated with germinal matrix 
hemorrhage (GMH) and periventricular leukomalacia (PVL). HII affecting the 
term baby and can vary in its impact upon the brain depending on the severity 
and length of insult.  An acute severe insult can result in damage to the basal 
gangl ia (posterior putamen, subthalamic nucl eus, head of caudate nucleus, 
hippocampus) thalamus and peri -rolandic cortex and subcort ical white matter.  
This is in contrast to damage to the parasagittal white matter in the setting of a 
chronic but low-grade hypoxic/hypoperfusion insult .    The changi ng patterns of 
damage and different gestational ages relates to the varying distribution of the 
blood supply and vascular watershed terr itories in the maturing fetal brain (12).  
A hypoxic insult will  often lead to a generalised brain insult but there are c ases 
of focal brain damage that have been attributed to a hypoxic insult that do not 
follow the conventional pattern of injury as described above.  The reasons for 
focal brain damage in HII remain unclear but may be related to areas of active 
myelination at the time of insult (13) areas of greatest metabolic demand or 
occur in cel ls that are enzyme deficient.  For example, damage to the anterior 
lobule of the cerebel lar vermis is well  recognised in acute profound hypoxic 
injury (14, 15).   
Our cases are unique demonstrating isolated damage to the superior cerebellar 
vermis.  It  is possible that other abnormalit ies may have been demonstrated if  
these patients underwent neuro -imaging in the neonatal period, however 
subsequent MRI brain studies revealed no sequ elae of hypoxic insult in the 
remaining brain.  MRI imaging in cases of HII is highly recommended due to its’  
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sensitivity to identify areas of damage although in some cases MRI can be 
normal.    
The cerebel lar vermis develops separately from the cerebellar  hemispheres and 
why it  is specif ically targeted in some cases of hypoxic insult remains unclear.  
The Purkinje cel ls of the vermis may be deficient in certain proteins, including 
aldolase C, and therefore may not be able to recover from a sudden hypoxic 
insult,  potential ly leading to focal areas of damage (16).   
We have described two cases of isolated superior cerebel lar vermis volume loss 
with associated signal change, present on both T2 -weighted and FLAIR 
sequences and these f indings can be attributed t o a hypoxic insult in the term 
infant occurring in the perinatal period.  In both cases, the pregnancy was 
otherwise uneventful but there were features of neonatal encephalopathy and 
low Apgars with no other identif iable cause for damage to the vermis and 
subsequent cerebral palsy. Clinically these children both presented with 







Isolated volume loss and signal change in the superior cerebel lar vermis can be 
a sequela of HII in the term infant and present with signs and symptoms 
consistent with dyskinetic cerebral palsy,  an association that has not been 
previously described.  
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9.5 A review of fetal brain pathology acquired in utero 
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Many of the pathologies which have been ascribed to the perinatal period may 
also happen in utero. They may therefore be confused with a cause of perinatal 
encephalopathy and must be considered when reporting neonatal brain M RI 
studies. The MERIDIAN acquired pathology paper was the f irst to attempt to 
describe the range of common acquired in utero pathologies and their relative 
prevalence in clinical practice .  
 
Fetal stroke was the most common acquired pathology of the MERIDIA N cohort 
found in 3.5% of cases. The majority of strokes were haemorrhagic. There were 
also cases of brain hypoxic injury demonstrated in utero. This paper supports 
the premise that neonatal brain MRI should be performed in the f irst 5 days 
after delivery so that DWI imaging and standard brain imaging may be used to 
assess if  a  hypoxic brain injury occurred at a t ime point distantly preceding 
delivery 
 
We discussed the dif ference and indeed the overlap between developmental 
and acquired fetal brain patholo gy. A true congenital pathology wil l  often be 
due to a genetic disorder. A disruption is impaired development due to an 
acquired pathology affecting a structure at an immature stage with the end 
result being a secondary malformation. An example of this is  congenital CMV 





In utero  magnetic resonance (iuMR) imaging is used increasingly to assist 
prenatal diagnosis of fetal brain abnormalit ies. The diagnostic and clinical value 
is now supported by systematic reviews, meta -analyses and a formally powered 
prospective study –  ‘Magnetic resonance imaging to enhance the diagnosis of 
fetal brain developmental brain abnormalit ies in utero’ the MERIDIAN study (1 -
6). The results of the MERIDIAN st udy demonstrate improvements in diagnostic 
accuracy of at least 22% compared with brain abnormalit ies recognised on 
ultrasound. Positive effects on diagnostic confidence, prognostication and 
clinical management in anatomical sub -groups have also been reported (7-9). 
The purpose of iuMR in this situation is not only to confirm that the fetal brain 
is abnormal but to produce a definit ive or differential diagnosis in order to 
provide highest qual ity information regarding the signif icance of the f indings to 
the parents. One established step in medical image analysis is  to distinguish 
between ‘Developmental’  and ‘Acquired’ pathology although, as we explain 
later, this may be too simplistic for fetal brain pathology.  
In this review, we outline the many of the fet al brain abnormalit ies that can 
either be confidently classif ied as ‘acquired’ or there is a strong probability 
that they are ‘acquired’ after the f irst trimester of pregnancy. We wil l  present 
an analysis of the cases from the MERIDIAN cohort that f it  our definit ions of 
acquired pathologies and provide a pictorial review of the typical imaging 
appearances, as well  as to provide prevalence data on acquired brain 
pathology.  
General review of acquired pathology of the fetal brain  
The factors responsible for acquired fetal brain damage are usually a result of 
stroke (haemorrhagic or ischemic), generalised hypoxic/ischemic injury 
(including reperfusion injury), infection, toxic or metabolic abnormalit ies or 
intracranial mass lesions.   
Fetal stroke is defined as  brain injury resulting from ischemic, thrombotic or 
haemorrhagic causes (focal or multifocal)  between 14gw and the onset of 
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labour (10).   General ised hypoxic-ischaemic injury to the fetal brain is not 
usually included in this definit ion of fetal stroke an d is discussed separately. 
The prevalence of fetal stroke is not known. There is a low detection rate in 
utero and the diagnosis  is often not suspected until  post -natal imaging has been 
performed and raised the possibil ity of an in-utero  event. Also, many cases of 
fetal stroke remain undiagnosed, particularly if  there are no (or minor) cl inical 
sequelae, as may occur following in utero germinal matrix and/or 
intraventricular haemorrhage. Ozuduman et al.  reviewed 47 cases of fetal 
stroke from the pre-2004 published l iterature and added seven cases from their 
own institution. 49/54 (91%) of those fetuses had haemorrhagic stroke on pre -
natal imaging and 5/54 (9%) had ischemic stroke. The difference in the rates of 
haemorrhagic and ischemic fetal stroke may resu lt from a detection bias as 
intracranial haemorrhage is relatively easy to detect on USS, unlike ischaemic 
stroke. iuMR imaging is l ikely to have improved diagnostic accuracy for ischemic 
stroke but was used only in the later cases in the review. Another i mportant 
f inding was the number of fetuses thought to have intra -ventricular 
haemorrhage as the only intracranial abnormality on pre -natal imaging (n=15) 
but were shown to have brain involvement on outcome reference data (8/15 –  
53%). The recognition of brain injury is important for prognosticat ion, although 
the brain injury may have occurred after the pre -natal imaging was performed 
in some cases. The authors could not attr ibute an aetiology for the fetal stroke 
in 50% of cases and the explanation was ofte n speculative in the others, 
although they made useful l ists of pathologies found in association with fetal 
stroke and classif ied them into maternal (e.g. diabetic ketoacidosis, 
thrombocytopenia, drug use), pregnancy -related (e.g. placental abruption, 
thrombosis, complication of multiple gestation) and fetal causes (e.g. pyruvate 
carboxylase deficiency, thrombocytopenia, coagulopathies, transplacental 
infections). Prognosis after fetal stroke was poor in their experience, with 51% 
resulting in fetal or neonatal death and over 50% of survivors were 




F i g u r e  9 . 5 . 1 .  I s c h e m i c  s t r o k e .  A x i a l  ( 1 a  a n d  1 b ) ,  C o r o n a l  ( 1 c )  a n d  p a r a s a g i t t a l  ( 1 d )  T 2 - w e i g h t e d  i m a g e s  o f  a  2 3 g w  
f e t u s  i n  u t e r o  w i t h  a n  a r t e r i a l  i n f a r c t i o n  o f  t h e  l e f t  c e r e b r a l  h e m i s p h e r e  i n v o l v i n g  t h e  p o s t e r i o r  d i v i s i o n  o f  t h e  
m i d d l e  c e r e b r a l  a r t e r y .  T h e r e  i s  n o  d e f i n i t e  e v i d e n c e  o f  h a e m o r r h a g e  o n  t h e  i n - u t e r o  M R  i m a g e s  b u t  t h e  e q u i v a l e n t  
T 2 - w e i g h t e d  i m a g e s  p o s t - m o r t e m  M R  i m a g e s  ( 1 e - 1 h )  s h o w  h a e m o r r h a g i c  t r a n s f o r m a t i o n .  
 
F i g u r e  9 . 5 . 2 .  R e c u r r e n t ,  m u l t i f o c a l  s t r o k e .  S a g i t t a l  ( 2 a ) ,  a x i a l  ( 2 b )  a n d  c o r o n a l  ( 2 c )  T 2 - w e i g h t e d  i m a g e s  o f  a  2 1 g w  
f e t u s  i n v e s t i g a t e d  f o r  v e n t r i c u l o m e g a l y  d i a g n o s e d  o n  u l t r a s o n o g r a p h y .  M i l d  v e n t r i c u l o m e g a l y  w a s  c o n f i r m e d  a n d  
t h e r e  w a s  a b n o r m a l  s i g n a l  i n  t h e  r i g h t  b a s a l  g a n g l i a  c o n s i s t e n t  w i t h  i n f a r c t i o n  ( a r r o w e d  o n  2 b  a n d  2 c ) .  R e p e a t  
i m a g i n g  a t  2 6 g w  ( 2 d - 2 f )  s h o w e d  p r o g r e s s i v e  v e n t r i c u l o m e g a l y  a n d  m u l t i p l e  a r e a s  o f  i n f a r c t i o n  s o m e  a s s o c i a t e d  w i t h  





F i g u r e  9 . 5 . 3 .  H a e m o r r h a g i c  s t r o k e .  C o r o n a l  ( 3 a  a n d  3 b )  T 2 - w e i g h t e d  i m a g e s  o f  a  3 5 g w  f e t u s  s h o w s  a  l a r g e  a r e a  o f  
f o c a l  c y s t i c  e n c e p h a l o m a l a c i a  c e n t r e s  o n  t h e  r i g h t  t e m p o r a l  l o b e  a n d  e x t e n d i n g  i n t o  t h e  f r o n t a l  l o b e .  T h e  c a v i t y  h a s  
i r r e g u l a r  m a r g i n s  a n d  e v i d e n c e  o f  s u b a c u t e  h a e m a t o m a  ( 3 c  a n d  3 d ) .  T h e r e  i s  m a s s  e f f e c t  w i t h  e f f a c e m e n t  o f  t h e  
i p s i l a t e r a l  l a t e r a l  v e n t r i c l e ,  m i d l i n e  s h i f t  a n d  c o n t r a - l a t e r a l  v e n t r i c u l o m e g a l y ,  p r o b a b l y  s e c o n d a r y  t o  h y d r o c e p h a l u s .   





F i g u r e  9 . 5 . 4 .  R e c u r r e n t ,  m u l t i f o c a l  h a e m o r r h a g i c  s t r o k e .  A  f e t u s  w a s  s h o w n  t o  h a v e  m i l d  v e n t r i c u l o m e g a l y  o n  
u l t r a s o n o g r a p h y  a t  2 1 g w .  A x i a l  T 2 - w e i g h t e d  i m a g e s  a t  2 2 g w  f e t u s  ( 4 a  a n d  4 b )  c o n f i r m  v e n t r i c u l o m e g a l y  a n d  s h o w  a  
l o w  s i g n a l  m a s s  r e l a t e d  t o  t h e  t e c t a l  p l a t e  a n d  e x t e n d i n g  i n t o  t h e  p i n e a l  c i s t e r n  ( a r r o w e d  o n  4 a  a n d  4 b ) .  T h i s  w a s  
t h o u g h t  t o  r e p r e s e n t  h e m o s i d e r i n  r e l a t e d  t o  e i t h e r  e a r l i e r  h a e m o r r h a g e  o r  a  c a v e r n o m a .  T h e  f e t u s  h a d  a  f u r t h e r  
i u M R  s t u d y  a t  3 0 g w  b e c a u s e  o f  i n c r e a s i n g  v e n t r i c u l o m e g a l y .  A x i a l  T 2 - w e i g h t e d  ( 4 c )  a n d  F L A I R  ( 4 d )  c o n f i r m  s e v e r e  
v e n t r i c u l o m e g a l y  a n d  s h o w  a  n e w  i n t r a - p a r e n c h y m a l  h a e m a t o m a  i n  t h e  l e f t  t e m p o r a l  l o b e .   N o  s p e c i f i c  c a u s e  w a s  
d i s c o v e r e d .  
 
Ischemic stroke may be thrombotic or embolic and the fetus is potentially 
susceptible to emboli not only arising from its own circulation but from the 
vascular compartment of the placenta or as a complication of  a multi -fetal 
pregnancy. The latter is most l ikely to occur in cases of monochorionic twinning 
complicated by death of one twin and emboli from the demised twin may pass 
to the surviving twin because of the vascular anastomoses in the single 
placenta. Thrombosis in the placental/umbilical vascular bed can occur for 
many reasons but is frequently associated with chorioamnionitis,  resulting in an 
increased risk of fetal stroke. It  should also be not ed that certain genetic 
predisposit ion syndromes (e.g. COL4A1) may exacerbate the effect of a vascular 
insult (11). Although fetal stroke is clearly an acquired lesion,  if  it  occurs at a 
sensitive point of brain development it  may produce lesions that are typically 
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described as ‘Developmental’.  One such mechanism is the ‘fetal brain 
disruption sequence’  which may be the consequence of several forms of 
vascular injury to the fetal brain (emboli ,  haemorrhage, vaso -constriction and 
DIC) and is l inked to the development of abnormalit ies such as septo -optic 
dysplasia and schizencephaly (12 -13). Reports of ‘reparative polymicrogyria’ are 
also appearing in the l iterature following ischemic stroke in the survivors of co -
twin demise in mono -chorionic pregnancies (14-15).  
 
Discussion of haemorrhagic stroke in pediatric or adult practice would include 
ruptured intracranial vascular abnormalit ies, particularly aneurysms and pial 
arteriovenous malformations (AVM). Both of those have relat ively high 
prevalence in the general population and AVM are usually considered to be 
congenital lesions. Comstock and Kirk  reported 25 000 fetal US studies in 1991 
and only four vascular abnormalit ies were found, three vein of Galen 
aneurysmal malformations (VGAM) and a lesion described as an ‘AVM’ in the 
paper but on review it  was probably an arterio -venous f istula (16). VGAM and 
fistulae are more l ikely to injure the fetal brain by ischemic, rather than 
haemorrhagic, mechanisms (see below). Convincing reports of the ante -natal 
detection of fetal haemorrhagic stroke arising as a result of a ruptured pial 
AVM (or aneurysm) are exceptional ly rare (17).  
 
Generalised hypoxic- ischaemic injury of the fetal brain  
There are a number of reasons why all  parts of the fetal brain may not receive 
sufficient blood and/or oxygen including maternal causes (e.g. prolonged 
hypotension), placental causes (e.g. abruption), abnormalit ies of the fetus per 
se  (e.g. cardiac) or as complicat ion of a multi -fetal pregnancy. The resulting 
brain injury will  depend on such factors as severity, duration and maturity of 
the fetus but it  is most l ikely to produce bilateral and symmetrical injury. One 
possible outcome in the third trimester fetus is p eriventricular leukomalacia 
(often with germinal  matrix haemorrhage) but it  should be appreciated that 
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periventricular leukomalacia is an end result of injury from many aetiologies, 
such as infection and inflammation, and is not specif ic for hypoxic/ ische mic 
injury.  More extensive brain injury in the form of global encephalomalacia with 
micrencephaly/ microcephaly may result from pathology such as VGAM, which 
are rare arteriovenous malformations of the choroidal system that develop in 
the embryonic stage.  Generalised encephalomalacia may occur in fetuses with 
VGAM secondary to high f low ‘steal’  phenomenon or intracranial venous 
hypertension. In a recent iuMR study of 83 fetuses with antenatally detected 
VGAM showed that 16% had encephalomalacia, which was often severe (18). 
The authors describe the middle cerebral artery ‘pseudofeeders’ s ign (enlarged 
branches aris ing as a result of impaired cerebral blood flow) as a predictor of 
encephalomalacia at  birth, as seen in f igure 9.5.6. Co-twin demise in 
monochorionic twin pregnancies can also cause general ised encephalomalacia 
in the surviving twin, probably aris ing from adverse global haemodynamic 
effects as well  as fetal stroke as discussed above.  
 
 
F i g u r e  9 . 5 . 5 .  A  f e t u s  w i t h  e s t a b l i s h e d  e n c e p h a l o m a l a c i a  o f  t h e  c e r e b r a l  h e m i s p h e r e s .   A x i a l  ( 5 a - 5 c )  s a g i t t a l  ( 5 d )  a n d  
c o r o n a l  ( 5 e  a n d  5 f )  T 2 - w e i g h t e d  i m a g e s  p e r f o r m e d  a t  2 9 g w  s h o w  m i c r o - e n c e p h a l y ,  s e v e r e  v e n t r i c u l o m e g a l y  a n d  
e x t e n s i v e  d e s t r u c t i o n  o f  t h e  c e r e b r a l  h e m i s p h e r e s .  T h i s  o c c u r r e d  i n  a  f e t u s  w i t h  R h e s u s  i s o i m m u n i s a t i o n  ( c o u r t e s y  





F i g u r e  9 . 5 . 6 .  T w o  f e t u s e s  w i t h  v e i n  o f  G a l e n  a n e u r y s m a l  m a l f o r m a t i o n s .  T h e  f i r s t  f e t u s  ( 6 a - 6 c )  i m a g e d  a t  x  g w  ( E S S )  
s h o w s  a  l a r g e  v e i n  o f  G a l e n  a n e u r y s m a l  m a l f o r m a t i o n  w i t h  e x t e n s i v e  l o s s  o f  v o l u m e  f r o m  t h e  c e r e b r a l  h e m i s p h e r e s  
o n  s a g i t t a l  ( 6 a )  a n d  a x i a l  ( 6 b )  T 2 - w e i g h t e d  i m a g e s  a n d  a b n o r m a l  h i g h  s i g n a l  o n  T 1 - w e i g h t e d  i m a g e s  ( 6 c ) ,  p r o b a b l y  
i n d i c a t i n g  m i c r o - h e m o r r h a g e  o r  m i c r o - c a l c i f i c a t i o n .  C o m p a r i s o n  i s  m a d e  w i t h  a n o t h e r  f e t u s  w i t h  a  v e i n  o f  G a l e n  
a n e u r y s m a l  m a l f o r m a t i o n  i m a g e d  a t  3 4 g w  i n  w h i c h  t h e r e  i s  n o  l o s s  o f  v o l u m e  o r  e n c e p h a l o m a l a c i a  ( 6 d - 6 f ) .  N o t e  t h e  
e n l a r g e d  b r a n c h e s  o f  t h e  m i d d l e  c e r e b r a l  a r t e r y  i n  t h e  f e t u s  w i t h  e n c e p h a l o m a l a c i a  ( a r r o w e d  o n  6 b )  d e s c r i b e d  a s  
t h e  ‘ p s e u d o f e e d e r ’  s i g n  r e s u l t i n g  f r o m  o f  i m p a i r e d  c e r e b r a l  b l o o d  f l o w  t h a t  a r e  n o t  p r e s e n t  i n  t h e  o t h e r  f e t u s  -  s e e  
t h e  t e x t  f o r  d e t a i l s .    
 
 
Infections of the fetal brain  
The fetus is relatively protected from micro -organisms whilst  in utero  but 
infection can occur by agents crossing the placenta or ascending the maternal 
genito-urinary system, particularly if  the amniotic membranes are ruptured. 
The acronym ‘TORCHES’ is often used to describe the commonest infective 
agents that cause trans-placental infection (Toxoplasmosis, Other, Rubella, 
Cytomegalovirus (CMV), HErpes, Syphilis) .  The number of agents in the ‘Other’ 
category continues to increase and the aide memoire has been lengthened to 
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‘CHEAP TORCHES’, to include Chicken Pox (Varicel la-Zoster virus), Hepatit is B, 
C, D and E, Enteroviruses, A IDS (HIV), Parvovirus B19. The most recent addition 
of Zika virus to this l ist  may challenge the creators of the acronyms.  
CMV infection is the most frequently implicated agent to cause congenital 
infections in many countries but fetal infections from HIV and Zika pr esent 
challenges on a global scale. One feature of transplacental infections of the 
fetus is the relationship between the stage at which the fetus was infected and 
the effect on the fetus. Signif icant infect ions occurring in the f irst trimester 
often result in death of the fetus and spontaneous abortion/stil lbirth. If  CMV 
infection is acquired in the early second trimester the virus appears to have a 
predilection for infecting the rapidly dividing cel ls in the germinal matrix 
(ventricular zone). As a result ,  normal neuro-glial proliferation, migrat ion 
and/or organisation of the cerebral cortex can be severely affected. The range 
of imaging f indings have been explained in relation to the timing of the 
infection  e.g. second trimester infections at the time of neuronal/glial 
proliferation may produce microcephaly and/or micrencephaly, whereas 
agyria/l issencephaly is more l ikely to result from a failure of migration, and 
polymicrogyria results from abnormal cortical organisation (19 -20). Fetuses 
infected with CMV in the third trimester tend to have gliotic reactions in the 
white matter and multifocal periventricular calcif icat ions. Although it  is 
important to consider infection with CMV when a fetus is demonstrated to have 
microcephaly and a cortical formation abn ormality it  should be appreciated 
that similar appearances can result from genetic disorders such as those 
affecting the rapamycin signal l ing pathway (P13K -AKT3-mTOR pathway) (21-22).  
 
Leruez-Vil le and Vil le described USS f indings that may provide a clue to CMV 
infection under the headings of ‘severe USS brain abnormalit ies’ ‘mild USS brain 
abnormalit ies’ and ‘extra -cerebral USS abnormalit ies’ (23). Many of those are 
non-specif ic and, in our experiences, the referral information from USS in cases 
ultimately shown to have CMV infection typically have some combination of 
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‘microcephaly’,  ‘ventriculomegaly’ ,  ‘enlarged extra -axial spaces’ or ‘germinal 
cysts’ on USS. Picone et al.  studied 38 fetuses with proven congenital CMV 
infection and concluded that iuMR sho uld be performed whenever the USS 
examination was not completely normal or extra -cerebral manifestations of the 
infection were reported (23). Doneda and colleagues  also studied 38 fetuses 
with confirmed CMV infection and reported added diagnostic value for  iuMR in 
18/38 (47%) cases (20). The sensitivity of  USS in ante -natal diagnosis should be 
considered as low as 35% whilst the addition of iuMR is thought to produce 
negative predictive values close to 90%.  
 
 
F i g u r e  9 . 5 . 7 .  A  f e t u s  w i t h  c o n f i r m e d  t r a n s p l a c e n t a l  i n f e c t i o n  w i t h  c y t o m e g a l o v i r u s .  A x i a l  ( 7 a  a n d  7 b )  a n d  c o r o n a l  
( 7 c )  T 2 - w e i g h t e d  i m a g e s  o f  a  2 3 g w  f e t u s  w i t h  m i l d  v e n t r i c u l o m e g a l y  o n  u l t r a s o u n d .  F e t a l  a s c i t e s  h a d  b e e n  
r e c o g n i s e d  a t  2 0 g w .  M i l d  v e n t r i c u l o m e g a l y  i s  c o n f i r m e d  o n  i u M R  b u t  t h e r e  i s  a l s o  m i c r o - e n c e p h a l y ,  p o o r  
v i s u a l i s a t i o n  o f  t h e  s y l v i a n  f i s s u r e s  a n d  u n e v e n  c o r t i c a l  p l a t e s  i n  t h e  f r o n t a l  r e g i o n s .  P a t c h y  a b n o r m a l  s i g n a l  
i n t e n s i t y  i s  p r e s e n t  o n  a x i a l  d i f f u s i o n  w e i g h t e d  i m a g i n g  ( 7 d ) .   
 
There is less information about the iuMR imaging of fetuses infected by 
Toxoplasma gondii although the pathology and USS l iterature are helpful (25). 
Here, too, the gestat ional age at infection appears to correlate with 
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morphology; toxoplasmosis acquired in the second trimester tends to cause 
microcephaly, l ikely by damaging the developing cerebral hemispheres and 
leading to more severe neurological impairment. Chorioret init is is also 
common. Infection in the third trimeste r tends to produce dystrophic brain 
calcif ications (denser than CMV and often parenchymal) and a non -
communicating hydrocephalus, the latter secondary to a generalised 
destructive process of the ependyma with obstruction to CSF f low usually in the 




F i g u r e  9 . 5 . 8 .  A  f e t u s  w i t h  c o n f i r m e d  t r a n s p l a c e n t a l  i n f e c t i o n  w i t h  t o x o p l a s m o s i s .  T h e  p r e g n a n c y  w a s  c o m p l i c a t e d  b y  
p r e m a t u r e  r u p t u r e  o f  t h e  m e m b r a n e s  a t  1 6 g w  a n d  a n  a b s e n t  s e p t u m  p e l l u c i d u m  w a s  r e c o g n i s e d  o n  u l t r a s o n o g r a p h y  
a t  2 0 g w .  i u M R  w a s  p e r f o r m e d  a t  2 0 g w  a n d  c o r o n a l  c o n f i r m s  a  d i s r u p t e d  s e p t u m  p e l l u c i d u m  ( 8 a ) ,  v e n t r i c u l o m e g a l y ,  
e f f a c e d  e x t e r n a l  C S F  s p a c e s  a n d  a  r e l a t i v e l y  l a r g e  h e a d  c o n s i s t e n t  w i t h  h y d r o c e p h a l u s .  T h e r e  i s  a b n o r m a l  h i g h  s i g n a l  
o n  a x i a l  i n  t h e  p o s t e r i o r  p o r t i o n s  o f  t h e  c e r e b r a l  h e m i s p h e r e s  ( 8 b  a n d  8 c )  w h i c h  a l s o  s h o w  r e s t r i c t e d  d i f f u s i o n  ( 8 d -
8 f ) .  E x t e n s i v e  e n c e p h a l o m a l a c i a  w a s  s h o w n  o n  a u t o p s y  a n d  i n f e c t i o n  w i t h  t o x o p l a s m o s i s  w a s  c o n f i r m e d .   
 
Ascending infections are often bacterial and may result in direct infection of 
the fetus. Inflammation may also result in fetal brain injury in utero. Pre -labour 
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rupture of the amniotic membranes leads to an ascending infection, involving 
the chorionic palate and/or umbilical vessels (chorioamnionit is) and the fetal 
brain may be injured “at a distance” by the release of cytokines and other 
inflammatory agents.  Fetuses in the second and early third trimester are at 
particular risk by this mechanism, possibly because of the lack of protective 
agents in the immature brain. Fetuses that survive this process often develop 
periventricular leukomalacia.  
 
 
F i g u r e  9 . 5 . 9 .  A  f e t u s  w i t h  b r a i n  i n j u r y  p r e s u m e d  s e c o n d a r y  t o  c h o r i o a m n i o n i t i s .  T h e  p r e g n a n c y  w a s  c o m p l i c a t e d  b y  
p r e m a t u r e  r u p t u r e  o f  t h e  m e m b r a n e s  a t  2 8 g w  f o l l o w e d  b y  r e d u c e d  f e t a l  m o v e m e n t s  a n d  i u M R  i m a g i n g  a t  2 9 g w .   
A x i a l  ( 9 a - 9 c ) ,  c o r o n a l  ( 9 d )  a n d  s a g i t t a l  ( 9 e )  T 2 - w e i g h t e d  i m a g e s  s h o w s  g e n e r a l i s e d  b r a i n  s w e l l i n g  a n d  r e s t r i c t e d  
d i f f u s i o n  ( 9 f ) .  C a r d i a c  a c t i v i t y  w a s  p r e s e n t  a t  t h e  t i m e  o f  i m a g i n g  b u t  t h e  f e t u s  w a s  s t i l l b o r n  t h e  f o l l o w i n g  d a y .  A  
p r e s u m p t i v e  d i a g n o s i s  o f  i n f l a m m a t o r y  b r a i n  i n j u r y  s e c o n d a r y  t o  c h o r i o a m n i o n i t i s  w a s  m a d e .    
 
Toxic and Metabolic disorders  
Numerous chemicals and medications are teratogenic, including several that 
appear to have a predilection for the de veloping central nervous system. 
Leading examples include aminopterin, phenytoin, many chemotherapeutic 
agents, ret inoic acid (vitamin A) and alcohol.  
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Di Mauro and Garone described the wide range of possible inheritable 
metabolic disorders and described t hose involving glycogenesis and 
mitochondrial defects of the fetus in detail  (26). Mendelian or maternally 
inherited disease may be present in a fetus but not have a morphologic 
manifestation; many metabolic disorders do not produce brain injury until  afte r 
birth (in infancy, childhood, or even adulthood). Reasons why a fetus may be 
involved but not be affected in utero  are numerous, e.g.  a genetic defect may 
produce a mutated ‘mature’ enzyme which has a fetal counterpart that is not 
involved or the mother is able to metabolise an abnormal gene product or the 
build-up of a toxic intermediate compound made by the fetus.  Defects of the 
mitochondrial respiratory chain are amongst the most important inheritable 
metabolic disorders in terms of brain involvement and impaired oxidative 
metabolism in the child or adult metabolically active areas. In  contrast, fetal 
t issues rely more on anaerobic gl ycolysis for ATP production rather than 
oxidative mechanisms, hence providing a measure of protection (27). A normal 
iuMR study in these situations should never be used to exclude a metabolic 
disorder in a fetus; there may be non -specif ic f inding on iuMR that may raise 
suspicion (e.g. germinolytic cysts).  
 
Intracranial mass lesions  
Intracranial mass lesions cover a wide range of potential pathologies including 
neoplastic and non-neoplastic entit ies. Intracranial neoplastic lesions diagnosed 
in utero  are exceptionally rare and their prevalence is diff icult  to quantify with 
certainty. Intracranial tumours are reported to have been found in 0.34/mill ion 
new-borns and account for approximately 1% of pediatric CNS tumours but 
intracranial tumours may result in f etal demise, and therefore the true 
incidence may be underestimated (28). One paper, reporting the ante -natal 
imaging f indings of 27 fetuses with histologically confirmed intracranial 
tumours (24 with iuMR imaging), pooled the experience of 11 collaboratin g 
centres over 14 years (29). Germ cell  tumours were by far the commonest 
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neoplastic lesion, accounting for 15/27 cases (56%) of which 13 were 
teratomas. There were 4/27 (15%) glial -based tumours and small numbers of 
craniopharyngiomas,  hamartomas, choroid  plexus papi l lomas,  
haemangioblastomas, and a single undifferentiated tumour. 26/27 neoplasms 
originated from the supratentorial compartment (one case of  
 
 
F i g u r e  9 . 5 . 1 0 .  A  f e t u s  w i t h  p y r u v a t e  d e h y d r o g e n a s e  d e f i c i e n c y  h a d  i u M R  i m a g i n g  p e r f o r m e d  a t  3 4 g w .  C o r o n a l  ( 1 0 a  
a n d  1 0 b ) ,  a x i a l  ( 1 0 c )  a n d  s a g i t t a l  ( 1 0 d )  T 2 - w e i g h t e d  i m a g e s  s h o w  a b s e n c e  o f  t h e  c o r p u s  c a l l o s u m ,  s e v e r e  
v e n t r i c u l o m e g a l y ,  a  t h i n  p a r e n c h y m a l  m a n t l e  w i t h  s i m p l i f i e d  g y r a l  p a t t e r n  a n d  c e r e b e l l a r  h y p o p l a s i a .  T h e  e n z y m e  




haemangioblastoma was infratentorial) and most were very large at the time of 
diagnosis. Although teratomas were more often partially cyst ic, it  appears 
diff icult  to provide a reliable histological diagnosis from iuMR imaging based on 
morphology. 23 pregnancies were terminated after ante -natal  diagnosis of a 
tumour, there were two neonatal deaths, and two children were alive at the 
time of reporting the case series (30).  
Non-neoplastic intracranial mass lesions include arachnoid cysts, and we have 
included extra-axial haematoma in this group for the analysis  described below. 
Another recently described entity that appears to be specif ic to the fetus is 
dural venous sinus ectas ia with thrombosis (DVSET). This is shown on imaging 
as an enlargement of the venous confluence, posterior portion of the superior 
sagittal sinus and transverse sinuses, containing clot often of different ages but 
with no f istulae present. Haemorrhagic or ischaemic brain complications with 
this entity are rare although mass effect can be signif icant (31). The aetiology is 
uncertain but many authorities regard DVSET as self - l imiting and good 





F i g u r e  9 . 5 . 1 1 .  A  f e t u s  w i t h  a  n o n - n e o p l a s t i c  i n t r a c r a n i a l  m a s s  l e s i o n .  T h e  i n i t i a l  i u M R  i m a g i n g  s t u d y  w a s  p e r f o r m e d  
a t  2 1 g w  ( 1 1 a  a n d  1 1 b )  S h o w s  a n  e x t r a - a x i a l  m a s s  l e s i o n  c e n t r e d  o n  t h e  v e n o u s  c o n f l u e n c e  a n d  e x t e n d i n g  t o  i n v o l v e  
t h e  p o s t e r i o r  p o r t i o n  o f  t h e  s u p e r i o r  s a g i t t a l  s i n u s  a n d  t r a n s v e r s e  s i n u s e s .  T h e  m a s s  c o n t a i n s  t h r o m b u s  a t  d i f f e r e n t  
s t a g e s  o f  e v o l u t i o n .  T h e r e  i s  s i g n i f i c a n t  m a s s  e f f e c t  w i t h  a n t e r i o r  d i s p l a c e m e n t  a n d  c o m p r e s s i o n  o f  t h e  c e r e b e l l u m  
a n d  b r a i n s t e m .  A  d i a g n o s i s  o f  d u r a l  v e n o u s  s i n u s  e c t a s i a  w i t h  t h r o m b o s i s  w a s  m a d e .  A  r e p e a t  s t u d y  a t  2 6 g w  ( 1 1 c  
a n d  1 1 d )  s h o w s  g r e a t e r  i n v o l v e m e n t  o f  t h e  t r a n s v e r s e  s i n u s e s  b u t  r e d u c e d  c o m p r e s s i o n  o f  t h e  b r a i n ,  w i t h  C S F  
v i s i b l e  b e t w e e n  t h e  c e r e b e l l u m  a n d  t h e  m a s s .  I m a g i n g  a t  3 1  w e e k s  ( 1 1 e  a n d  1 1 f )  s h o w s  f u r t h e r ,  b u t  i n c o m p l e t e ,  





F i g u r e  9 . 5 . 1 2 .  I n t r a c r a n i a l  v a s c u l a r  t u m o u r  d e m o n s t r a t e d  o n  i u M R  i m a g i n g  i n  a  2 6 g w  f e t u s  f r o m  a  t w i n  p r e g n a n c y  
( t h e  o t h e r  t w i n  w a s  n o r m a l ) .   S a g i t t a l  ( 1 2 a ) ,  c o r o n a l  ( 1 2 b )  a n d  a x i a l  ( 1 2 c )  T 2 - w e i g h t e d  i m a g e s  s h o w  a  l a r g e  m a s s  
l e s i o n  i n  t h e  p o s t e r i o r  p a r t  l e f t  c e r e b r a l  h e m i s p h e r e .  T h e  m a s s  i s  h y p e r - v a s c u l a r  w i t h  m u l t i p l e  f l o w  v o i d s  f r o m  l a r g e  
v e s s e l s  a n t e r i o r l y  a n d  t h e  s u p e r i o r  s a g i t t a l  s i n u s  i s  d i l a t e d  d u e  t o  a r t e r i o v e n o u s  s h u n t i n g .  S a g i t t a l  e c h o - p l a n a r  
i m a g e  ( 1 2 d )  s h o w s  m a r k e d  h y p o - i n t e n s i t y  i n  t h e  m a s s  d u e  t o  t h e  i n t e r n a l  h a e m o r r h a g e  a n d  v a s c u l a r i t y .  H i s t o l o g i c a l  





F i g u r e  9 . 5 . 1 3 .  I n t r a c r a n i a l  m a s s  l e s i o n ,  p r o b a b l y  n e o p l a s t i c .  S a g i t t a l  ( 1 2 a ) ,  c o r o n a l  ( 1 2 b  a n d  1 2 c )  a n d  a x i a l  ( 1 2 d -
1 2 f )  T 2 - w e i g h t e d  i m a g e s  o f  a  2 3 g w  f e t u s  w i t h  a  l a r g e  e x t r a - a x i a l  m a s s  l e s i o n ,  w h i c h  h a s  s o l i d  a n d  c y s t i c  
c o m p o n e n t s .  T h e r e  w a s  d o c u m e n t e d  i n c r e a s e  i n  s i z e  a n d  m a s s  e f f e c t  o v e r  t w o  w e e k s .  H i s t o l o g i c a l  d i a g n o s i s  w a s  n o t  
a c h i e v e d  b u t  r a d i o l o g i c a l l y  t h e  m a s s  w a s  m o s t  l i k e l y  t o  b e  a  t e r a t o m a .   
 
Prevalence of acquired fetal brain pathology in the MERIDIAN cohort  
Full  details of the MERIDAN study are reported elsewhere but are summarised 
here (6). A pregnant woman aged 16 years, or more, was potentially eligible for 
recruitment if  the fetus had any brain abnormality detected at USS at ≥18gw by 
a formally trained fe tal medicine consultant. The group consisted of 570 fetuses 
with brain abnormalit ies undergoing iuMR imaging within 2 weeks of the USS, 
and an outcome reference diagnosis was avai lable. There were 369 fetuses 
imaged between 18-23gw and 201 fetuses ≥ 24gw.  Retrospective review of the 
MERIDIAN cohort, leads us to suspect that 38/570 cases (6.7%) are best 
classif ied as acquired fetal brain pathology on the basis of the iuMR imaging 
and confirmed on outcome reference data (table 1). In 28/38 (74%) the same 
pathology was shown on USS, but the acquired pathology was not suspected on 
USS in the remaining 10 fetuses (26%). A further 7/570 (1.2%) fetuses had 
acquired pathology diagnosed on USS but excluded on iuMR imaging and 
outcome reference data (those cases invol ving suspected tumours, calcif ication, 
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haemorrhage and DVSET). Stroke was the suspected underlying cause of the 
acquired pathology in 20/38 (53%) of cases, most of which were haemorrhagic 
(14/38, and occurred in 20/570 (3.5%) in the MERIDIAN cohort. Genera lised 
hypoxia/ischaemia was suspected in 9/38 (24%) based on the distribution of 
damage. Intra-cranial mass lesions accounted for 7/38 (18%) and all  were non -
neoplastic, extra-axial masses. Both infective cases (2/38 –  5%) resulted from 
confirmed transplacental CMV infection. Please note that the cases shown in 






We have shown that acquired lesions are comparatively rare causes of fetal 
intracranial pathology and accounted for le ss than 7% of cases in one recent, 
large study. The dist inction between ‘developmental’  and ‘acquired’ fetal brain 
pathology can be dif f icult in some cases and is often considered too simplistic 
by many researchers. Another approach is to distinguish betwe en a 
malformation, a consequence of a malformation, a disruption, and acquired 
pathology.  Malformations result from an alteration of the primary 
developmental programme, which is non -progressive after it  has f irst manifest, 
whilst a malformation consequen ce occurs when a malformation results in 
additional pathology, either further malformations or destructive pathologies. 
These pathologies have been reviewed in earlier publications regarding fai led 
commissuration and posterior fossa abnormalit ies.  
A disruption is impaired development of a structure damaged in an immature 
stage with the end result being a ‘secondary’ malformation. Finally, an acquired 
lesion  is due to damage to a previously normal structure. Unfortunately, this 
approach is not straightforward and practical ly it  is often diff icult to distinguish 
between these mechanisms with confidence. However, both cases of CMV 
infection found in the MERIDIAN cohort were accompanied by obvious cortical 
formation abnormalit ies and could be classif ied as a di sruption in the more 
detailed classif ication although the etiology is an obvious acquired pathology. 
In addition, the unilateral cerebellar hypoplasia cases that we have classif ied as 
acquired pathology (stroke) in this paper could also be considered as 
disruptions. Fetal stroke appears to be the most common acquired pathology 








Teaching points  
The fetal brain can be damaged in utero from a wide range of acquired 
pathologies that are well  demonstrated on iuMR imaging.  
Acquired pathology can damage structure that have otherwise formed properly 
or interfere with the formation process of a structure that is not yet mature  
In the authors experience, fetal stroke is the commonest acq uired fetal brain 
pathology 
Fetal stroke is frequently hemorrhagic  
Transplacental CMV infection often disrupts normal development of the 
cerebral hemispheres  
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Diagnosis on iuMR and confirmed 
on Outcome Reference Data 
Mostly likely category of 
acquired pathology 
26: Unilateral hypoplasia of cerebellar 
hemisphere and cerebellar vermis 
Stroke (ischaemic) 
27: Diffuse supratentorial white 




37 Posterior fossa arachnoid cyst with 
displaced but normal cerebellum 
Intracranial mass lesion (extra-
axial) 
43 Subdural collections Intracranial mass lesion (extra-
axial haemorrhage) 
94 Focal cortical injury Stroke (ischaemic) 
97 Dural ectasia and thrombosis, 
displaced but normal brain 
Intracranial mass lesion (extra-
axial) 
142 Periventricular leukomalacia Generalised 
hypoxia/ischaemia 
144 Unilateral hypoplasia of cerebellar 
hemisphere with haemorrhage 
Stroke (haemorrhagic) 
201 Intra-ventricular haemorrhage Stroke (haemorrhagic) 
227 Unilateral hypoplasia of cerebellar 
hemisphere  
Stroke (ischaemic) 





321 Generalised cerebral and 




397 Generalised cerebral and 




404 Germinal matrix haemorrhage  Stroke (haemorrhagic) 
484 Unilateral hypoplasia of cerebellar 
hemisphere  
Stroke (ischaemic) 
410 Microcephaly, generalised 
malformation of cerebrum 
Infection (confirmed 
congenital CMV infection) 
425 Periventricular leukomalacia, 
germinal matrix and 
intraventricular haemorrhage 
Stroke (haemorrhagic) 
432 Germinal matrix haemorrhage  Stroke (haemorrhagic) 
433 Generalised encephalomalacia and 
haemorrhage in germinal matrix 
Generalised 
hypoxia/ischaemia 
495 Germinal matrix haemorrhage  Stroke (haemorrhagic) 
505 Bilateral cerebral 




509 Generalised encephalomalacia and 
haemorrhage in germinal matrix 
Generalised 
hypoxia/ischaemia 
583 Unilateral hypoplasia of cerebellar 
hemisphere and Blake’s pouch cyst 
Stroke (ischaemic) 
617 Intraventricular haemorrhage Stroke (haemorrhagic) 
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635 Intraventricular haemorrhage Stroke (haemorrhagic) 
734 Generalised encephalomalacia and 
haemorrhage in germinal matrix 
Generalised 
hypoxia/ischaemia 
753 Intraventricular and choroid plexus 
haemorrhage 
Stroke (haemorrhagic) 
754 Extradural haematoma Intracranial mass lesion (extra-
axial haemorrhage) 
776 Dural ectasia and thrombosis, 
displaced but normal brain 
Intracranial mass lesion (extra-
axial) 
884 Generalised encephalomalacia Generalised 
hypoxia/ischaemia 
897 Dural ectasia and thrombosis, 
displaced but normal brain 
Intracranial mass lesion (extra-
axial) 
940 Unilateral temporal lobe 
haematoma and focal 
encephalomalcia 
Stroke (haemorrhagic) 
966 Lobar and intraventricular 
haemorrhage  
Stroke (haemorrhagic) 
1022 Brainstem, unilateral temporal 
lobe haematoma with 
intraventricular haemorrhage 
Stroke (haemorrhagic) 
1048 Microcephaly, generalised 
malformation of cerebrum 
Infection (confirmed 
congenital CMV infection) 
1054 Intraventricular haemorrhage Stroke (haemorrhagic) 
1071 Dural ectasia and thrombosis, 
displaced but normal brain 




1102 Unilateral hypoplasia of cerebellar 
hemisphere and cerebellar vermis 
Stroke (ischaemic) 
 
Table 9.5.1 MERIDIAN case numbers with diagnosis on iuMR 
             
             
             
             




9.6 Watershed stroke – an unexpected complication of respiratory syncytial virus 
bronchiolitis: a case report  
 
Riley G, Rittey CD, Connolly DJA and Mordekar SR  
 
European Journal of Medical Case reports (2017) 1; 36 -39  
 
A watershed injury to the brain affects the vascular boundary zone between the 
mature middle cerebral arteries and the anterior/posterior cerebral arteries. 
This vascular watershed territory only appears after 34 -36gw when the major 
cerebral arteries mature and take on the configuration commonly seen in 
adults.  
 
Watershed injuries can be induced by a combination of hypotension and 
hypoxia producing hypoperfusion. For instance, this can be produced in adults 
who suffer a cardiac arrest and have inadequate cardio -pulmonary 
resuscitation.  
 
In neonates it  was known that a respiratory syncytial virus (RSV) chest infection 
producing bronchiolit is could induce signif icant cardiorespiratory dysfunction 
requiring urgent admission to hospital and supportive care. It  had not 
previously been reported that this cardiorespiratory dysfunction could be so 
severe that it  might induce a hypoperfusion injury to the brain injuring the 
watershed territories and radiologically mimicking a chronic partial asphyxia.  
Radiological ly and cl inically a post-natal cardiorespiratory col lapse may produce 
MRI and clinical features indistinguishable from a perinatal CPH. A post -natal 
collapse and CPH can produce additive injury to the brain and can only be 
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We report a case of watershed stroke in a young child, occurring as an 
unexpected complication of severe respiratory syncytial virus (RSV) 
bronchiolit is . RSV is a common childhood pathogen, with many reported 
extrapulmonary manifestations. Neurological involvement was once bel ieved to 
be temporary or reversible; diffusion -weighted MRI proved that seizures in our 
patient were a consequence of more signif icant peripheral perfusion failure and 
stroke. It  is important to distinguish the reversible effects of RSV from those 
alternative pathological sequelae necessitating changes in clinical management 









Watershed infarction (WSI) is a type of stroke attributed to perfusion failure at 
the periphery of adjacent non -anastomosing arterial territories in the brain. 
Various pathophysiological origins have been alluded to –  such as systemic 
hypotension, arterial stenosis/occlusion and microemboli . 1 - 3  In the newborn, 
after 36 weeks gestational age, it  is generally thought to arise from severe 
systemic hypotensive episodes ± hypoxaemia. 4  WSI can be a devastating event, 
as profound neurological disabil ity and even death may ensue. Such sequelae 
could be curtailed in the young chi ld with promising new neuroprotective 
techniques if  introduced early. 5  
The Paediatrician and the Paediatric Radiologist should be alert to watershed 
stroke and to the gamut of childhood conditions having a described causal 
association. To our knowledge, no such association has been reported with 
respiratory syncytial  virus (RSV) infection.  
We bring to your attention a case of peripheral perfusion fai lure and waters hed 
stroke as an unexpected complication of severe RSV -positive bronchiolar 
infection in a young child.  
Case Summary  
The child is a boy born pre-term at 28 weeks’ gestation by emergency caesarean 
section for maternal pre-eclampsia, weighing 937grams and wi th a head 
circumference of 26.5cm (50 t h  centile). Following 2 months intensive care 
treatment for surfactant -deficiency pulmonary disease, he was discharged 
home with continuous low flow oxygen therapy. Other conditions of 
prematurity included patent ductu s arteriosus and foramen ovale, osteopaenia 
with long bone fractures and gastro -oesophageal reflux. Neurological 
examination and cranial ultrasound were unremarkable.  
At 3 months of age, he was re-admitted to the paediatric intensive care unit 
(PICU) with acute bronchiolit is,  diagnosed clinical ly and on chest radiograph –  
and subsequently confirmed on nasal washings as RSV -positive. He required 
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endotracheal intubation and ventilation for 48 hours, during which time he 
developed pneumothoraces that were succe ssful ly drained. Inotropic support 
was not required. On PICU day 3, he developed acute symptomatic focal 
seizures with secondary generalisation with corresponding electro -
encephalogram (EEG) changes. Seizures were treated effectively with 
intravenous phenobarbital and midazolam. He was treated prophylactically on 
intravenous Cefotaxime and Acyclovir. Lumbar puncture showed normal 
microscopy, protein,  glucose, and lactate. CSF virology was negative for herpes 
simplex virus and RSV. On day 22, the patient was  discharged home without 
regular antiepileptic medications. Brain magnetic resonance imaging (MRI) was 
performed 12 hours post -onset, which demonstrated restr icted diffusion in 
keeping with acute watershed territory infarction [f igure 9.6.1].  
Clinical examination at 8 months chronological age (5 months corrected 
gestational age) demonstrated good head control on ventral suspension, 
appropriate use of both hands with hand -to-mouth co-ordination, and good 
visual tracking. He was fully oral ly fed. On examinati on, his head circumference 
was 39 cm (9 th  centile),  with normal tone and reflexes with no focal 
neurological signs.  
Clinical examination at 13 months chronological age (10 months corrected) 
demonstrated sitt ing unsupported, as well  as weight -bearing and standing with 
support. He had achieved hand to hand transfer of objects but no pincer grasp. 
As far as vocalisation is concerned, he used both vowel and consonant babble.  
He blew raspberries,  recognised his name but had no single words.  On 
examination, his head circumference was 41.9 cm (<0.4 t hcenti le). His weight   
and height were below the 0.4 th  centile. His tone and ref lexes were normal with 
no focal neurological  signs.  
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Figure 9.6.1a  
Figure 9.6.1b  
Figure 9.6.1c   






Our patient was admitted to PICU with severe RSV -posit ive bronchiolit is and 
episodes of respiratory decompensation requiring ventilatory support; and 
subsequently developed acute symptomatic seizures after three days. However, 
throughout the PICU stay blood pressure was stable.  CSF examination was 
normal with no evidence of RSV encephali t is . While seizures –  among other 
acute neurological symptoms and signs –  have been reported as temporary or 
reversible manifestations of RSV; 6 - 9  to our knowledge there are no such reports 
implicating WSI and stroke.  
RSV is a common pathogen in childhood respiratory infections, and 
extrapulmonary manifestations are becoming increasingly recognised as reasons 
for acute deterioration. Around 3% of all  babies with bronchiolit is develop 
more serious symptoms, such as diff i culty breathing, that require hospital 
admission. This is more common in premature babies and in those born with a 
heart or lung condition . Our case had several risk factors.    
Neurological manifestations were reported in 39% (n = 121) of RSV -positive 
bronchiolit is patients on a PICU. These included seizures, central apnoeas, 
lethargy, feeding/swallowing diff iculties,  muscle tone abnormalit ies, as well  as 
elevated cerebrospinal f luid protein levels. 7  However, in our case, CSF protein 
was normal. Similar manifestations were found in 1.2% (n = 964) of ward -based 
patients –  with milder bronchiol it is . 8  
RSV-related seizures have been described as both general ised tonic –clonic and 
focal seizures with altered consciousness and focal motor features or eye 
deviation, as well  as status epilepticus. 7 - 8  Encephalopathy was felt  to be the 
cause of seizures in 1.8% (n=487) in a tertiary centre study. 9  Hyponatraemia is 
commonly associated with RSV and possibly accounts for some seizures. 6 , 1 0  
Focal temporal lobe ‘slowing’ wa s seen on electroencephalogram in one case. 8  
Generally, neuroimaging has proven non -contributory.  
In our case, MR Neuroimaging appearances were characteristic of acute 
bilateral ly symmetric cort ical watershed infarction (WSI) [f igure 1]. WSI occurs 
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at border-zones between the territories supplied by 2 (or 3) non -anastomosing 
arterial systems –  cortical WSI between ACA, MCA and PCA; and internal WSI 
between deep and superficial MCA or between superficial MCA and superficial 
ACA. Susceptibil ity of the border -zone areas is thought to result from their 
situation at the ‘peripheral f ield’ where perfusion pressure is lowest. Peripheral 
perfusion failure (ischaemia) is the crit ical physiological process most l ikely 
secondary to precipitous drops in systemic arteria l blood pressure rather than 
hypoxia.1  Micro-embolic disease has also been implicated in the aetiology of 
WSI.2 - 3  
The pathogenesis of WSI in the case of severe RSV infection is  uncertain; the 
general process is probably due to respiratory fai lure with asph yxia and/or 
periods of central apnoea, result ing in reduced blood oxygenation 
(hypoxaemia). With prolonged hypoxaemia, cardiac hypoxia occurs, leading to 
diminished cardiac output and ultimately to brain hypoperfusion. Local brain 
tissue hypoxaemia is  probably contributory rather than the primary underlying 
cause for stroke. RSV encephalit is is an unlikely cause in our case.  And while 
conditions of prematurity pre -existed, these were shown to be stable or 
improving. Embolic phenomena are unlikely in this a ge-group.  
It  is important to distinguish extrapulmonary organ 
dysfunction/decompensation as a temporary or reversible manifestation of RSV 
infection, from structural pathological sequelae necessitating changes in 
clinical management. The acute treatment is largely supportive, generally 
requiring escalation of care to the intensive care unit setting.  Promising new 
neuroprotective strategies designed to l imit the extent of brain injury caused 
by hypoxia-ischemia are under investigation. Many of th ese treatment 
strategies, including hypothermia and administrat ion of excitatory amino acid 
antagonists, have a l imited window of effectiveness (in some cases as l itt le as 6 
hours), making early stroke detection crit ical ly important. 5   
The prognosis for ch i ldren with watershed infarct is variable in the long term. 
Severe motor impairment is uncommon, simulating an early normal outcome 
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prompting discharge from follow -up when reviewed at 12-18 months.  However, 
suboptimal head growth, behavioural problems and delay in language are 
common. Several studies have now, however, shown that these children may 
‘grow into their deficits’ and it  is this group in particular that require more 
long-term follow-up well into chi ldhood. As our chi ld is currently only 13 
months old and is cl inical ly progressing quite well  despite the progressive 
microcephaly, a repeat MRI brain scan has occurred so far. Specif ic cognitive 
functions continue to develop throughout childhood.  As it  is impossible to 
examine a function that has not yet developed, short term fol low -up does not 
exclude further cognitive decline and behavioural diff iculties especially at 
secondary school age.   
Our case wil l  be closely monitored in Neurology cl inic, and follow -up MR 






RSV has many reported extrapulmonary manifestations. Neurological 
involvement, previously bel ieved to be temporary or reversible, could be more 
signif icant due to peripheral perfusion failure and stroke. Waters hed stroke 
should be considered a potential complication of severe RSV -positive 
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9.7 Perinatal Arterial Ischemic Stroke in term babies 
 
Hart AR, Connolly DJA and Singh R  
 
Paediatrics and Child Health (2018) 28: 417 -423 
 
Perinatal arterial ischaemic stroke (PAIS) was reviewed in this paper that 
described the incidence, mechanism of action, anatomy, r isk factors and clinical 
presentation. The acute and chronic imaging features on CT and MRI were 
described and presented with  suggestions for acute management and prognosis.  
 
EEG and MRI in the neonatal period were useful for prognost ication and yet 
should be interpreted with caution as there are examples of neonates with 
restricted diffusion in the cerebral cortex, basal gangl ia and cerebral peduncles, 
but in whom outcome is much better than predicted. This may reflect Wallerian 
degeneration in some of the deep structures following acute infarction to the 
cortex mimicking true primary PAIS of the deep structures.  
 
Cerebral plast icity may al low the developing brain to ascribe a new region of 
the cerebral cortex the functional role that would have been performed by the 
infarcted brain. The capacity for plasticity reduces with the age of the patient 







Perinatal arterial ischaemic stroke (PAIS) affects between 1:2300 and 1:4000 
births, so most paediatricians will  see cases during their working l ife. The exact 
cause of PAIS in an individual usually is unknown, and discussion may occur 
about whether prothrombotic investigations, aspirin or anticoagulation are 
needed. The causes, investigation and treatment of PAIS are completely 
different from stroke in the older paediatric and adult group. Outcome tends to 
be good, although cerebral palsy may be s een in up to 30% of cases, epi lepsy in 
15-25% and cognitive problems may also occur. Fortunately, EEG and MRI can 
help identify those children with PAIS at the highest risk of neuro -
developmental diff iculties. This paper reviews what we know about the 
potential mechanisms causing PAIS, what investigations are necessary, and the 






Most trainees and consultants who care for neonates will  see several children 
with a perinatal arterial ischaemic stroke (PAIS) during their career. The 
presentation of the child with PAIS can generate questions such as:  
why? 
was it  caused by a diff icult  delivery?  
do we need to do prothrombotic investigations in the baby or mother?  
is anticoagulation or aspirin necessary?  
what is the chi ld’s prognosis?  
The investigation and management of perinatal arterial ischaemic stroke are 
very different from strokes affecting older children or adults. This review 






Perinatal arterial ischaemic stroke (PAIS) is defined as “a group of 
heterogeneous conditions in which there is a focal disruption of cerebral blood 
flow secondary to arterial or cerebral venous thrombosis or embolization, 
between 20 weeks of  fetal l i fe through to the 28 t h  postnatal day, conf irmed by 
neuroimaging or neuropathologic studies”.  
 
Haemorrhage may occur secondari ly into an area of infarction, but we usually 




The incidence of PAIS is diff icult  to establish, and previous f igures tend to be 
derived from neuropathological data. The most common estimations are 
between 1 in 2300 and 1 in 4000 births, so a reasonable sized neonatal 
intensive care unit will  see a hand ful of cases each year. This estimation relies 
on both the child having symptoms and being diagnosed correctly: 
paediatricians and neurologists wil l  be familiar with children who present later 
in l ife with focal epilepsy or signs of unilateral cerebral pal sy whose imaging 
reveals evidence of PAIS and where the child was asymptomatic or had mild 
symptoms that settled spontaneously in the neonatal period. Similarly, outcome 
following PAIS can be entirely normal, and it  is possible that a number of 
children and adults that have suffered from PAIS, had normal outcome, and 
never received a diagnosis. Therefore, this estimation of incidence should be 





MECHANISM OF ACTION 
The exact cause of PAIS is often unknown. Traditionally, PAIS has bee n 
explained as being caused by a blood clot forming within the ageing placenta, 
entering the fetal circulation, embolising across the patent foramen ovale, to 
the left ventricle, into the ascending aorta to one of the main three branches of 
the thoracic aorta and then up either the vertebral arteries or more commonly 
entering the common and then internal carotid arteries, before involving the 
intracranial vasculature, where it  blocks one or more of the main arterial 
branches (see f igure s 1 and 2 for a revis ion of the neuroanatomy of the 
cerebral arterial branches  and the brain supplied). The most common site for 
PAIS to occur is the middle cerebral artery, with the left side affected in 
approximately 67%, right 26%, and bilateral involvement in 7%.  
 
Determining whether this hypothesis is correct is problematic because of its 
low incidence, our inabil ity to identify which foetuses will  develop PAIS, the 
diff iculty in establishing when the stroke occurred, the delay between the event 
occurring and symptom onset  and diagnosis with the possible transition from 
the fetal to the neonatal circulation and cardiac configurat ion, and the 





F ig u r e  9 . 7 . 1 .   A r t er ia l  b l o o d  s u p p l y  to  t h e  b ra i n  





F ig u r e  9 . 7 . 2  A r t e r ia l  v a s cu la r  te r r i to r i es  o f  th e  b ra in  
Or ig in a l  im a g e  p ro d u ced  f o r  th i s  p u b l i c a t io n  
 
A number of risk factors have been suggested for PAIS (table 9.7.1). These 
factors are associations and should not be taken to be the “cause of PAIS”: 
there are many neonates with similar r isk factors who do not develop PAIS, and 
some without any who do. Gen erally speaking, the more r isk factors present, 
the greater the risk of PAIS occurring. Martinez -Biarge et al (2016) showed 64% 
of controls without PAIS had no risk related to labour, compared to 15% of 
babies with PAIS. The presence of 1 r isk factor was a ssociated with an increased 
risk of PAIS with an odds ratio of 5.63, and 2 or more risk factors were 
associated with an odds ratio for PAIS of 19.14. Of particular mention is the 
role of instrumental delivery: the risk of PAIS developing fol lowing spontane ous 
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vaginal delivery or elective caesarean section is much lower than for 





Maternal risk factors Pregnancy / labour risk factors 
 
Fetal / neonatal risk factors 
Nulliparity 
Family history of seizures or other 
neurological disease 
Maternal past history of 









Chronic poor placental perfusion with 
added acute abnormality 
Abnormal placental vessels or umbilical 




Maternal pyrexia over 38C 
Chorioamnionits 
Prolonged second stage of labour 
Meconium stained liquor 
Fetal bradycardia or decelerations 
Prolonged rupture of membranes 
Tight nuchal cord 
Ventouse delivery 
Emergency caesarean section, particularly 
after failed instrumental delivery  
Umbilical arterial pH <7.10 
Male sex 
Small for gestational age 
 
Apgar score 3 at 1 minute 





Early onset sepsis or 
meningitis 
 
Congenital heart disease 
 
Need for ECMO 
 
 
Table 9.7.1: Suggested risk factors for PAIS in the literature, often from case control studies 
 
The role of thrombophilia as a risk factor for PAIS is debatable. Pregnancy is 
naturally associated with hyper -coagulabil ity in mothers and babies, and the 
fetus has a high haemoglobin and packed cell  volume. This may be exacerbated 
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by neonatal dehydration as feeding is being established. But should 
prothrombotic factors be sought in the mother and baby? Günther et al noted 
in 2000 that 68.1% (62 out of 91) neonates with PAIS had at least 1 
prothrombotic risk factor compares to 24.2% of the con trol group, which gave 
an odds ratio of 6.7. They noted:  
22.0% had raised l ipoprotein (a) compared to 5.5% controls (OR 4.84)  
18.7% had Factor V 1691GA compared to 5.5% controls (OR 3.95)  
4.4% had prothrombin 20210GA compared to 2.2% controls (OR 2.04) 
16.5% had MTHFR TT677 genotype compared to 10.9% of controls OR1.59  
and 6.6% had protein c deficiency.  
 
Kocaman studied older children with presumed PAIS and looked at 
prothrombotic risk factors, f inding the most commonly detected prothrombotic 
factors were:  
51% had MTHFR mutations  
Factor V Leiden was noted in 20% of cases  
Increased l ipoprotein (a) in 11%.  
 
More recently, in 2017, Curtis et al showed there were no differences in pro -
thrombophilia markers in chi ldren with PAIS. This is supported by out come 
studies: strokes rarely reoccur in the children that have had PAIS, and the 
recurrence risks for future pregnancies in the same mothers is also low. It  is the 
also the author’s experience that haematologists may decline to look for 
prothrombotic agents, stating that the results are hard to interpret in the 
neonatal period and that the results do not change patient management given 
the low recurrence r isk. Our view is that routine analysis of prothrombotic 
agents is not necessary following straight -forward PAIS, but should be 
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considered in more complex cases, such as where multiple arterial terr itories 
are involved, there are emboli or thrombi in other regions or the body, where 
the stroke occurs distant from birth towards the end of the neonatal period,  or 
where a strong family history exists.  
 
Where strokes and / or haemorrhages are extensive, particularly if  there is a 
family history of early onset stroke, kidney or retinal disease, or cataracts, the 
COL4A1 (OMIM 120130) gene should be studied. This i s a gene coding for 
collagen within the basement membranes, including of blood vessels, and is 
inherited in an autosomal dominant manner, leading to early onset stroke, 
renal and retinal vessel abnormalit ies and cataracts.  
 
CLINICAL PRESENTATION 
The most typical cl in ical presentation is in a child who did not require 
resuscitation at birth and presents between day 1 to 5 of l ife with focal 
seizures, usual ly clonic. There may have been parental concern before this 
presentation, such as with j itteriness, poo r feeding, crying / irritabil ity, or 
sleepiness, but chi ldren with PAIS are not typically encephalopathic. Case 
reports do describe large PAIS associated with raised intracranial pressure and 
coning, but these are exceptional cases and most neurological ex aminations in 
babies with PAIS are normal. The patency of the sutures and fontanelles in the 
neonatal skull  a llows for brain swell ing not possible to survive without surgical 
intervention in the adult/fused cranium.  
Prior to the diagnosis being made, it  i s usual to consider and treat for other 
aetiologies of neonatal seizures, such as sepsis / meningo -encephalit is,  inborn 
errors of metabolism or congenital structural brain abnormalit ies, but 
investigations for and treatments of these diagnoses can be stopp ed when PAIS 
is diagnosed, and infection ruled out. It  may be worth exploring placental 
histology to look for abnormalit ies l ike fetal thrombotic vasculopathy, but most 
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neonates are well  at birth and do not need resuscitation, so the placenta may 
have been disposed of by the time the PAIS becomes manifest. 
Echocardiography may be considered in the early post ictal phase.  
 
NEUROIMAGING 
Cranial ultrasound is  available quickly on most neonatal units.  Cowan et al 
demonstrated in 2005 that cranial ultrasound in e xperienced hands shows 
abnormalit ies in up to 68% of neonates with PAIS, and the diagnostic rate 
increases to 84% if  the neonates is imaged after day 4. Neonates with PAIS and 
normal cranial ultrasound imaging (CrUS) tended to have small infarcts, or 
strokes affect ing the posterior cerebral artery territories. Unfortunately, not 
everyone has such a wealth of cranial ultrasound experience avai lable in their 
unit,  and other studies have suggested only 30% of neonates with PAIS have 
abnormalit ies on CrUS. Eith er way, when the child is acutely unwell cranial 
ultrasound imaging should be performed to look for evidence for stroke and to 
rule out other differential diagnoses, such as intraventricular haemorrhage or 
structural brain abnormalit ies. CrUS should not re place Magnetic Resonance 
Imaging (MRI) of the brain, which has better diagnostic rates and shows the 
extent of the stroke more clearly.  
 
MRI of the brain involves using different MRI sequences (e.g.  T1, T2, Proton 
density (PD), gradient echo T2*, SWI and DWI), each of which have their own 
benefits, in analysing the appearances of  the brain in different planes. The 
standard T2-weighted imaging will  usually show abnormalit ies in the 
distribution of the PAIS, including high signal in the white matter, cortex and 
the basal ganglia / thalami. A loss of grey / white matter differentiation may 
also be seen in the cortex and/or basal ganglia (f igure 3). Diffusion weighted 
MRI (DWI) looks at the abil ity of extracel lular water molecules to diffuse within 
tissues. In areas of infarction, the extracellular water molecule diffusion is 
reduced (or restr icted), which is easily highlighted as brightness on b700 DWI 
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images and as dark regions on the corresponding “apparent diffusion 
coefficient” or “ADC” maps, shown in f igur e 3. DWI changes are evident early 
on and may be easier to see than on conventional MRI but then begin to 
normalise (disappear) on the ADC map 5 -7 days after the ictus. T2 images are 
useful to detect PAIS but may over -estimate the area of the brain affecte d by 
the stroke. Areas of restricted diffusion (high b700 DWI and low ADC value) are 
more l ikely to represent the true/permanent infarct.  
MRI can visual ise blood vessels within the brain util is ing standard T2 and PD 
imaging, and also with Magnetic Resonanc e Angiography (MRA) and Magnetic 
Resonance Venography (MRV). MRA and MRV can be performed with techniques 
which depend on the f low of blood (time -of-f l ight and phase contrast) or with 
the use of gadolinium (the MRI contrast agent). The f low dependent seque nces 
can be prone to artefact, especially in neonates due to slower f low rates than 
in other children, and correlation with standard imaging is required. It  is not 
necessary to perform MRA and/or MRV in all  cases of neonatal PAIS. In the vast 
majority of cases angiographic imaging will  be normal. The radiologist should 
review the imaging and suggest when angiographic sequences may be helpful . It  
may be worth discussing the use of MRA or MRV with your neuroradiologists in 
complex cases with unusual symptoms,  extensive stroke, or where the PAIS 




Figure 9.7.3 Magnetic resonance imaging in the axial plane of Perinatal Arterial Ischaemic Stroke (PAIS) in the middle cerebral artery territorie. Left 
column T1-weighted, middle column T2-weighted, and right column diffusion weighted sequences. Row a – PAIS affecting the territory of the main branch 
of the left middle cerebral artery. Images show loss of grey white matter differentiation on T1w and T2w sequences with restricted diffusion on DWI. Row 
b – imaging performed outside the neonatal period demonstrates maturation of the PAIS from row a. Row c – imaging demonstrates a right head of 
caudate nucleus acute infarct with restricted diffusion 





The management of a neonate with PAIS is supportive. Often antibiotics and 
antivirals will  have been started, which can be stopped when the diagnosis is 
confirmed, and infection has been ruled out. Anti -epileptic drugs may be 
started if  the seizures are frequent or prolonged. They should be withdrawn 
quickly once seizures have settled, as these will  be “acute symptomatic” and 
will  usual ly resolve quickly. Prolonged courses over weeks or months can cause 
signif icant s ide-effects and should be avoided. EEG ma y be required for 
neonates with frequent or prolonged seizures, and can provide useful 
prognostic information, as discussed later. There is no role in  neonates for 
thrombolysis, thrombectomy, aspirin or anti -coagulation, unless an aetiology 
has been found,  such as congenital cardiac disease, or the history is complex, 
thrombosis / stroke extensive, or it  occurs towards the end of the neonatal 
period and distant from the delivery.  
 
Referrals to outpatient physiotherapy and a neurodevelopmental cl in ic should  
be made to ensure early diagnosis of developmental impairment or unilateral 
(hemiplegic) spastic cerebral palsy (CP).  
 
PROGNOSIS 
A general overview of the outcomes of children following PAIS is provided by 
Chabrier et al (2016), who followed children up to 7 years. They found:  
Cerebral palsy  
32% of children had cerebral palsy, but these were at the milder end of the 
spectrum on the Gross Motor Funct ion Classif icat ion Scale. A similar proportion 
of children had mild functional l imitations with f ine motor s ki l ls  
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Other studies support this f inding but noted that 94.7% of children with 
unilateral PAIS and 66.7% of bilateral PAIS walked independently. Not al l  of 
these had a normal gait:  79.6% and 70.0% of children with unilateral and 
bilateral PAIS respectively  walked with a normal gait. The side of the stroke or 
presence of comorbidities did not affect these results.  
 
Epilepsy  
Around 15-25% of children with PAIS develop epilepsy, and around 5% develop 
epileptic spasms.  
 
Cognitive / language and schooling  
Developmental scores were in the normal range for most children following 
PAIS  
Language scores were reduced with 49% having impaired language abil it ies 
aged 7 years. Both expressive and receptive communication skil ls were 
affected.  
Most children attended mainst ream school, although additional education 
support was required in around 28%. 8.8% of children with PAIS may need 
special school education.  
 
An interesting observation is that developmental quotients or estimations of 
cognitive abi l it ies can be normal ear ly on, but full  stage intel l igence quotients 
(IQ) lower by school age. This may be mediated through attentional, 
concentrat ion and executive functioning problems. Bosenbark et al (2017) 
noted that children with PAIS showed lower abil it ies on formal testing  of these 
skil ls,  and the deficits were worse with a larger stroke and in the presence of 




This general overview of the development of these children is useful,  but are 
there tools to predict outcome in an individual child? Fortunatel y, yes. Mercuri 
et al (1999) showed that EEG can be used to identify children at high risk. A 
child with a normal background EEG, with or without epileptiform 
abnormalit ies, is l ikely to have a good outcome. The presence of an abnormal 
EEG background with epileptiform abnormalit ies is associated with cerebral 
palsy. Interestingly, no marker of antenatal / perinatal r isk factors nor the 
neonatal neurological examination helped predict outcome.  
 
Neonatal MRI also has a role in prognost ication. Mercuri et al describe their 
experience of MRI and studied three areas of the brain: the cortex / white 
matter, the basal ganglia and the thalami, and the internal capsule. 
Involvement of any two of these areas was not associated with the 
developmental of CP, but the ri sk of CP was high where all  three areas were 
affected. It  should be remembered that the thalami are supplied by the 
posterior circulation, whilst the basal ganglia (caudate, putamen and Globus 
pall idus) are supplied by the anterior circulation. This reflec ts what is intuitive: 
the more extensive the stroke, the higher the risk of neuro -developmental 
abnormalit ies. Cl inicians should use the data cautiously: it  is sti l l  possible for a 
child with two of these areas affected on the MRI to develop neurological 
abnormalit ies, including unilateral CP. Good quality neuro -developmental 







Most paediatricians will  see perinatal arterial ischaemic stroke in the course of 
their career, and the neonatal period is a common time of l ife to have stroke 
because of the hyper -coagulable state of the pregnant woman and fetus. 
Although various risk factors are known for PAIS, the exact cause and timing is 
not. It  most commonly presents within the f irst days of birth wit h focal clonic 
seizures, although pre-existing sleepiness, feeding diff iculties or j itteriness may 
have been noted. Cranial ultrasound may be useful in experienced hands, but 
MRI is required to confirm the diagnosis and look at the extent of the stroke. 
Few investigations or treatments are needed once the diagnosis is made. Pro -
thrombotic investigations are not required as a matter of routine for simple, 
unilateral PAIS and should be reserved for unusual strokes, where thrombosis 
affects other parts of the body, or there is a strong family history. No anti -
coagulation or aspirin is needed in simple PAIS, but may be considered on 
special cases, such as congenital heart disease. Anti -epi leptic drugs should be 
used to treat recurrent or prolonged acute symptoma tic seizures and should be 
stopped before discharge.  
 
Outcome is generally good. Around 30% of children with PAIS develop cerebral 
palsy, usual ly uni lateral (hemiplegic) unless the stroke is bilateral. Nearly all  
wil l  walk independently with normal gait . Chi ldren typical ly do well cognitively, 
with developmental scores in the normal range, although a surprising number 
need additional educational support in the classroom. There is a suggestion 
that developmental abil ity and IQ falls as a chi ld gets older, which may be 
related to problems with attention, concent ration and executive function skil ls 
as the demands put on a child in the educational environment increase. 
Alternatively, social factors may be important to this late fall  in IQ. The risk of 
epilepsy is around 20%, and children with this comorbidity are m ore l ikely to 
experience cognitive, attentional and other learning diff icult ies. General ly 
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speaking, the larger the stroke, the more l ikely a child is to have cognitive / 
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9.8 Aetiological investigation in early developmental impairment – are they worth it? 
 
 
Hart AR, Sharma R, Atherton M, Alabed S,  Simpson S, Barfield S, Cohen J ,  
McGlashan N, Ravi A, Parker M and Connolly DJA  
 
 




Tony Hart, Paul Griff iths, Ruth Batty and I have published several papers on the 
investigation of children with early developmental impairment (EDI). We have 
looked at the use of MR spectroscopy in the investigation of all  chi ldren with 
EDI (Batty et al) .  We have investigated the wide range of diagnostic algorithms 
util ised in the UK for the assessment of children with EDI (Hughes et al).   
 
In this paper we have then used the information that we had gathered from 
previous studies and gone on to review the c ost effectiveness of those 
investigational algorithms (Hart, Sharma et al) .  This led to the development of 
an investigational algorithm for children with EDI that should signif icantly 
reduce the investigational cost burden to the NHS, with far fewer number s of 
children requiring MRI under general anaesthesia and also far fewer 
biochemical tests. There is a suggestion from the genetics fraternity that a full  
genome investigation will  be all  that is mandated. However,  it  is evident that 
clinically, biochemica lly and anatomically (radiologically) a genetic abnormality 




I  also believe that high quality early imaging investigat ion can not only predict 
outcome in acquired pathologies such as HIE which may  go on to produce EDI 
and/or cerebral palsy, but in future may be used to init iate early targeted 





ABSTRACT   
 
Objective:  To study the frequency a diagnosis is made in children with early 
developmental impairment  (EDI),  and the contribution made to diagnosis by 
specif ic investigations.  
Design:  Retrospective case note review  
Setting:  Community, neurodisabil ity and neurology department at a UK 
tertiary centre  
Participants:  Children referred to determine the degree and cause of EDI in 
whom a cause was not evident on init ial history and examination. Participants 
were divided into two groups: EDI and no additional features (EDI -) and EDI 
with additional features (EDI+).  
Main outcome measures:  The frequency a cause was found for the child’s 
EDI, and which tests were diagnostic.  
Results:  699 participants, 68.8% male, median age at investigation 2 years 8 
months (range 3 months –  11 years 5 months). 61 (8.7%) of participants had n o 
investigations, and children with EDI - were less l ikely to be investigated 
(2=12.5, p<0.05). A diagnosis was made in 166 children (23.7%) and was more 
frequent in EDI+ (EDI- 9.9%, EDI+ 27.3%, 2  19.0; p<0.05). Ful l  blood count, 
zinc, porphyrin, renal or  l iver function, bone profile, biotinidase, creatinine 
kinase, or lead level revealed no diagnoses. The fol lowing investigations found 
causes for EDI: MRI (23.1%), microarray (11.5%), Fragile X (0.9%), plasma amino 
acids (1.2%), urine organic acids (0.9%) and thyroid function tests (0.5%).   
Conclusions:  The majority of “screening” investigations for EDI are not 
diagnostic, highlighting an area of potential cost saving for the NHS. We 







Early developmental  impairment (EDI) occurs when a child’s developmental 
skil ls fall  two standard deviations or more below the population mean in two or 
more developmental  domains. (1, 2) 10-12% of children have a developmental 
impairment, (3, 4) and 1-3% of children have EDI. (1, 3) The causes of EDI include 
genetic, metabolic, antenatal,  endocrine and infective conditions, amongst 
others. The number of recommended investigations has increased over the last 
20 years, (1, 3, 5-16) although opinion varies on whether children with EDI are 
investigated appropriately, and the usefulness of specif ic investigat ions.(17) 
This work aims to determine the frequency an aetiology was found for EDI, and 







Children with EDI referred to community paediatrics, neuro -disabil ity or 
neurology services at Sheffield Children’s Hospital between January 2010 and 
December 2015 were identif ied by searching the clinic letter database. Children 
were included if  the referral was to assess the level of developmental 
impairment or determine cause. Children were not included if  they were 
referred for another reason, such as epilepsy management, or if  the cause was 
obvious on init ial assessment (such as trisomy 21).  
 
Clinical phenotype and investigation results  
Clinical features were noted and two groups established: EDI without additional 
features (EDI-) and EDI with additional features (EDI+). Subgroups of additional 
features were formed if  the feature was thought clinical ly relevant and affected 
at least 5 participants.  
 
Four paediatricians reviewed the results of all  investigation the participants 
had to determine the cause of their EDI. Results were categorised as:  
normal;  
abnormal but non-diagnostic (for example just outside the reference range);  
diagnostic.  
Where doubt existed about the categorisation of the investigation, the f irst 
author was the f inal arbiter. Two neuroradiologists reviewed participants’ 
neuroimaging and categorised them as:  
“normal”;  
“specif ic abnormalit ies that explained the participant’s EDI or pointed towards 
a diagnosis”;  
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“specif ic or non -specif ic abnormalit ies that did not suggest an aetiology” as per 
previous methodology (Griff iths 2011).  
A Consultant Paediatric Neuroradi ologist was the f inal arbiter on 
categorisat ion.  
 
A diagnosis was considered to be an investigation result explaining the cause of 
a child’s EDI, allowing parents to comprehend the problem and the child to 
access educational support, as per Makela et al. (18) Non-aetiological f indings 
were considered diagnostic, such as “cortical brain malforma tion”, based on 
Makela’s f indings, as were test results pointing towards a diagnosis proven on 
another investigation.  
 
Statistical analysis  
We report the frequency part icipants received the investigations recommended 
in our hospital guideline (supplementa ry table one), the frequency each test 
was diagnostic, and differences in the frequency of diagnostic investigations 
between EDI- and EDI+ groups using a chi  squared test calculated on an online 
chi squared generator. p<0.05 was assumed to be statistical ly  s ignif icant.  The 
hospital cl inical governance department approved this work and no ethical 






Participant characteristics  
715 participants were referred for assessment and aetiological invest igation of 
EDI. 16 part icipants were excluded because a diagnosis was obvious at f irst 
assessment or insuff icient clinical details  were avai lable. 481/699 (68.8%) 
participants were male, 218 (31.2%) were female. Median age at t ime of 
assessment was 2 years 8 months, (range 3months to 11years 5 months). A 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 9.8.1:  The frequency a diagnosis was achieved in participants, and the frequency investigations on our 
guidelines were normal, abnormal non-diagnostic, and diagnostic.  
 
1 Thyroid function: a) boy presented at 1yr 10mo as a placid baby with EDI most obvious in motor skills and with hypotonia. Autoimmune 
hypothyroidism diagnose and he improved with treatment although subsequently developed ASD; b) ex-preterm (29w) girl investigated at 4yr 
7mo years to a mother with learning difficulties, had general developmental impairment, especially in speech skills who improved on treatment 
but had attention and behavioural difficulties; c) girl investigated at 5yr 6mo for EDI, nystagmus with a history of maternal illicit drug use in 
pregnancy – showed improvement on treatment, but not to normal abilities. Dual diagnosis is being investigated.  
2 Plasma amino acids: a) boy investigated at 4yr 1mo with EDI and seizures whose brother had similar phenotype diagnosed with 
homocystinura; b) 4 month old boy with EDI, microcephaly, hypertonia, and poor visual function with low serum and CSF serine, diagnosed with 
serine deficiency; c) girl investigated at 2yr 11mo with EDI, brittle hair, eczema, and dysmorphia diagnosed with ethylmalonic aciduria; d) boy 
investigated at 4yr 7mo with EDI and faltering growth diagnosed with lysinuric protein intolerance; e) boy investigated at 10mo with EDI, visual 
impairment and Hypotonia noted to have low serum and CSF serine, diagnosed as serine deficiency. 
3 Urine organic acids: Ex-premature girl investigated at 8mo for EDI, acquired microcephaly, and faltering growth with raised lactate and 
glutamate, subsequently diagnosed with pyruvate dehydrogenase deficiency; see case c) and d) in the plasma amino acid results
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Investigation and diagnosis rates   
61/699 (8.7%) participants had no investigations: 23/142 (16.2%) participants 
with EDI- and 38/557 (4.1%) with EDI+ (2=12.5, p<0.05). The local guidel ine 
was followed in entirety in 45 (6.4%) participants. A diagnosis was made in 
14/142 (9.9%) children with EDI -,  and 152/557 (27.3%) with EDI+ (2  19.0; 







whom a cause 
was found (%) 
Investigations 
 








Microarray Fragile X MRI brain 
All participants with EDI and 
additional features (n=557) 





















Additional features and a family 
history of EDI / LD or 
neurological disease like 
seizures (n=115) 





















Consanguity admitted by family 
(n=26) 




























































































Hypertonia / upper motor 
neurone findings (spasticity, 
dystonia, brisk reflexes) (n=82) 












































Gait abnormalities, tremor, 
cerebellar signs or other 
movement disorders (n=49) 































































Hearing difficulties (n=27) 
 





















Cardiac disorder, including 
congenital cardiac lesions (n=24) 





















Airway problem / tracheostomy 
/ sleep apnoea (n=14) 





















Feeding / swallowing difficulties 
(n=28) 





















Hepatomegaly, abnormal liver 
function tests, splenomegaly or 
other features suggestive of 
inborn error of metabolism 
(n=12) 





















Kidney, urinary tract 
abnormalities (n=17) 





















Poor growth / failure to thrive / 
short stature (n=61) 
















0/46 (0%) 1/39 (2.6%) 2 (6.5%) 0/12 (0%) 5/44 (11.4%) 0 (0%) 14 (35.9%) 
Obesity (n=17) 
 





















Skeletal / rheumatological 
disorder (n=16) 





















Features suggestive of ASD 
(n=99) 
 





















Concerns about attention (n=14) 
 





















Antenatal concerns e.g. 
hydrops, alcohol or drug use 
(n=24) 





















Ex-preterm (but not felt to 
explain EDI) (n=59) 





















         
 
Table 9.8.2:  The frequency thyroid function, plasm amino acids, urine organic acids, microarray, karyotype, 
and MR imaging were positive subgroups of additional features 
 
 
Table 9.8.3 Local guidelines for investigations in children with early developmental impairment and costs over time frame of study 
Blood samples 
Full blood count £3 
Zinc protoporphyrin £13.79 
Renal function £12 
Liver function £12 
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Thyroid function £12 
Bone profile (calcium and phosphate) £12 
Plasma amino acids £80 
Biotinidase £52 
Creatine kinase (boys only) £12 
Lead level £15 
Chromosome (pre 2012) or microarray (post 2012) £350 




Organic acids £89 
Glycosaminoglycans (if older than three months) £104 
 
Other recommendations (not studied in this article) 
Audiology referral 
Ophthalmology referral – not mandatory, to consider if concerns 
 




Results of specific investigations  
The proportion of participants who received each invest igation on our 
guideline is shown in table 1. None of the following tests revealed a 
diagnosis: full  blood count, zinc porphyrin, renal or l iver function, bone 
profi le, biotinidase, creatinine kinase, or lead level.  
 
During our study period karyotype was replaced by CGH microarray 
screening. 430/669 (64.3%) part icipants had a microarray only, 84 (12.0%)  
 
had karyotype analysis only, 12 (1.7%) had both microarray and  karyotype 
analysis. Of the 442 participants who had microarray testing,  51 (11.5%) 
were diagnostic, and 49 (11.1%) were a non -diagnostic abnormal result,  such 
as polymorphisms or results of uncertain signif icance (supplementary table 
2).  Participants with EDI+ were more l ikely to receive microarray testing 
(65.2% versus 55.6%, 2  4.4; p<0.05) but diagnostic rates were similar 
between groups (EDI - 11.4%, EDI+ 11.6% (2  0.0; p=0.96). Table  9.8.4 
demonstrates the proportion of diagnost ic microarrays for each  additional 
feature. Participants with dysmorphia had similar diagnostic rates to 
participants with EDI+ but no dysmorphia (11.8% versus 11.5%, 2  0.2; 
p=0.66). Fragi le X was requested in 113/699 (16.2%) participants, 32 of 
whom had a family history of learning / developmental diff iculties. Fragile X 
was abnormal in one case: a 2.8 -year-old boy with EDI who had no family 
history or additional  features. A number of genetic diagnoses were made 





Diagnostic microarray results 
 
Chromosome 1p36,13 deletion (3 cases) 
Chromosome 1q21 deletion  
Chromosome 1q21 duplication  
Chromosome 2p25 deletion 
Chromosome 2p16 deletion 
Chromosome 2q deletion 
Chromosome 4q33 deletion 
Chromosome 5q23 deletion (two cases) 
Chromosome 5q from q34 to q35   
Chromosome 5 microdeletion 
Chromosome 7q11 deletion 
Chromosome 7q35 deletion 
Chromosome 7p22 duplication  
Chromosome 10 duplication with breakpoints within q22.3 and q23.31 
Chromosome 11 deletion with breakpoints q14.1 and q22.1 
Chromosome 11p15 duplication 
Chromosome 12 duplication with breakpoints q14.1 and q15 
Chromosome 13q12 deletion 
Chromosome 15q11 deletion (four cases) 
Chromosome 15q13 deletion (four cases) 
Chromosome 15q11 deletion 
Chromosome 15 microduplication (three cases) 
Chromosome 16p11 duplication (three cases) 
Chromosome 16p13 duplication  
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Chromosome 17q21 deletion 
Chromosome 17 duplication with breakpoints q11.1 and q12 
Chromosome 17q12 duplication  
Deletion of short arm of chromosome 18  
Chromosome 18q22 deletion 
Chromosome 22q11 duplication  
Chromosome 22q13 deletion  
Chromosome 22q13 deletion 
Chromosome Xq26 deletion  
Chromosome Xq24 deletion including UBE2a gene  
Chromosome 22q11 duplication 
Duplication long arm X chromosome including PLP1 gene  
Duplication of X chromosome Xq28 (2 cases) 
 
Single gene or clinical diagnoses  
 
Bardet Biedl Syndrome - 5 cases  
Neurofibramotisis type 1 - 3 cases 
SLC2A1 (GLUT1) mutation - 2 cases 
Rett Syndrome - 1 case 
Angelman syndrome - 1 case 
Kabuki syndrome - 2 cases (1 genetic, 1 clinical) 
Cornelia de Lange syndrome - 1 case 
Kleefstra syndrome - 1 case 
Creatine transport deficiency - 1 case 
RYR1 mutation – 1 case 
287 
 
ASPM microcephaly mutation - 1 case 
UBE2A mutation - 1 case 
PHGDH mutation - 1 case 
CASK1 mutation - 1 case 
COL4A1 mutation - 1 case 
SLC9A6 mutation - 1 case 
NRXN1 mutation - 1 case 
PLP1 (Pelizaeus-Merzbacher disease) - 1 case 
DGUOK (mitochondrial depletion) mutation - 1 case 
SLC7A7 mutation (lysinuric protein intolerance) - 1 case 
PDHA1 mutation (pyruvate dehydrogenase deficiency) - 1 case 
SLC6A8 mutation (creatine transport deficiency) - 1 case 
ETHE1 mutation (ethylmalonic aciduria) - 1 case 
Tetrasomy 18p - 1 case 
Sotos syndrome (clinical diagnosis) - 1 case 
Odho symdrome (clinical diagnosis) - 1 case 
Atypical ataxia telangiectasia (clinical diagnosis, gene negative) - 1 case 
Fetal alcohol syndrome - 1 case 
Table 9.8.4: Summary of genetic diagnoses made  
 
Thyroid function was diagnostic in 3 participants, all  of whom had additional 
features (table 9.8.1). Plasma amino acid screens were diagnostic in 5 
participants, and urine organic acids were diagnostic in three patients, two 
of whom had abnormal plasma am ino acids. Clinicians ordered a variety of 






Investigation Number of 
participants 
(% of total) 
Comments 
 
Blood investigations  
 
Clotting 5 Abnormal in one patient, but already known to be abnormal prior to 
referral for investigation of EDI 
Folate 8 Not diagnostic in any participant 
C Reactive 
Protein 
1 Not diagnostic in any participant 
Erythrocyte 
sedimentary rate 
4 Not diagnostic in any participant 
Glucose 58 No abnormalities 
Lactate 178 Persistently abnormal in one boy investigated at 1.4 years of age with 
dysmorphia, pulmonary stenosis, squint and hypertonia; MRS showed 
lactate peak although respiratory chain enzymes normal and no genetic 
diagnosis of mitochondrial disease made. 
Acylcarnitine 
screen 
100 Not diagnostic in any participant 
Magnesium 3 Not diagnostic in any participant 
Ammonia 67 Not diagnostic in any participant 
Homocysteine 11 Not diagnostic in any participant 
Uric acid 103 Not diagnostic in any participant 
Lipid / 
cholesterols 
40 Not diagnostic in any participant 
White cell 
enzymes 
45 Not diagnostic in any participant 
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Very long chain 
fatty acids 




46 Not diagnostic in any participant 
Galactossemia 
screen 
15 Not diagnostic in any participant 
Copper 21 Not diagnostic in any participant 
Caeruloplasmin 20 Not diagnostic in any participant 
Free T3 9 Not diagnostic in any participant 
Cortisol 12 Not diagnostic in any participant 
Vitamin A 7 Not diagnostic in any participant 
Vitamin B12 10 Not diagnostic in any participant 
Vitamin D 193 Low levels were not felt to be the aetiological cause of EDI in any 
participant 
Vitamin E 9 Not diagnostic in any participant 
Coeliac screen 40 Not diagnostic in any participant 
Amylase 5 Not diagnostic in any participant 
Parathyroid 
hormone 
48 Not diagnostic in any participant 
Immunoglobulins 42 Not diagnostic in any participant 
LDH 3 Not diagnostic in any participant 
Alpha 
fetoprotein 
5 Not diagnostic in any participant 
ANA 4 Not diagnostic in any participant 
Rheumatoid 
factor 











150 Not diagnostic in any participant 
Urine creatinine 13 Not diagnostic in any participant 




30 Often done after a marginally low uric acid, normal in all participants 
 




58 Lactate raised in one boy investigated at 1.4 years of age with 
dysmorphia, pulmonary stenosis, squint and hypertonia; MRS showed 
lactate peak although respiratory chain enzymes normal and no genetic 
diagnosis of mitochondrial disease made. 
 
Glucose low in two patients: a boy investigated at 1.7years with EDI, 
Hypotonia, seizures and paroxysmal upgaze when fasted; a girl 
investigated at 1.9years with EDI, left hemiplegia and seizures. Both 
confirmed to have mutations in Glut 1 deficiency syndrome gene 
CSF amino acids 19 Diagnostic in two cases: a boy, investigated at 4 months of age for 
developmental impairment, poor visual function, evolving dystonia and 
microcephaly diagnosed with serine deficiency; a boy investigated at 
0.8 years for developmental impairment, poor visual function and 
microcephaly whose plasma amino acids revealed low serine, 






32 Not diagnostic in any participant 





Skeletal survey 2 Not diagnostic in any participant 
Muscle biopsy 9 Not diagnostic in any participant 
Fibroblast 
culture 
2 Sent for variety of tests - Not diagnostic in any participant 
Table 9.8.5: Number of participants receiving additional investigations   
 
Neuroimaging 
MR imaging was performed in 368/699 (55%) participants. Chi ldren with 
EDI+ were more l ikely to receive neuroimaging compared to EDI - (additional 
features 60.7% versus 21.1% for no additional features, 2  71.0; p<0.05). 
MRI was diagnostic in 86 (23.3%) participants: 82/338 (24.3%) participants 
with EDI+ and 4/30 (13.3%) EDI - (2  1.8; p=0.18). Table 9.8.6 shows the 




MR abnormalities All participants EDI and no additional 
features 
EDI and additional 
features 
 




Hypoxic ischaemic injury: 
 
Periventricular leukomalacia 













18 0 17 
Brain malformation 
 
37 2 35 
Phakomatoses / tumours 
 
3 1 2 
Previous infection 
 




3 0 3 
Totals 
 
85 4 81 
 
Specific or non-specific abnormalities not likely to explain EDI 
 
Posterior fossa abnormalities, 
such as Chiari malformation 
6 1 5 




Under-opercularisation of the 
Sylvian fissure 
 
0 0 0 
Reduced volume of white 
matter / grey matter 
20  2 18 
Delayed myelination 
 
12 0 12 
Non-specific white matter 
abnormality or focal gliosis 
30 2 28 
Arachnoid cyst 
 
2 0 2 
Optic nerve hypoplasia without 





Subdural collection / effusion 
 
0 0 0 
Non-specific MRS 
abnormalities 
1 1 1 
Total 75 6 69 






Why investigate for the cause of EDI?  
The reasons why families wish to know the aetiology include: (18)  
Validation, i .e. proof  of a credi ble problem and to help explain the problem 
to the affected child or siblings and others  
To provide prognostic information and help set real istic expectations / plans  
For any potential treatment  
To allows better access to educational support  
To provide the opportunity for early intervention   
To provide support opportunities  
The “need to know”  
For prenatal test ing and recurrence risk  
Not all  diagnoses are equally effective at enabling access to educational 
support, despite children having similar levels of  disabi l ity. Descriptive 
diagnoses could be equally, if  not more, effective as aetiological diagnoses.    
 
Investigating the cause of EDI  
There is l itt le agreement on the best way to investigate a chi ld with EDI, 
with wide variation in opinion existing bet ween UK paediatricians. (17) Over 
the years, the number of recommended investigations for EDI has 
increased,(1, 3, 5-16) although the evidence base for this is lacking.  
 
A cause for EDI was found in 23.7% of our participants, and many of the f irst 





Biotinidase levels are a recent addition to published guidel ines, (3, 12) and 
the features of biotinidase deficiency include seizures, hypotonia, laryngeal 
stridor, tachypnoea, apnoea, alopecia, skin rash, hearing loss, optic atrophy 
or conjunct ivit is,  ataxia, fungal infection and recurrent myelopathy (19-23) 
Additional clues include abnormal organic acid results or 
hyperammonaemia. (19) It  is not clear that biotindiase deficiency presents 
with EDI-.(24) Recommendations that 3500 children need to be tested to 
diagnose one case, and the suggestion that this is cost effective, (25) are not 
based on high quality evidence. Furthermore, the incidence of biotinidase 
deficiency on newborn screening suggests pick up rates would be much 
lower.(19) Our view is that serum biot inidase  should not be a f irst l ine 
investigation, and only performed in children with suggest ive features.  
 
High blood lead levels are associated with learning / developmental and 
mental health issues that can persist into adulthood, (26, 27) and low levels 
of blood lead (5-10µg/dl) are associated with reading and writing 
diff iculties. (28) However, it  is unlikely that a modern chi l d would have 
moderate or severe EDI because of extremely high lead levels alone, 
particularly since the proportion of children with high lead levels has fallen 
markedly to 0.8% in the US. (29, 30) Therefore, routine lead levels appear to 
be unnecessary.  
 
Creatinine kinase is recommended in boys with EDI to facil itate early 
diagnosis of Duchenne Muscular Dystrophy (DMD), (3, 12) ensure treatment 
with steroids and / or newer drugs, and for entry into research studies. No 
child in our study had DMD, and a CK was not indicated routinely in the 101 
girls who had it.  Nevertheless, a CK is ch eap and there remain good reasons 




Investigations l ikely to determine the cause of EDI  
The investigations that revealed a diagnosis in our cohort were:  
thyroid function  
plasma amino acids  
urine organic acids  
microarray / karyotype 
Fragi le X  
MR imaging.  
 
Congenital hypothyroidism is usually diagnosed on newborn screening in the 
UK, unless it  ar ises from pituitary failure. Autoimmune hypothyroidism will  
also be missed, as noted in our cohort. The cost of each test is low (£12). 
Given 469 part icipants were tested and 3 were positive for this diagnosis, 
two of whom showed improvement on treatment, the cost per diagnosis in 
our cohort was £1876, which appears cost effective given the subsequent 
impact on treatment  and outcome.  
 
Plasma amino acids were diagnostic in 1.2% of our participants, all  of whom 
had EDI+. Organic acids were abnormal in  0.9%, two of whom had abnormal 
plasma amino acids. Other metabolic investigations were performed in our 
cohort, outside of the guideline, but were rarely diagnostic. The diagnosis 
rates in previous studies vary, reflecting the cohort’s characteristics, the 
investigations performed, whether newborn screening was available, and 
whether adults in mental institutions born before ne wborn screening were 
included. Because our participants with a positive result had EDI+, we do not 
recommend metabolic tests in EDI - . In children with EDI+, metabolic tests 
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should be f irst l ine where concern exists about an inborn error of 
metabolism.(3) Where no such concern exists, t hey should be second line or 
performed if  the presentation changes or other results point towards these 
conditions.  
 
Microarray found a diagnosis in over 10% of our cases, with similar 
frequencies between EDI- and EDI+. Therefore, we advocate microarray 
testing in al l  chi ldren with EDI. Fragile X testing is recommended in our 
guideline for all  children who have a family history of EDI / learning 
diff iculties, but this was rarely fol lowed. Ironically, the affected child had no 
additional cl inical features or  family history. We recommend Fragi le X 
testing as second line if  the microarray is  normal in children with a family 
history of learning diff iculties and / or dysmorphic features. Cases that are 
not tested should be evaluated over t ime, and Fragile X reque sted if  the 
child develops features consistent with the diagnosis. Where no diagnosis is 
found after init ial investigations in children with EDI+ or a relevant family 
history, referral to a clinical geneticist should be considered. We await 
further data from gene exome studies on their usefulness when a microarray 
is negative.   
 
The role of MRI in EDI is controversial,  particularly as sedation or general 
anaesthetic is required for those who cannot l ie sti l l .  Consensus statements 
in 1997 and 2003 recommended MRI only in children with EDI and additional 
symptoms, based on a belief that children with EDI and no additional 
symptoms were unlikely to have structural brain abnormalit ies. (1, 5) There 
was a paucity of data to support this view. Our previous analysis between 
1998 - 2006 showed 22.2% of participants with EDI - and 27.6% with EDI+ had 
specif ic abnormalit ies, but methodological f laws existed with this data. (31) 
A prospective study between 2007 -2008 the rates of specif ic abnormalit ies  
were 7.5% for EDI- and 28% (21/75) for EDI+. (32) Our current data shows 
298 
 
that MR imaging has the highest diagnostic rates of any tests, with 13.3% in 
children without additional features and 24% in those with additional 
features. The lack of  a statistical difference between groups is probably a 
type 2 statist ical error.  
 
Clinically, we advocate a common -sense approach. In a child with EDI -,  MRI 
should not be a f irst l ine test because of the anaesthetic and/or sedation 
risks .  Where no diagnosis is found on first l ine laboratory test ing, MRI 
should be discussed with the  family, including the l ikelihood that no specif ic 
treatment is available for any abnormality, and the risks of general 
anaesthesia.  In those with EDI+, MRI should be f irst l ine if  a high risk of 
specif ic MRI abnormalit ies is l ikely: skeletal dysplasia (4 2.9%), signs of 
upper motor neurone involvement (39.2%), refractory or focal seizures 
(approximately 37.0%), ophthalmological  signs (35.9%), failure to thrive not 
explained by poor calorif ic input (35.9%),  antenatal concerns such as 
maternal drug use or hydrops (31.3%), feeding / swallowing diff iculties 
(30.4%), gait  or movement abnormalit ies (28.2%), central mediated 
hypotonia (27.7%), and airway problems (27.3%). In other chi ldren, MRI 
could be second line test following discussion with the parents or def erred.   
 
It  is our unit’s policy to perform MR spectroscopy in al l  chi ldren with EDI, to 
detect conditions l ike cerebral creatine deficiency. (32) We found a further 
case of creatine transporter deficiency using MRS, a chi ld with large lactate 
peak suspected to have a defect in pyruvate metabolism, and third 
participant with a non-specif ic reduction in choline levels. Because MRS 
adds around 8 minutes to acquisit ion times, and creatine deficiencies are 





Limitations with our data  
As with previous retrospective data on the investigation of children with 
EDI, (31) our data has many methodological f laws. We relied upon the 
documentation in medical notes and cl inic letters to phenotype our 
participants, and it  is possible that features may have been missed by 
clinicians or not documented. Many recommended invest igations were not 
performed in all  participants and we do not know why clinicians ordered 
specif ic additional tests. Final ly, because data results from review in busy 
clinics, we have no formal developmental assessment to confi rm the 
diagnosis, assess severity, or domains affected.   
 
New recommendation on how to investigate EDI  
There is a pervasive view amongst paediatricians that it  is kinder to perform 
all  necessary investigations in one go, but our results show this to be a 
wasteful approach. Cost savings could be redirected to other areas of care, 
such as therapy or psycholog y. We propose a diagnostic algorithm in f igure 1 
based on our data. Guidelines cannot cover every clinical eventuality and 
should not stop clinicians ordering additional investigat ions where a high 





F ig u r e  9 . 8 . 1  P ro p o s ed  d ia g n o s t i c  a lg o r i th m  f o r  i n v es t ig a t i o n  o f  E D I  
 
CONCLUSIONS  
Many investigat ions recommended as “first l ine” to determine a cause of EDI 
are rarely diagnosti c and can be safely deferred without missing diagnoses. 
This has cost saving implications to the NHS. We recommend a streamlined 
guideline based on our results. A paucity of evidence exists on the best way 
to investigate EDI. Previous work and recommendati ons are based on 
retrospect ive studies with poor participant phenotyping and inconsistent 
choice of investigations. A prospective study is needed to evaluate the 
optimal and most cost -efficient way to investigate chi ldren with EDI 
301 
 
according to the degree of their EDI, the domains affected, and the 
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